
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Genes (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Genes (Basel)</journal-id><journal-id journal-id-type="publisher-id">genes</journal-id><journal-title-group><journal-title>Genes</journal-title></journal-title-group><issn pub-type="epub">2073-4425</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">32854217</article-id><article-id pub-id-type="pmc">7565831</article-id><article-id pub-id-type="doi">10.3390/genes11090989</article-id><article-id pub-id-type="publisher-id">genes-11-00989</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Regulation of mTORC1 by Upstream Stimuli</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3977-9886</contrib-id><name><surname>Melick</surname><given-names>Chase H.</given-names></name><xref ref-type="aff" rid="af1-genes-11-00989">1</xref><xref ref-type="aff" rid="af2-genes-11-00989">2</xref><xref ref-type="aff" rid="af3-genes-11-00989">3</xref></contrib><contrib contrib-type="author"><name><surname>Jewell</surname><given-names>Jenna L.</given-names></name><xref ref-type="aff" rid="af1-genes-11-00989">1</xref><xref ref-type="aff" rid="af2-genes-11-00989">2</xref><xref ref-type="aff" rid="af3-genes-11-00989">3</xref><xref rid="c1-genes-11-00989" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-genes-11-00989"><label>1</label>Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; <email>chase.melick@utsouthwestern.edu</email></aff><aff id="af2-genes-11-00989"><label>2</label>Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA</aff><aff id="af3-genes-11-00989"><label>3</label>Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA</aff><author-notes><corresp id="c1-genes-11-00989"><label>*</label>Correspondence: <email>Jenna.Jewell@UTSouthwestern.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>25</day><month>8</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2020</year></pub-date><volume>11</volume><issue>9</issue><elocation-id>989</elocation-id><history><date date-type="received"><day>30</day><month>7</month><year>2020</year></date><date date-type="accepted"><day>23</day><month>8</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 by the authors.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>The mammalian target of rapamycin (mTOR) is an evolutionary conserved Ser/Thr protein kinase that senses multiple upstream stimuli to control cell growth, metabolism, and autophagy. mTOR is the catalytic subunit of mTOR complex 1 (mTORC1). A significant amount of research has uncovered the signaling pathways regulated by mTORC1, and the involvement of these signaling cascades in human diseases like cancer, diabetes, and ageing. Here, we review advances in mTORC1 regulation by upstream stimuli. We specifically focus on how growth factors, amino acids, G-protein coupled receptors (GPCRs), phosphorylation, and small GTPases regulate mTORC1 activity and signaling.</p></abstract><kwd-group><kwd>mTORC1</kwd><kwd>amino acids</kwd><kwd>G-protein coupled receptors</kwd><kwd>small GTPases</kwd><kwd>kinases</kwd><kwd>phosphorylation</kwd><kwd>cell growth</kwd><kwd>metabolism</kwd><kwd>and autophagy</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-genes-11-00989"><title>1. Introduction</title><p>In 1964, a scientific expedition ventured to Rapa Nui (also known as Easter Island) to collect soil and plants samples [<xref rid="B1-genes-11-00989" ref-type="bibr">1</xref>,<xref rid="B2-genes-11-00989" ref-type="bibr">2</xref>,<xref rid="B3-genes-11-00989" ref-type="bibr">3</xref>]. These samples were brought back to Canada, and rapamycin was isolated from the bacterium Streptomyces hygroscopicus in 1972. Initially, rapamycin was characterized as an antifungal agent, and further studies identified rapamycin to be an immunosuppressant. The ability of rapamycin to inhibit cell growth was discovered later. Experiments demonstrated that rapamycin formed a complex with peptidyl-prolyl cis-trans isomerase FK506-binding protein 12 (FKBP12) [<xref rid="B4-genes-11-00989" ref-type="bibr">4</xref>]. Through genetic screens, the target of rapamycin (TOR) was first discovered in yeast, where mutations in TOR were resistant to rapamycin [<xref rid="B5-genes-11-00989" ref-type="bibr">5</xref>,<xref rid="B6-genes-11-00989" ref-type="bibr">6</xref>,<xref rid="B7-genes-11-00989" ref-type="bibr">7</xref>]. Biochemical experiments in mammalian cells revealed that the rapamycin-FKBP12 complex specifically targets and inhibits the mammalian target of rapamycin (mTOR) [<xref rid="B8-genes-11-00989" ref-type="bibr">8</xref>,<xref rid="B9-genes-11-00989" ref-type="bibr">9</xref>,<xref rid="B10-genes-11-00989" ref-type="bibr">10</xref>]. Through affinity purification, the FKBP12-rapamycin complex was shown to bind a large molecular weight protein called mTOR (also referred to FRAP, RAFT1). Currently, rapamycin and rapamycin analogs (rapalogs) are commonly used as cancer and transplant therapeutics. Decades later, the precise mechanism of how mTOR is regulated is still being elucidated. mTOR coordinates multiple physiological processes through downstream signaling networks. In this review, we discuss the progress made in the understanding mTOR, specifically mTOR complex 1 (mTORC1) regulation by upstream stimuli.</p></sec><sec id="sec2-genes-11-00989"><title>2. mTOR</title><p>mTOR is an evolutionarily conserved Ser/Thr protein kinase that is classified in the phosphatidylinositide 3 kinase (PI3K)-related kinase family within the human phylogenetic kinome tree. mTOR functions as the catalytic subunit of two distinct complexes, referred to as mTORC1 and mTORC2. Rapamycin and rapalogs inhibit mTORC1 activity allosterically, while mTORC2 demonstrates short-term rapamycin insensitivity [<xref rid="B11-genes-11-00989" ref-type="bibr">11</xref>,<xref rid="B12-genes-11-00989" ref-type="bibr">12</xref>,<xref rid="B13-genes-11-00989" ref-type="bibr">13</xref>]. The rapamycin-FKBP12 complex binds to the FKBP12-rapamycin-binding (FRB) domain on mTOR reducing availability of the catalytic cleft, resulting in some substrates unable to access the active site. Prolonged treatment of rapamycin is thought to inhibit mTORC2 through the sequestration of mTOR in some cell types [<xref rid="B14-genes-11-00989" ref-type="bibr">14</xref>,<xref rid="B15-genes-11-00989" ref-type="bibr">15</xref>]. ATP-competitive inhibitors like Torin1 have also been developed, which directly target the catalytic site and inhibit the kinase activity of mTOR [<xref rid="B16-genes-11-00989" ref-type="bibr">16</xref>].</p></sec><sec id="sec3-genes-11-00989"><title>3. mTORC1</title><p>mTORC1 consists of three main core components: mTOR, regulatory protein associated with mTOR (Raptor) and mammalian lethal with Sec13 protein 8 (mLST8, also referred to as G&#x003b2;L) (<xref ref-type="fig" rid="genes-11-00989-f001">Figure 1</xref>, Left) [<xref rid="B17-genes-11-00989" ref-type="bibr">17</xref>,<xref rid="B18-genes-11-00989" ref-type="bibr">18</xref>,<xref rid="B19-genes-11-00989" ref-type="bibr">19</xref>]. Raptor acts as a substrate recognizing subunit that facilitates mTOR phosphorylation through the TOR signaling (TOS) motif found in some mTORC1 substrates [<xref rid="B20-genes-11-00989" ref-type="bibr">20</xref>,<xref rid="B21-genes-11-00989" ref-type="bibr">21</xref>]. Mutations in the TOS motif were shown to render mTORC1 downstream targets, such as the phosphorylation of p70 ribosomal S6 kinase 1 (S6K1) and eIF4E-binding protein 1 (4EBP1, also known as PHAS-1), insensitive to amino acid changes [<xref rid="B22-genes-11-00989" ref-type="bibr">22</xref>]. mLST8 is a positive regulator of mTORC1, stabilizing the association between Raptor and mTOR, and stimulating mTOR kinase activity [<xref rid="B19-genes-11-00989" ref-type="bibr">19</xref>]. mTORC1 contains two additional negative regulators, Proline-rich Akt substrate 40 kDa (PRAS40) [<xref rid="B23-genes-11-00989" ref-type="bibr">23</xref>,<xref rid="B24-genes-11-00989" ref-type="bibr">24</xref>,<xref rid="B25-genes-11-00989" ref-type="bibr">25</xref>] and DEP-domain-containing mTOR-interacting protein (DEPTOR) [<xref rid="B26-genes-11-00989" ref-type="bibr">26</xref>]. PRAS40 acts as a direct inhibitor of substrate binding through the interaction with Raptor, repressing mTORC1 activity [<xref rid="B24-genes-11-00989" ref-type="bibr">24</xref>]. PRAS40 phosphorylation by mTORC1 relieves the negative regulation, increasing mTORC1 signaling [<xref rid="B27-genes-11-00989" ref-type="bibr">27</xref>]. The postsynaptic density 95, discs large, zonula occludens-1 (PDZ) domain of DEPTOR directly interacts with mTOR to inhibit activity [<xref rid="B26-genes-11-00989" ref-type="bibr">26</xref>]. Additionally, mTOR has been shown to promote its own activity via the E3 ubiquitin ligase Skp1, Cullin1, F-box (SCF) adaptor, &#x003b2;TrCP, mediated degradation of DEPTOR [<xref rid="B28-genes-11-00989" ref-type="bibr">28</xref>,<xref rid="B29-genes-11-00989" ref-type="bibr">29</xref>,<xref rid="B30-genes-11-00989" ref-type="bibr">30</xref>].</p><p>When localized to the lysosome, mTORC1 directly interacts with and is activated by the small GTPase Ras homolog enriched in brain (Rheb) [<xref rid="B24-genes-11-00989" ref-type="bibr">24</xref>,<xref rid="B31-genes-11-00989" ref-type="bibr">31</xref>]. However, some mTORC1 mediated process, such as protein translation, presumably occur in the cytoplasm [<xref rid="B32-genes-11-00989" ref-type="bibr">32</xref>]. Additionally, mTORC1 has been observed in other subcellular locations such as the mitochondria [<xref rid="B33-genes-11-00989" ref-type="bibr">33</xref>], stress granules [<xref rid="B34-genes-11-00989" ref-type="bibr">34</xref>], and at the plasma membrane [<xref rid="B35-genes-11-00989" ref-type="bibr">35</xref>]. mTORC1 components have also been reported at multiple locations within the cell [<xref rid="B36-genes-11-00989" ref-type="bibr">36</xref>]. For example, mTOR and Raptor were detected in the nucleus [<xref rid="B37-genes-11-00989" ref-type="bibr">37</xref>]. A more complete discussion of this topic has been reviewed previously [<xref rid="B36-genes-11-00989" ref-type="bibr">36</xref>].</p><p>mTORC1 regulates a multitude of cellular processes, such as protein translation, autophagy, lysosome biogenesis, lipid synthesis, and growth factor signaling [<xref rid="B38-genes-11-00989" ref-type="bibr">38</xref>]. mTORC1 regulates translation via the phosphorylation of S6K1 at Thr 389 to activate S6K1 [<xref rid="B17-genes-11-00989" ref-type="bibr">17</xref>]. S6K1 then proceeds to promote translation initiation through the subsequent phosphorylation of factors such as eukaryotic translation initiation factor 4B (eIF4B) [<xref rid="B39-genes-11-00989" ref-type="bibr">39</xref>]. Additionally, mTORC1 phosphorylates 4EBP1 at multiple sites (Thr 37, Thr 46, Ser 65, Thr 70) to promote translation [<xref rid="B40-genes-11-00989" ref-type="bibr">40</xref>]. Once 4EBP1 is phosphorylated it dissociates from eIF4E, which allows the recruitment of the other translation initiation proteins eIF4G and eIF4A [<xref rid="B41-genes-11-00989" ref-type="bibr">41</xref>]. mTORC1 disrupts Unc-51 like autophagy activating kinase 1 (ULK1) interaction with 5&#x02032;AMP-activated protein kinase (AMPK) through the phosphorylation of Ser 757 (equivalent to Ser 758 in human) on ULK1, to regulate autophagy [<xref rid="B42-genes-11-00989" ref-type="bibr">42</xref>]. Sterol-responsive element-binding protein (SREBP) promotes de novo lipid synthesis [<xref rid="B43-genes-11-00989" ref-type="bibr">43</xref>]. mTORC1 positively regulates SREBP through the phosphorylation and activation of S6K1 or through the multiple site phosphorylation and inhibition of Lipin1, another mTORC1 substrate [<xref rid="B43-genes-11-00989" ref-type="bibr">43</xref>,<xref rid="B44-genes-11-00989" ref-type="bibr">44</xref>,<xref rid="B45-genes-11-00989" ref-type="bibr">45</xref>]. mTORC1 negatively regulates transcription factor EB (TFEB), which promotes genes for lysosomal biogenesis and autophagy machinery at Ser 142 and Ser 211, preventing TFEB nuclear translocation [<xref rid="B46-genes-11-00989" ref-type="bibr">46</xref>,<xref rid="B47-genes-11-00989" ref-type="bibr">47</xref>,<xref rid="B48-genes-11-00989" ref-type="bibr">48</xref>]. Phosphorylation of growth factor receptor-bound protein 10 (Grb10) by mTORC1 at Ser 501 and Ser 503 negatively regulates growth factor signaling through IGF-1 receptor [<xref rid="B49-genes-11-00989" ref-type="bibr">49</xref>,<xref rid="B50-genes-11-00989" ref-type="bibr">50</xref>]. A more comprehensive review of mTORC1 substrates and downstream signaling pathways controlled by mTORC1 is elsewhere [<xref rid="B38-genes-11-00989" ref-type="bibr">38</xref>,<xref rid="B39-genes-11-00989" ref-type="bibr">39</xref>,<xref rid="B51-genes-11-00989" ref-type="bibr">51</xref>].</p></sec><sec id="sec4-genes-11-00989"><title>4. mTORC2</title><p>Similar to mTORC1, mTORC2 consists mTOR and mLST8. However, mTORC2 contains rapamycin insensitive companion of mTOR (Rictor) as the substrate recognizing component (<xref ref-type="fig" rid="genes-11-00989-f001">Figure 1</xref>, Right) [<xref rid="B12-genes-11-00989" ref-type="bibr">12</xref>,<xref rid="B13-genes-11-00989" ref-type="bibr">13</xref>]. Additionally, mTORC2 is comprised of the negative regulator DEPTOR. mTORC2 contains mammalian stress-activated MAPK-interacting protein 1 (mSin1) [<xref rid="B52-genes-11-00989" ref-type="bibr">52</xref>,<xref rid="B53-genes-11-00989" ref-type="bibr">53</xref>,<xref rid="B54-genes-11-00989" ref-type="bibr">54</xref>], which is necessary for the assembly of mTORC2 on the plasma membrane [<xref rid="B55-genes-11-00989" ref-type="bibr">55</xref>]. Activation of mTORC2 depends on the pleckstrin homology (PH) domain of mSin1 that binds to phosphatidylinositol 3,4,5-triphosphate (PtdIns(3,4,5)P3, also referred to as PIP3) at the plasma membrane [<xref rid="B56-genes-11-00989" ref-type="bibr">56</xref>]. Lastly, mTORC2 consists of protein observed with Rictor 1/2 (Protor1/2, also known as PRR5) [<xref rid="B57-genes-11-00989" ref-type="bibr">57</xref>].</p><p>mTORC2 has been observed in multiple locations throughout the cell. Using a reporter of endogenous mTORC2 activity, a study showed mTORC2 associates with the plasma membrane, mitochondria, and on endosomal vesicles [<xref rid="B58-genes-11-00989" ref-type="bibr">58</xref>]. mTORC2 has also been reported to localize to the endoplasmic reticulum (ER) and ER associated membranes, such as mitochondria-associated ER membranes (MAMs) [<xref rid="B36-genes-11-00989" ref-type="bibr">36</xref>]. mTORC2 can regulate MAM integrity through the mTORC2 substrate Rac-&#x003b1; Ser/Thr-protein kinase (Akt, also known as PKB) [<xref rid="B59-genes-11-00989" ref-type="bibr">59</xref>]. Lastly, evidence showed mTORC2 may shuttle to the nucleus, however the function of mTORC2 in the nucleus remains unknown [<xref rid="B37-genes-11-00989" ref-type="bibr">37</xref>].</p><p>mTORC2 regulates physiological processes through the phosphorylation and activation of downstream substrates like the protein kinase A, G and C (AGC) family. Protein kinase C &#x003b1; (PKC&#x003b1;) at Ser 657 was the first identified substrate of mTORC2 [<xref rid="B13-genes-11-00989" ref-type="bibr">13</xref>]. Other PKC family members have been shown to be phosphorylated and activated by mTORC2, including PKC&#x003b4;, PKC&#x003be; (Thr 560), PKC&#x003b3;, and PKC&#x003b5; to regulate cytoskeletal remodeling and cell migration [<xref rid="B60-genes-11-00989" ref-type="bibr">60</xref>,<xref rid="B61-genes-11-00989" ref-type="bibr">61</xref>,<xref rid="B62-genes-11-00989" ref-type="bibr">62</xref>]. mTORC2 phosphorylates Akt on Ser 473 to promote cell survival, proliferation and growth [<xref rid="B63-genes-11-00989" ref-type="bibr">63</xref>]. Akt mediates these processes through the subsequent phosphorylation of substrates such as Forkhead box O1/3 (FoxO1/3a) at Thr 32 and Ser 253, glycogen synthase kinase 3 &#x003b2; (GSK3-&#x003b2;) at Ser 9, and tuberous sclerosis complex 2 (TSC2) at Ser 939 and Thr 1462 [<xref rid="B54-genes-11-00989" ref-type="bibr">54</xref>,<xref rid="B64-genes-11-00989" ref-type="bibr">64</xref>,<xref rid="B65-genes-11-00989" ref-type="bibr">65</xref>,<xref rid="B66-genes-11-00989" ref-type="bibr">66</xref>]. Lastly, through the phosphorylation of serum/glucocorticoid-regulated kinase 1 (SGK1) at Ser 422, mTORC2 controls processes like ion transport and cell growth [<xref rid="B67-genes-11-00989" ref-type="bibr">67</xref>]. mTORC2 will not be discussed further in this review, and mTORC2 has been reviewed elsewhere [<xref rid="B38-genes-11-00989" ref-type="bibr">38</xref>,<xref rid="B51-genes-11-00989" ref-type="bibr">51</xref>,<xref rid="B68-genes-11-00989" ref-type="bibr">68</xref>].</p></sec><sec id="sec5-genes-11-00989"><title>5. Upstream Signaling to mTORC1</title><p>mTORC1 activation is controlled by growth factors, nutrients, energy status, and stress (<xref ref-type="fig" rid="genes-11-00989-f002">Figure 2</xref>). Growth factor signaling regulates the tuberous sclerosis complex (TSC) [<xref rid="B38-genes-11-00989" ref-type="bibr">38</xref>]. Hamartin (TSC1), tuberin (TSC2), and Tre2-Bub2-cdc16 (TBC)1 domain family, member 7 (TBC1D7) comprise TSC [<xref rid="B69-genes-11-00989" ref-type="bibr">69</xref>]. TSC represses Rheb through its GTPase activating protein (GAP) activity, converting Rheb-guanosine triphosphate (GTP) to Rheb-guanosine diphosphate (GDP) [<xref rid="B70-genes-11-00989" ref-type="bibr">70</xref>,<xref rid="B71-genes-11-00989" ref-type="bibr">71</xref>]. Under TSC inhibition, Rheb is GTP bound, allowing binding and allosteric activation of mTORC1 through a conformational change [<xref rid="B31-genes-11-00989" ref-type="bibr">31</xref>,<xref rid="B72-genes-11-00989" ref-type="bibr">72</xref>]. Multiple upstream signals converge on TSC to regulate mTORC1 activity. For example, Akt [<xref rid="B73-genes-11-00989" ref-type="bibr">73</xref>], extracellular signal-regulated kinase (ERK) [<xref rid="B74-genes-11-00989" ref-type="bibr">74</xref>], p90 ribosomal S6 kinase 1 (RSK1) [<xref rid="B75-genes-11-00989" ref-type="bibr">75</xref>], I&#x003ba;B kinase &#x003b2; (IKK&#x003b2;) [<xref rid="B76-genes-11-00989" ref-type="bibr">76</xref>], and MAPKAPK2 (MK2) [<xref rid="B77-genes-11-00989" ref-type="bibr">77</xref>] can phosphorylate and inhibit TSC2 [<xref rid="B78-genes-11-00989" ref-type="bibr">78</xref>] to activate mTORC1. Additionally, Wnt signaling can inhibit GSK3 phosphorylation of TSC2 to stimulate mTOR signaling. Other stimuli such as inflammation, hypoxia, low energy status, and DNA damage positively regulate the TSC complex to inhibit mTORC1 activity. Human diseases such as TSC and Lymphangioleiomyomatosis (LAM) result from mutations in the genes encoding TSC components, leaving mTORC1 in a constitutively active state [<xref rid="B79-genes-11-00989" ref-type="bibr">79</xref>,<xref rid="B80-genes-11-00989" ref-type="bibr">80</xref>]. TSC signaling represents an important signaling cascade that regulates mTORC1.</p><p>Low energy levels during glucose deprivation activate AMPK [<xref rid="B81-genes-11-00989" ref-type="bibr">81</xref>,<xref rid="B82-genes-11-00989" ref-type="bibr">82</xref>,<xref rid="B83-genes-11-00989" ref-type="bibr">83</xref>] through the phosphorylation of liver kinase B1 (LKB1) [<xref rid="B84-genes-11-00989" ref-type="bibr">84</xref>]. AMPK directly phosphorylates TSC2, increasing TSC2 GAP function [<xref rid="B85-genes-11-00989" ref-type="bibr">85</xref>]. In addition, AMPK phosphorylates mTORC1 component Raptor, increasing Raptor-14-3-3 binding and inhibiting mTORC1 [<xref rid="B86-genes-11-00989" ref-type="bibr">86</xref>]. During glucose deprivation, DNA damage response pathways lead to the inhibition of mTORC1 through the induction of tumor suppressor protein 53 (TP53) [<xref rid="B87-genes-11-00989" ref-type="bibr">87</xref>]. Other forms of stress, like hypoxia, result in mTORC1 inhibition. DNA damage and development 1 (REDD1) inhibits mTORC1 through TSC2, independently of AMPK [<xref rid="B88-genes-11-00989" ref-type="bibr">88</xref>,<xref rid="B89-genes-11-00989" ref-type="bibr">89</xref>].</p></sec><sec id="sec6-genes-11-00989"><title>6. Differential Regulation of mTORC1 by Amino Acids</title><p>Amino acids promote the lysosomal translocation and activation of mTORC1 [<xref rid="B90-genes-11-00989" ref-type="bibr">90</xref>,<xref rid="B91-genes-11-00989" ref-type="bibr">91</xref>]. Once at the lysosome mTORC1 becomes activated by Rheb GTP-bound downstream of growth factor signaling [<xref rid="B92-genes-11-00989" ref-type="bibr">92</xref>,<xref rid="B93-genes-11-00989" ref-type="bibr">93</xref>]. Thus, amino acids and growth factors are crucial in achieving optimal mTORC1 activity. mTORC1 activity is still sensitive to amino acid starvation in Tsc1 and Tsc2 knockout cells, demonstrating that growth factors and amino acids are distinct pathways that regulate mTORC1 activity [<xref rid="B94-genes-11-00989" ref-type="bibr">94</xref>,<xref rid="B95-genes-11-00989" ref-type="bibr">95</xref>,<xref rid="B96-genes-11-00989" ref-type="bibr">96</xref>].</p><p>The discovery of the Rag GTPases in 2008 advanced our understanding of how amino acid activate mTORC1 (<xref ref-type="fig" rid="genes-11-00989-f003">Figure 3</xref>A) [<xref rid="B90-genes-11-00989" ref-type="bibr">90</xref>,<xref rid="B97-genes-11-00989" ref-type="bibr">97</xref>]. The Rag GTPase family of proteins consists of four members: RagA, RagB, RagC, and RagD [<xref rid="B98-genes-11-00989" ref-type="bibr">98</xref>]. RagA and RagB can form a heterodimer with RagC and RagD, with the possibility of forming four distinct complexes. RagA and RagB have high sequence similarity and are functionally redundant. Similarly, RagC and RagD are highly similar and also functionally redundant [<xref rid="B98-genes-11-00989" ref-type="bibr">98</xref>]. Deletion of RagA or RagB leads to the degradation of RagC and RagD, as the heterodimer stabilizes the Rag complex [<xref rid="B90-genes-11-00989" ref-type="bibr">90</xref>,<xref rid="B99-genes-11-00989" ref-type="bibr">99</xref>]. To activate mTORC1, RagA or RagB must be GTP bound while RagC/D is GDP bound. The active Rag GTPase complex binds to Raptor at the lysosome. The Ragulator complex is made up of p18, p14, MEK-binding partner 1 (MP1), chromosome 7 open reading frame 59 (C7orf59), and Hepatitis B virus X interacting protein (HBXIP) (LAMTOR 1-5, respectively). The Ragulator anchors the Rag complex and Raptor bound mTORC1 to the lysosomal surface through the N-terminal region of p18 [<xref rid="B90-genes-11-00989" ref-type="bibr">90</xref>,<xref rid="B91-genes-11-00989" ref-type="bibr">91</xref>,<xref rid="B100-genes-11-00989" ref-type="bibr">100</xref>,<xref rid="B101-genes-11-00989" ref-type="bibr">101</xref>]. Thus, the Rag GTPase-Ragulator complex plays an essential role in the recruitment and activation of mTORC1.</p><p>The guanine nucleotide loading of the Rag GTPases is controlled by guanine nucleotide exchange factors (GEFs) and GAPs. The Ragulator and solute carrier family 38 member 9 (SLC38A9) have been suggested to act as GEFs for RagA/B [<xref rid="B100-genes-11-00989" ref-type="bibr">100</xref>,<xref rid="B102-genes-11-00989" ref-type="bibr">102</xref>]. Ragulator GEF function and Rag GTPase-Ragulator binding depend on the lysosomal v-ATPase [<xref rid="B103-genes-11-00989" ref-type="bibr">103</xref>,<xref rid="B104-genes-11-00989" ref-type="bibr">104</xref>,<xref rid="B105-genes-11-00989" ref-type="bibr">105</xref>]. Amino acids that accumulate within the lysosomal lumen signal to the v-ATPase through an &#x0201c;inside out&#x0201d; mechanism of sensing, which in turn enhances GEF activity of the Ragulator. SLC38A9 functions as a GEF for RagA by stimulating GDP release from RagA upon activation specifically from Arg [<xref rid="B102-genes-11-00989" ref-type="bibr">102</xref>]. A trimeric complex known as GATOR1, consisting of DEP domain-containing 5 (DEPDC5), nitrogen permease regulator-like 2 (NPRL2), and nitrogen permease regulator-like 3 (NPRL3), acts as a GAP for RagA/B [<xref rid="B106-genes-11-00989" ref-type="bibr">106</xref>]. GATOR1 promotes RagA and RagB to hydrolyze GTP and inhibits mTORC1 during amino acid starvation conditions [<xref rid="B107-genes-11-00989" ref-type="bibr">107</xref>]. Upstream of GATOR1, GATOR2 positively regulates mTORC1 activity [<xref rid="B106-genes-11-00989" ref-type="bibr">106</xref>]. GATOR2, comprised of meiosis regulator for oocyte development (MIOS), WD repeat domain 24 (WDR24), WD repeat domain 59 (WDR59), Seh1 like nucleoporin (SEH1L) and Sec13 homolog nuclear pore and COPII coat complex component (SEC13), binds to and inhibits GATOR1 through an unclear mechanism. Another complex called KICSTOR is comprised of Kaptin (KPTN), integrin &#x003b1; FG-GAP repeat containing 2 (ITFG2), C12orf66 and seizure threshold 2 (SZT2), and tethers GATOR1 to the lysosome. GATOR1 requires KICSTOR to negatively regulate mTORC1 in response to amino acid deprivation [<xref rid="B108-genes-11-00989" ref-type="bibr">108</xref>,<xref rid="B109-genes-11-00989" ref-type="bibr">109</xref>]. Folliculin (FLCN) is a GAP for RagC or RagD. The folliculin interacting protein 2 (FLCN-FNIP2) complex GAP activity was shown to promote mTORC1-Rag heterodimer binding [<xref rid="B110-genes-11-00989" ref-type="bibr">110</xref>,<xref rid="B111-genes-11-00989" ref-type="bibr">111</xref>].</p><p>Some amino acid sensors for the Rag GTPase-dependent pathway have been identified. For example, two Arg sensors for mTORC1 have been identified for mTORC1, cellular Arg sensor for mTORC1 (CASTOR1) and SLC38A9 [<xref rid="B112-genes-11-00989" ref-type="bibr">112</xref>,<xref rid="B113-genes-11-00989" ref-type="bibr">113</xref>,<xref rid="B114-genes-11-00989" ref-type="bibr">114</xref>,<xref rid="B115-genes-11-00989" ref-type="bibr">115</xref>,<xref rid="B116-genes-11-00989" ref-type="bibr">116</xref>]. CASTOR1 homodimers or CASTOR1/2 heterodimer bind to and inhibit GATOR2 under Arg deprivation. CASTOR1 was shown to directly bind to Arg through the aspartate kinase, chorismate mutase, TyrA (ACT) domains. SLC38A9 interacts with the Ragulator, and cells lacking SLC38A9 have defective Arg-mediated mTORC1 activation. SLC38A9 has also been shown to play a role in mTORC1 activation by cholesterol [<xref rid="B117-genes-11-00989" ref-type="bibr">117</xref>]. Sestrin2 acts as a Leu sensor to inhibit GATOR2 during Leu withdrawal [<xref rid="B118-genes-11-00989" ref-type="bibr">118</xref>,<xref rid="B119-genes-11-00989" ref-type="bibr">119</xref>], and other amino acids like Met, Ile, and Val can disrupt the Sestrin2-GATOR2 interaction similar to Leu [<xref rid="B120-genes-11-00989" ref-type="bibr">120</xref>]. S-adenosylmethionine (SAM) sensor upstream of mTORC1 (SAMTOR) has been shown to be a sensor for a metabolite of Met. SAMTOR negatively regulates mTORC1 activity through the association with GATOR1 under Met deprivation [<xref rid="B121-genes-11-00989" ref-type="bibr">121</xref>]. The discovery of more sensors will reveal the differential regulation of mTORC1 by individual amino acids.</p><p>As mentioned above, SLC38A9 has been identified as part of the lysosomal machinery to control mTORC1. Other SLC transporters have been shown to regulate mTORC1 activity. For example, SLC15A4 was shown to transport His and oligopeptides out of the lysosome into the cytosol [<xref rid="B122-genes-11-00989" ref-type="bibr">122</xref>]. In B lymphocytes, loss of SLC15A4 impaired lysosomal acidification, and the study suggested the v-ATPase could be functionally or conformationally altered, negatively affecting mTORC1 activity. Another study showed that interleukin-18 (IL-18) enhanced the surface expression of the nutrient transporters CD98/LAT1 (encoded by slc3a2/slc7a5, respectively) in natural killer (NK) cells for amino acids to induce a metabolic change, such as enhanced glycolysis [<xref rid="B123-genes-11-00989" ref-type="bibr">123</xref>]. CD98/LAT1 is a bidirectional transporter for Leu and Gln [<xref rid="B124-genes-11-00989" ref-type="bibr">124</xref>,<xref rid="B125-genes-11-00989" ref-type="bibr">125</xref>]. Increasing the expression of the CD98/LAT1 heterodimer, also known as the System L transporter, enhanced mTORC1 activation by Leu. SLC3A2/SLC7A5, in addition to SLC1A5, have also been demonstrated to promote mTORC1 activity through Gln regulation [<xref rid="B126-genes-11-00989" ref-type="bibr">126</xref>]. SLC36A1 (PAT1), which transports Ala, Gly and Pro, was shown to positively regulate mTORC1 activation [<xref rid="B127-genes-11-00989" ref-type="bibr">127</xref>,<xref rid="B128-genes-11-00989" ref-type="bibr">128</xref>]. This transporter was found to drive mTORC1 signaling and contribute to cyclin dependent kinase 4/6 (CDK4/6) inhibitor resistance in melanoma. SLCs have been relatively understudied, and their involvement in amino acid signaling to mTORC1 should be a major focus of future research [<xref rid="B129-genes-11-00989" ref-type="bibr">129</xref>].</p><p>The Rag GTPase pathway was once considered the main mechanism for activation of mTORC1 by amino acids. However, it is now understood that a Rag GTPase-independent pathway exists, where Gln and Asn can activate mTORC1 (<xref ref-type="fig" rid="genes-11-00989-f003">Figure 3</xref>B) [<xref rid="B99-genes-11-00989" ref-type="bibr">99</xref>]. In mammalian cells lacking the Rag GTPases, Gln was sufficient to stimulate mTORC1 lysosomal localization and activation. The activation of mTORC1 in this pathway required the v-ATPase and another small GTPase called adenosine diphosphate ribosylation factor 1 (Arf1) [<xref rid="B99-genes-11-00989" ref-type="bibr">99</xref>]. This was prefaced by a study in mouse cardiomyocytes demonstrating that a Cre-loxP RagA and RagB double conditional knockout mouse model retained mTORC1 activity [<xref rid="B130-genes-11-00989" ref-type="bibr">130</xref>]. Furthermore, Asn was found important for promoting mTORC1 activity in cancer cells [<xref rid="B131-genes-11-00989" ref-type="bibr">131</xref>]. Finding more signaling components and sensors will be important in order to further understand the Rag-independent pathway. Although, amino acids filtering through the Rag-dependent and Rag-independent pathways have been demonstrated to facilitate mTORC1 activation at the lysosome, the full mechanism of how each individual amino acid functions to stimulate mTORC1 remains largely unknown.</p><p>Leu, Arg, Met, and Gln have previously been shown to stimulate mTORC1 activity. However, a recent study from our group demonstrated that other amino acids are capable of activating mTORC1 (<xref rid="genes-11-00989-t001" ref-type="table">Table 1</xref>) [<xref rid="B132-genes-11-00989" ref-type="bibr">132</xref>]. Using mouse embryonic fibroblast (MEF) and human embryonic kidney 293A (HEK293A) cells, we found that 10 out of the 20 standard amino acids can activate mTORC1 in a time and dose dependent manner. Eight of these amino acids filter through the Rag-dependent pathway and have been involved in the regulation of mTORC1 activity (Ala [<xref rid="B133-genes-11-00989" ref-type="bibr">133</xref>,<xref rid="B134-genes-11-00989" ref-type="bibr">134</xref>], Arg [<xref rid="B112-genes-11-00989" ref-type="bibr">112</xref>,<xref rid="B113-genes-11-00989" ref-type="bibr">113</xref>,<xref rid="B114-genes-11-00989" ref-type="bibr">114</xref>,<xref rid="B115-genes-11-00989" ref-type="bibr">115</xref>,<xref rid="B116-genes-11-00989" ref-type="bibr">116</xref>,<xref rid="B135-genes-11-00989" ref-type="bibr">135</xref>], His [<xref rid="B122-genes-11-00989" ref-type="bibr">122</xref>], Leu [<xref rid="B90-genes-11-00989" ref-type="bibr">90</xref>,<xref rid="B118-genes-11-00989" ref-type="bibr">118</xref>,<xref rid="B119-genes-11-00989" ref-type="bibr">119</xref>], Met [<xref rid="B121-genes-11-00989" ref-type="bibr">121</xref>,<xref rid="B133-genes-11-00989" ref-type="bibr">133</xref>,<xref rid="B136-genes-11-00989" ref-type="bibr">136</xref>], Ser [<xref rid="B133-genes-11-00989" ref-type="bibr">133</xref>], Thr, and Val [<xref rid="B133-genes-11-00989" ref-type="bibr">133</xref>]). Ser, Thr, and Ala only induced a minor activation of mTORC1. These amino acids can be metabolized into pyruvate, which has been previously shown to positively regulate mTORC1 [<xref rid="B137-genes-11-00989" ref-type="bibr">137</xref>]. Moreover, it had been previously shown that some of these amino acids bind to known Rag-dependent sensors. Sestrin2 is a Leu sensor, but other amino acids (Met and Val) can disrupt the Sestrin2-GATOR2 interaction similar to Leu [<xref rid="B120-genes-11-00989" ref-type="bibr">120</xref>]. CASTOR1 is an Arg sensor and does not appear to bind to other amino acids [<xref rid="B112-genes-11-00989" ref-type="bibr">112</xref>]. Rag-dependent amino acids were also observed to induce mTORC1 activation quickly at ~15 min, whereas the Rag-independent amino acids took longer ~1 h for a peak in mTORC1 activity. Two amino acids filter through the Rag-independent pathway (Asn [<xref rid="B131-genes-11-00989" ref-type="bibr">131</xref>] and Gln [<xref rid="B99-genes-11-00989" ref-type="bibr">99</xref>,<xref rid="B131-genes-11-00989" ref-type="bibr">131</xref>,<xref rid="B134-genes-11-00989" ref-type="bibr">134</xref>,<xref rid="B138-genes-11-00989" ref-type="bibr">138</xref>,<xref rid="B139-genes-11-00989" ref-type="bibr">139</xref>]). In addition to activating mTORC1, surprisingly these ten amino acids induce mTORC1 lysosomal localization. Both the Rag-dependent and Rag-independent pathways require the v-ATPase and lysosomal function for the activation of mTORC1 [<xref rid="B99-genes-11-00989" ref-type="bibr">99</xref>,<xref rid="B104-genes-11-00989" ref-type="bibr">104</xref>,<xref rid="B140-genes-11-00989" ref-type="bibr">140</xref>]. Interestingly, Asn like Gln also requires the small GTPase Arf1 to activate mTORC1 [<xref rid="B99-genes-11-00989" ref-type="bibr">99</xref>]. Despite recent advances, there are many open questions remaining to how these specific amino acids stimulate mTORC1 activity.</p><p>With the advancement of cryo-electron microscopy (cryo-EM) technology, the structural understanding of components involved in amino acid signaling to mTORC1 have been better elucidated. Two different structures of mTORC1 with subunits mTOR, Raptor, and mLST8 were solved at a global resolution of 5.9 &#x000c5; [<xref rid="B141-genes-11-00989" ref-type="bibr">141</xref>] and 4.4 &#x000c5; [<xref rid="B142-genes-11-00989" ref-type="bibr">142</xref>]. These structures reveal how FKBP-rapamycin can inhibit some mTORC1 substrates from entering the catalytic cavity. Further studies of a 3.0 &#x000c5; mTORC1 and a 3.4 &#x000c5; structure of Rheb-mTORC1 demonstrate how Rheb causes global conformational change realigning active site residues within mTORC1 and allosterically activating mTORC1 [<xref rid="B72-genes-11-00989" ref-type="bibr">72</xref>]. Crystal structures of components in the amino acid sensing pathway such as GATOR1 alone or complexed with the Rag GTPases [<xref rid="B107-genes-11-00989" ref-type="bibr">107</xref>], Sestrin2 [<xref rid="B118-genes-11-00989" ref-type="bibr">118</xref>], and CASTOR1 [<xref rid="B115-genes-11-00989" ref-type="bibr">115</xref>] have also been solved. Recently, two reports built three-dimensional models of mTORC1 bound to Rheb, Rag GTPases and the Ragulator on the lysosomal surface [<xref rid="B143-genes-11-00989" ref-type="bibr">143</xref>,<xref rid="B144-genes-11-00989" ref-type="bibr">144</xref>]. Importantly, it demonstrates why only a specific nucleotide state of the Rag GTPases (RagA GTP-bound/RagC GDP-bound) allows binding of mTORC1. A newly identified region on Raptor referred to as the &#x0201c;Raptor claw,&#x0201d; further illustrated how Raptor and the Rag GTPases bind. The Raptor &#x003b1;-solenoid region detects the nucleotide state of RagA while the &#x0201c;claw&#x0201d; detects RagC. Structural findings like these illustrate a comprehensive understanding of the mTORC1 amino acid signaling pathway.</p></sec><sec id="sec7-genes-11-00989"><title>7. mTORC1 Regulation by GPCR Signaling</title><p>G-protein-coupled receptors (GPCRs) are seven-transmembrane pass proteins that are activated by an upstream ligand or agonist, resulting in the activation of multiple downstream signaling cascades [<xref rid="B145-genes-11-00989" ref-type="bibr">145</xref>]. GPCRs are highly conserved, and over 800 are encoded in the human genome [<xref rid="B146-genes-11-00989" ref-type="bibr">146</xref>]. GPCRs are coupled to the heterotrimeric G-proteins &#x003b1;, &#x003b2; and &#x003b3;. G&#x003b1; proteins are inactive in the GDP-bound state bound to &#x003b2; and &#x003b3;. GPCRs function as a receptor-catalyzed GEF to activate G&#x003b1; subunit and separate G&#x003b1; from the G&#x003b2;&#x003b3; dimer through a conformational change. GTP hydrolyzing to GDP is the rate limiting step for G&#x003b1; activity. The GDP-bound G&#x003b1; subunit then rejoins the &#x003b2;&#x003b3; dimer until the next activating cycle [<xref rid="B147-genes-11-00989" ref-type="bibr">147</xref>]. After G&#x003b1; protein activation, the GPCR itself is phosphorylated by GPCR kinases (GRKs) followed by receptor internalization. This represents the classical view of GPCR signaling which occurs transiently at the cell surface followed by endocytosis [<xref rid="B148-genes-11-00989" ref-type="bibr">148</xref>]. There are currently four different G&#x003b1; proteins: G&#x003b1;<sub>s,</sub> G&#x003b1;<sub>i/o</sub>, G&#x003b1;<sub>q/11</sub> and G&#x003b1;<sub>12/13</sub> [<xref rid="B149-genes-11-00989" ref-type="bibr">149</xref>]. G&#x003b1;<sub>s</sub> and G&#x003b1;<sub>i/o</sub> regulate adenylate cyclases (ACs). G&#x003b1;<sub>s</sub> stimulates AC activity through binding, while G&#x003b1;<sub>i/o</sub> inhibits AC activity. Activation of ACs increase production and accumulation of intracellular 3&#x02032;,5&#x02032;-cyclic adenosine monophosphate (cAMP). Elevated cAMP levels regulate protein kinase A (PKA), exchange protein activated by cyclic AMP (EPAC), and cyclic-nucleotide-gated ion channels. Negative regulators of G&#x003b1;<sub>s</sub> signaling are cyclic nucleotide phosphodiesterases (PDEs), which can degrade cAMP [<xref rid="B150-genes-11-00989" ref-type="bibr">150</xref>]. G&#x003b1;<sub>q/11</sub> activates phospholipase C (PLC) and PLC can convert PIP2 to inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG) [<xref rid="B151-genes-11-00989" ref-type="bibr">151</xref>]. IP3 gates a calcium channel in the ER to regulate cytoplasmic concentration of calcium. Furthermore, DAG is a substrate for synthesis of phosphatidic acid, which acts as a signaling lipid. Lastly, G&#x003b1;<sub>12/13</sub> targets GEFs for the small GTPase Ras homolog gene family (Rho), which has a role in actin cytoskeleton regulation [<xref rid="B152-genes-11-00989" ref-type="bibr">152</xref>]. Additional details on GPCR signaling can be found in other reviews [<xref rid="B153-genes-11-00989" ref-type="bibr">153</xref>,<xref rid="B154-genes-11-00989" ref-type="bibr">154</xref>].</p><p>PKA is a Ser/Thr protein kinase holoenzyme that contains two catalytic and two regulatory domains [<xref rid="B155-genes-11-00989" ref-type="bibr">155</xref>]. The catalytic subunits release when two molecules of cAMP bind to each of the regulatory subunits [<xref rid="B156-genes-11-00989" ref-type="bibr">156</xref>]. Regulatory subunits (RI and RII) exist in either I/II&#x003b1; or I/II&#x003b2;. RI subunits localize mainly to the cytoplasm, while RII subunits are found at membrane organelles [<xref rid="B157-genes-11-00989" ref-type="bibr">157</xref>,<xref rid="B158-genes-11-00989" ref-type="bibr">158</xref>]. Recently our lab uncovered the molecular mechanisms by which GPCRs-G&#x003b1;<sub>s</sub> signaling can regulate mTORC1 [<xref rid="B159-genes-11-00989" ref-type="bibr">159</xref>]. Specifically, we found that G&#x003b1;<sub>s</sub>-coupled GPCRs increase cAMP to activate PKA and inhibit mTORC1 through the phosphorylation of Raptor on Ser 791 (<xref ref-type="fig" rid="genes-11-00989-f004">Figure 4</xref>). One report showed that PKA phosphorylates Raptor on Ser 791 to promote mTORC1 activation in 3T3-L1 adipocytes [<xref rid="B160-genes-11-00989" ref-type="bibr">160</xref>]. However, a previous study had contrasting results showing that mTORC1 inhibition and active PKA signaling promote lipolysis in 3T3-L1 adipocytes [<xref rid="B161-genes-11-00989" ref-type="bibr">161</xref>]. Additional literature has demonstrated a relationship between cAMP signaling and mTORC1 activity. Interestingly, cAMP has been observed to either stimulate [<xref rid="B162-genes-11-00989" ref-type="bibr">162</xref>,<xref rid="B163-genes-11-00989" ref-type="bibr">163</xref>,<xref rid="B164-genes-11-00989" ref-type="bibr">164</xref>,<xref rid="B165-genes-11-00989" ref-type="bibr">165</xref>,<xref rid="B166-genes-11-00989" ref-type="bibr">166</xref>] or inhibit [<xref rid="B167-genes-11-00989" ref-type="bibr">167</xref>,<xref rid="B168-genes-11-00989" ref-type="bibr">168</xref>,<xref rid="B169-genes-11-00989" ref-type="bibr">169</xref>,<xref rid="B170-genes-11-00989" ref-type="bibr">170</xref>,<xref rid="B171-genes-11-00989" ref-type="bibr">171</xref>,<xref rid="B172-genes-11-00989" ref-type="bibr">172</xref>] mTORC1 activity, depending on the cell line experimentally used. For example, luteinizing hormone/human chorionic gonadotropin (LH/hCG) mediated activation of cAMP was shown to promote mTORC1 activity and increase primary theca-interstitial (T-I) cell proliferation [<xref rid="B173-genes-11-00989" ref-type="bibr">173</xref>]. In MEF and HEK293A cells however, the increase of cAMP by pharmacological activation inhibited mTORC1 activity through PKA [<xref rid="B174-genes-11-00989" ref-type="bibr">174</xref>]. One study in neurons showed that PKA and mTORC1 activity correlated in promoting protein synthesis [<xref rid="B175-genes-11-00989" ref-type="bibr">175</xref>]. Moreover, another report showed that in striatonigral medium spiny neurons (MSNs), activation of mTORC1 requires PKA signaling [<xref rid="B176-genes-11-00989" ref-type="bibr">176</xref>]. In human adrenocortical cells, PKA stimulation induced the activation of the mTOR pathway [<xref rid="B177-genes-11-00989" ref-type="bibr">177</xref>]. Similarly, signaling from the prostaglandin E2 receptor and subsequent activation of cAMP and PKA promoted mTORC1 activity through the phosphorylation of S6K1, S6, and 4EBP1 in pancreatic cancer (PANC-1) cells [<xref rid="B178-genes-11-00989" ref-type="bibr">178</xref>]. Thus, cAMP-PKA signaling can activate or inhibit mTORC1 depending on the cell type.</p><p>The broad expression of GPCRs makes them excellent therapeutic targets [<xref rid="B179-genes-11-00989" ref-type="bibr">179</xref>,<xref rid="B180-genes-11-00989" ref-type="bibr">180</xref>,<xref rid="B181-genes-11-00989" ref-type="bibr">181</xref>,<xref rid="B182-genes-11-00989" ref-type="bibr">182</xref>,<xref rid="B183-genes-11-00989" ref-type="bibr">183</xref>]. In 2017, 34% of all FDA-approved drugs targeted GPCRs [<xref rid="B184-genes-11-00989" ref-type="bibr">184</xref>]. Understanding how GPCR signaling regulates mTORC1 will be important for the potential repurposing of GPCR drugs to treat mTORC1 hyperactivation (<xref rid="genes-11-00989-t002" ref-type="table">Table 2</xref>). Initially, G&#x003b1;<sub>i/o</sub>-coupled adrenergic receptor signaling was discovered to work through the PI3K pathway [<xref rid="B185-genes-11-00989" ref-type="bibr">185</xref>,<xref rid="B186-genes-11-00989" ref-type="bibr">186</xref>]. Additionally, mTOR-dependent vasopressin receptor signaling was shown to stimulate growth [<xref rid="B187-genes-11-00989" ref-type="bibr">187</xref>]. Studies of activated G&#x003b1;<sub>s</sub>-coupled thyroid stimulating hormone [<xref rid="B188-genes-11-00989" ref-type="bibr">188</xref>], prostaglandin F2&#x003b1; [<xref rid="B189-genes-11-00989" ref-type="bibr">189</xref>], and orexin 1/2 receptors [<xref rid="B190-genes-11-00989" ref-type="bibr">190</xref>] led to an increase in mTORC1 activity through an Akt-independent pathway. Most of the understood crosstalk between GPCRs and mTORC1 occurred through the PI3K-Akt signaling pathway [<xref rid="B191-genes-11-00989" ref-type="bibr">191</xref>,<xref rid="B192-genes-11-00989" ref-type="bibr">192</xref>]. Evidence connecting the pathways (through adrenergic, muscarinic, and &#x003ba; opioid receptors), lacked direct interaction [<xref rid="B193-genes-11-00989" ref-type="bibr">193</xref>,<xref rid="B194-genes-11-00989" ref-type="bibr">194</xref>,<xref rid="B195-genes-11-00989" ref-type="bibr">195</xref>,<xref rid="B196-genes-11-00989" ref-type="bibr">196</xref>]. GPCRs like Taste receptor type 1 member 1/3 (T1R1/T1R3) were demonstrated to sense amino acids, activate mTORC1 and inhibit autophagy [<xref rid="B197-genes-11-00989" ref-type="bibr">197</xref>]. Additionally, G&#x003b1;<sub>q/11</sub>, G&#x003b1;<sub>s</sub>, or G&#x003b1;<sub>i/o</sub>-coupled GPCR signaling was found to regulate REDD1 and activate mTORC1 [<xref rid="B198-genes-11-00989" ref-type="bibr">198</xref>]. Recently, more direct evidence demonstrated GPCR regulation of mTORC1. Lysosomal localized GPCR-like protein (GPR137B) was shown to regulate amino acid-dependent mTORC1 activity through RagA/B [<xref rid="B199-genes-11-00989" ref-type="bibr">199</xref>]. Moreover, GPR137B was shown to interact with mTOR, Raptor and RagA. Understanding GPCRs and mTORC1 crosstalk will be crucial in targeting and inhibiting mTORC1.</p><p>The A-kinase anchoring protein (AKAP) family are scaffolding proteins that tether PKA to unique subcellular locations through the PKA regulatory domain [<xref rid="B201-genes-11-00989" ref-type="bibr">201</xref>]. AKAPs are not only compartmentalized, but also tissue specific, potentially making them valuable therapeutic targets and even biomarkers [<xref rid="B155-genes-11-00989" ref-type="bibr">155</xref>,<xref rid="B202-genes-11-00989" ref-type="bibr">202</xref>]. Phosphoproteomic studies have identified potential mTORC1 interacting AKAPs: AKAP1, AKAP2, AKAP8, AKAP8L, AKAP9, AKAP10, AKAP11, AKAP12, AKAP13, and AKAP28 using mass spectrometry [<xref rid="B49-genes-11-00989" ref-type="bibr">49</xref>,<xref rid="B50-genes-11-00989" ref-type="bibr">50</xref>,<xref rid="B203-genes-11-00989" ref-type="bibr">203</xref>]. Recently, our lab uncovered a novel interaction between mTORC1 and an AKAP [<xref rid="B204-genes-11-00989" ref-type="bibr">204</xref>]. We reported that AKAP8L could promote mTORC1 mediated processes such as protein translation, cell growth and proliferation. We also demonstrated that AKAP8L is not involved in the PKA inhibition of mTORC1 through phosphorylation of Raptor on Ser 791 [<xref rid="B159-genes-11-00989" ref-type="bibr">159</xref>,<xref rid="B204-genes-11-00989" ref-type="bibr">204</xref>]. Another finding showed that mitochondrial AKAP1 supports mTORC1 activation through binding and suppressing Sestrin2, a negative regulator of Leu signaling to mTORC1 [<xref rid="B205-genes-11-00989" ref-type="bibr">205</xref>]. The relationship among AKAPs and mTORC1 need to be further explored. Negative regulators of cAMP signaling like the PDEs, have also been shown to take part in mTORC1 signaling [<xref rid="B166-genes-11-00989" ref-type="bibr">166</xref>].</p></sec><sec id="sec8-genes-11-00989"><title>8. mTORC1 Phosphorylation and Regulation</title><p>mTORC1 activity is regulated through phosphorylation by multiple upstream kinases (<xref rid="genes-11-00989-t003" ref-type="table">Table 3</xref>). Studies have shown that Akt can phosphorylate mTOR at Thr 2446 and Ser 2448 promoting activity [<xref rid="B206-genes-11-00989" ref-type="bibr">206</xref>]. A later report demonstrated the in vitro phosphorylation of mTOR by Akt at those sites [<xref rid="B207-genes-11-00989" ref-type="bibr">207</xref>,<xref rid="B208-genes-11-00989" ref-type="bibr">208</xref>]. Subsequent studies revealed that S6K1 can also phosphorylate mTOR at Ser 2448 [<xref rid="B209-genes-11-00989" ref-type="bibr">209</xref>]. Another study showed that AMPK can phosphorylate mTOR at site Thr 2446 [<xref rid="B210-genes-11-00989" ref-type="bibr">210</xref>]. Ser 1261 on mTOR was found to be phosphorylated via PI3K signaling, promoting mTORC1 activity [<xref rid="B211-genes-11-00989" ref-type="bibr">211</xref>]. It was suggested that mTOR also has the capability of autophosphorylation at site Ser 2481, as exemplified in vivo and in vitro, and this phosphorylation site on mTORC1 correlates with intrinsic catalytic activity [<xref rid="B212-genes-11-00989" ref-type="bibr">212</xref>,<xref rid="B213-genes-11-00989" ref-type="bibr">213</xref>]. Downstream of Akt, I&#x003ba;B kinase &#x003b1; (IKK&#x003b1;) can phosphorylate mTOR at Ser 1415 promoting mTORC1 activity increasing cell proliferation in cancer cells [<xref rid="B214-genes-11-00989" ref-type="bibr">214</xref>]. Another group found that mTOR phosphorylation occurred on sites Ser 2159 and Thr 2164, through mass spectrometry and phopho-specific antibodies, promoting mTORC1 signaling [<xref rid="B215-genes-11-00989" ref-type="bibr">215</xref>]. They later demonstrated that TANK-binding kinase 1 (TBK1) interacts with and phosphorylates mTOR on Ser 2159, to promote catalytic activity of mTOR [<xref rid="B216-genes-11-00989" ref-type="bibr">216</xref>]. These studies provided more insight on how mTOR modulation occurs through phosphorylation.</p><p>Raptor is also phosphorylated on multiple sites. mTOR itself has been reported to phosphorylate Raptor in vitro and in vivo on Ser 863, where Ser 863 phosphorylation promotes mTORC1 activity [<xref rid="B217-genes-11-00989" ref-type="bibr">217</xref>]. In a subsequent study, clusters of Raptor phosphorylation sites were reported, including Ser 696, Thr 706, Ser 855, Ser 859, Ser 863, and Ser 877 [<xref rid="B218-genes-11-00989" ref-type="bibr">218</xref>]. Reaffirming previous studies, failure to phosphorylate Ser 863 resulted in lack of phosphorylation of Ser 859 and Ser 855. This study suggested a possible hierarchical phosphorylation to the sites on Raptor. Some known phosphorylation sites on Raptor still need further mechanistic understanding. Mechanical stimulus has been shown to induce the phosphorylation of Raptor on Ser 696, Thr 706, and Ser 863 resulting in mTORC1 activation [<xref rid="B219-genes-11-00989" ref-type="bibr">219</xref>]. Phosphorylation of these three sites also altered Raptor interaction with PRAS40 and S6K1, but not mTOR. RSK phosphorylation of Ser 719, Ser 721, and Ser 722 on Raptor positively regulates mTORC1 kinase activity [<xref rid="B220-genes-11-00989" ref-type="bibr">220</xref>]. This RSK mediated phosphorylation of Raptor was shown to be independent of the PI3K pathway. A follow up study found that ERK1/2 phosphorylates Raptor on sites Ser 8, Ser 696, and Ser 863 promoting mTORC1 activity [<xref rid="B221-genes-11-00989" ref-type="bibr">221</xref>]. Moreover, the phosphorylation of Raptor on these three sites did not regulate Raptor interaction with mTORC1 substrates. Raptor can also be the subject of osmotic stress-induced phosphorylation. c-Jun N-terminal kinase (JNK) directly interacts with and phosphorylates Raptor sites Ser 696, Thr 706 and Ser 863 in vitro [<xref rid="B222-genes-11-00989" ref-type="bibr">222</xref>,<xref rid="B223-genes-11-00989" ref-type="bibr">223</xref>]. JNK phosphorylation of Raptor positively regulates mTORC1 activity. Glycogen synthase kinase-3 (GSK3) has also been demonstrated to phosphorylate Raptor on site Ser 859, elevating mTORC1 activity [<xref rid="B224-genes-11-00989" ref-type="bibr">224</xref>]. GSK3 inhibition did not affect the lysosomal localization of mTORC1. However, inhibiting GSK3 did promote autophagic flux and reduced cell proliferation. During mitosis, cell division control 2 (cdc2) phosphorylates Raptor at Ser 696 and Thr 706 and is important for the promotion of mTORC1 activity and cell cycle progression [<xref rid="B227-genes-11-00989" ref-type="bibr">227</xref>,<xref rid="B228-genes-11-00989" ref-type="bibr">228</xref>].</p><p>Raptor also has multiple phosphorylation sites that lead to negative regulation. Raptor is a direct substrate of AMPK, with target sites on Ser 722 and Ser 792 [<xref rid="B86-genes-11-00989" ref-type="bibr">86</xref>]. This leads to phosphorylated-Raptor binding to 14-3-3 and inhibition of mTORC1. Another group found that Nemo-like kinase (NLK) phosphorylates Raptor on Ser 863, suppressing mTORC1 activation by disrupting lysosomal localization [<xref rid="B225-genes-11-00989" ref-type="bibr">225</xref>]. Hyperosmotic or oxidative stress activates NLK and inhibits mTORC1 through Rag GTPase-dependent signaling. NLK disrupts the interaction between Raptor and the Rag-GTPases. We and another group demonstrated Raptor can be phosphorylated by PKA on Ser 791, resulting in the regulation of mTORC1 [<xref rid="B159-genes-11-00989" ref-type="bibr">159</xref>,<xref rid="B160-genes-11-00989" ref-type="bibr">160</xref>]. Our report suggests that PKA phosphorylates Raptor on Ser 791 as a downstream result of GPCR-cAMP signaling, negatively regulating mTOR activity. Conversely, the other study found that PKA phosphorylation of Raptor on Ser 791 promotes mTOR activity. Recently, a group discovered the Hippo pathway component LATS1/2 kinase phosphorylate Raptor on Ser 606. [<xref rid="B226-genes-11-00989" ref-type="bibr">226</xref>]. LATS1/2 phosphorylation of Ser 606 induced suppression mTORC1 was suggested to result in a decreased organ size in mice. These studies represent how targeting a critical signal integrator for mTORC1 can have such a big impact. Interestingly, some sites, like Ser 863, have multiple modes of upstream regulation through different kinases which provides insight into how mTORC1 can be involved in many different signaling pathways.</p></sec><sec id="sec9-genes-11-00989"><title>9. Small GTPases that Regulate mTORC1</title><p>In the Rag-dependent amino acid (Ala, Arg, His, Leu, Met, Ser, Thr, and Val) signaling pathway to mTORC1, RagA/RagB and RagC/RagD form a heterodimer to shuttle mTORC1 to the lysosome [<xref rid="B38-genes-11-00989" ref-type="bibr">38</xref>]. In the Rag-independent amino acid (Asn and Gln) pathway, Arf1 is required for signaling to mTORC1 [<xref rid="B99-genes-11-00989" ref-type="bibr">99</xref>]. Though these small GTPases are essential in their respective pathways, there are other small GTPases that are implicated in mTORC1 regulation (<xref rid="genes-11-00989-t004" ref-type="table">Table 4</xref>). As briefly mentioned, the small GTPase Rheb is crucial for mTORC1 activation at the lysosome [<xref rid="B38-genes-11-00989" ref-type="bibr">38</xref>]. Rheb also localizes to other organelles including the ER, Golgi apparatus, peroxisome, and the mitochondria [<xref rid="B229-genes-11-00989" ref-type="bibr">229</xref>,<xref rid="B230-genes-11-00989" ref-type="bibr">230</xref>,<xref rid="B231-genes-11-00989" ref-type="bibr">231</xref>,<xref rid="B232-genes-11-00989" ref-type="bibr">232</xref>,<xref rid="B233-genes-11-00989" ref-type="bibr">233</xref>,<xref rid="B234-genes-11-00989" ref-type="bibr">234</xref>,<xref rid="B235-genes-11-00989" ref-type="bibr">235</xref>]. TSC serves as GAP for Rheb [<xref rid="B70-genes-11-00989" ref-type="bibr">70</xref>,<xref rid="B71-genes-11-00989" ref-type="bibr">71</xref>]. Akt [<xref rid="B66-genes-11-00989" ref-type="bibr">66</xref>,<xref rid="B236-genes-11-00989" ref-type="bibr">236</xref>], ERK [<xref rid="B74-genes-11-00989" ref-type="bibr">74</xref>], RSK1 [<xref rid="B75-genes-11-00989" ref-type="bibr">75</xref>], and IKK&#x003b2; (I&#x003ba;B kinase &#x003b2;) [<xref rid="B76-genes-11-00989" ref-type="bibr">76</xref>] phosphorylate and inhibit TSC, which promotes Rheb bound to GTP and mTORC1 activation. In contrast, osmotic stress [<xref rid="B237-genes-11-00989" ref-type="bibr">237</xref>], AMPK [<xref rid="B238-genes-11-00989" ref-type="bibr">238</xref>], GSK3-&#x003b2; [<xref rid="B239-genes-11-00989" ref-type="bibr">239</xref>], REDD1 [<xref rid="B88-genes-11-00989" ref-type="bibr">88</xref>], and TP53 [<xref rid="B87-genes-11-00989" ref-type="bibr">87</xref>,<xref rid="B240-genes-11-00989" ref-type="bibr">240</xref>] have been shown to inhibit mTORC1 activity through TSC. A confirmed GEF for Rheb has yet to be identified. </p><p>Ras-related protein Ral-A (RalA) has been shown to induce mTORC1 signaling, downstream of Rheb [<xref rid="B241-genes-11-00989" ref-type="bibr">241</xref>]. The study suggests that RalA has an important function in amino acid activation of mTORC1. RalA was previously reported to be involved in proliferation and oncogenic transformation [<xref rid="B249-genes-11-00989" ref-type="bibr">249</xref>,<xref rid="B250-genes-11-00989" ref-type="bibr">250</xref>]. Additionally, RalA has been attributed to anchorage-independent growth signaling through association with the exocyst complex, which is involved in vesicle transport [<xref rid="B251-genes-11-00989" ref-type="bibr">251</xref>] and glucose transporter type 4 (Glut4) translocation to the plasma membrane [<xref rid="B252-genes-11-00989" ref-type="bibr">252</xref>]. This relationship might shed light on the function of RalA in mTORC1 signaling, either through receptor localization or possibly insulin signaling [<xref rid="B253-genes-11-00989" ref-type="bibr">253</xref>].</p><p>The Ras-related protein Rab (Rab) family of GTPases have also been demonstrated to regulate mTORC1 activity. The Rab proteins are canonically known for their role in regulating the process of vesicular trafficking [<xref rid="B242-genes-11-00989" ref-type="bibr">242</xref>]. However, it was demonstrated that Rab5, Rab7, Rab10, and Rab31 potently inhibited mTORC1 activity [<xref rid="B243-genes-11-00989" ref-type="bibr">243</xref>]. This study indicated that proper regulation of intracellular trafficking is important for mTORC1 activity. Furthermore, Rab5 inhibits mTORC1 activation by amino acids through a Rag GTPase-dependent manner. Reports also present Rab12 as a regulator of mTORC1 activity. Through the control of amino-acid transporter proton-coupled amino acid transporter 4 (PAT4), Rab12 mediates mTORC1 activity and autophagy [<xref rid="B244-genes-11-00989" ref-type="bibr">244</xref>]. PAT4 indirectly modulates mTORC1 and subsequently autophagy through uptake of amino acids. Rab8A was found to modulate mTORC1 signaling in an immune response context [<xref rid="B245-genes-11-00989" ref-type="bibr">245</xref>]. Enriched on macrophage ruffles, Rab8A recruits PI3K&#x003b3; as an effector to regulate Akt signaling resulting from Toll-like receptor 4 (TLR4), a bacterial sensor for the innate immune response. This results in the activation of mTORC1 in response to the TLR4 pathogen recognition altering the cytokine response. Lastly, amino acid stimulation results in Rab1A-mTORC1 interaction on the Golgi, and overexpression of Rab1A promotes mTORC1 dependent oncogenic growth [<xref rid="B233-genes-11-00989" ref-type="bibr">233</xref>]. The Rab family presents an important field of study and broadens the interconnection of mTORC1 and other trafficking proteins.</p><p>The Rho GTPases are known for their function in cytoskeleton mediation, cell migration, proliferation, and transcription [<xref rid="B254-genes-11-00989" ref-type="bibr">254</xref>]. The three most studied members are Rho, Rac, and Cdc42. The main functions of these GTPases are to control stress fibers in addition to focal adhesion formation, regulate membrane ruffling and filopodium formation, respectively [<xref rid="B254-genes-11-00989" ref-type="bibr">254</xref>]. Previously, it was suggested that TSC1/2 activates Rac1 and inhibits Rho, through an unknown mechanism in the regulation of actin and focal adhesion remodeling [<xref rid="B255-genes-11-00989" ref-type="bibr">255</xref>]. Rac1 has also been identified as an mTOR binding protein. Rac1 regulates mTORC1 activity independently of PI3K and localizes mTORC1 at cellular membranes [<xref rid="B246-genes-11-00989" ref-type="bibr">246</xref>]. The absence of Rac1 inhibits mTORC1 activation and decreases cell size. Follow up work in mammalian cells by another group showed RhoA also suppresses mTORC1 kinase activity through an unknown mechanism upstream of Rheb [<xref rid="B247-genes-11-00989" ref-type="bibr">247</xref>]. Interestingly, RhoA did not interact directly with Raptor but did reduce the autophosphorylation of mTOR on Ser 2481.</p><p>A recent study reported that when amino acids are limited, Ras related protein 1 (Rap1) changes lysosome abundance which leads to the suppression of mTORC1 signaling [<xref rid="B248-genes-11-00989" ref-type="bibr">248</xref>]. Under amino acid limiting conditions, Rap1 concentrates at the lysosomes. Conversely, depletion of Rap1 leads to increased lysosome availability resulting in more interaction with mTORC1. It will be interesting to know what mechanistic detail future findings will reveal about this starvation response.</p></sec><sec sec-type="conclusions" id="sec10-genes-11-00989"><title>10. Conclusions, Future Directions, and Outstanding Questions</title><p>Research continues to uncover new components and molecular mechanisms of how growth factors and amino acids filter through upstream regulators in order to control mTORC1. Recent identification of new individual amino acids that regulate mTORC1 signaling could indicate the existence undiscovered upstream sensors involved in mTORC1 activation. Additionally, newly found amino acids that potently activate mTORC1 warrant further exploration. The identification of additional components involved in the Rag-independent pathway will provide more molecular insight to Gln- and Asn-induced mTORC1 activation. Why there are two distinct amino acid signaling pathways to mTORC1 and the difference in the signaling kinetics of these pathways to mTORC1 is currently not understood.</p><p>Understanding the mechanistic details of mTORC1 signaling provides major advances to the research community. However, we should not lose sight of the larger goal: Elucidating how mTORC1 signaling affects cellular physiology and how this pathway can be targeted for therapeutic benefit. The dysregulation of mTORC1 can be found in many diseases ranging from diabetes, cancer, neurodegeneration and so forth [<xref rid="B38-genes-11-00989" ref-type="bibr">38</xref>]. Revealing how GPCR signaling regulates mTORC1 activity could help redefine the way we target mTORC1 clinically. For example, in 2017 approximately 9% of total therapeutics in clinical trials for diabetes were against GPCRs [<xref rid="B184-genes-11-00989" ref-type="bibr">184</xref>]. In fact, 11 GPCRs were involved in approved treatments, while 25 GPCR targeting drugs were under clinical trial at the time of the publication. The pursuit of treating type 2 diabetes has stimulated further interest in GPCR therapeutics [<xref rid="B256-genes-11-00989" ref-type="bibr">256</xref>,<xref rid="B257-genes-11-00989" ref-type="bibr">257</xref>]. The Glucagon-like peptide 1 (GLP-1) receptor agonist, exenatide, was the first GPCR targeted drug for type 2 diabetes in 2005, and several more GLP1 receptor agonists have been approved since. A recent study showed that GLP-1 receptor signaling involved mTOR [<xref rid="B200-genes-11-00989" ref-type="bibr">200</xref>], demonstrating that targeting GPCRs could have benefits in diabetic therapies with dysregulated mTORC1 signaling [<xref rid="B258-genes-11-00989" ref-type="bibr">258</xref>]. Other mTOR associated diseases, such as cancer, have also proved to be opportunistic for GPCR drug targets [<xref rid="B259-genes-11-00989" ref-type="bibr">259</xref>], as over 20 agents were in clinical trials at the time of that publication. Studying components of the GPCR-G&#x003b1;<sub>s</sub> pathway, such as AKAPs, PKA regulatory subunits, and phosphodiesterases involved in mTORC1 regulation, would also be extremely beneficial. For example, PKA phosphorylation of Ser 791 on Raptor leads to activation or inhibition of mTORC1 depending on the cell type. Therefore, utilizing FDA approved drugs (agonists and antagonists) that target GPCR-G&#x003b1;<sub>s</sub>, could modulate mTORC1 activity. Different tissues contain mixtures of GPCR populations [<xref rid="B179-genes-11-00989" ref-type="bibr">179</xref>,<xref rid="B180-genes-11-00989" ref-type="bibr">180</xref>]. Repurposing GPCR drugs for new indications could prove advantageous as about 33% of these drugs are known to have multiple uses as of 2017 [<xref rid="B184-genes-11-00989" ref-type="bibr">184</xref>]. Furthermore, there is potential use for treatment of mTOR related diseases that are either tissue specific or require multiple therapeutic approaches [<xref rid="B38-genes-11-00989" ref-type="bibr">38</xref>]. The failures of rapamycin due to the inadequacy of complete inhibition of mTORC1 leaves a desperate need for a better solution. Exploring mTORC1 regulation through GPCR signaling might provide an alternative method.</p><p>mTORC1 phosphorylation has provided more insight into the mechanism of mTORC1 regulation by upstream stimuli. Furthermore, studying the small GTPases involved in mTORC1 regulation contribute to another important area of research. Lysosomal translocation and activation of mTORC1 can be regulated by the Rag GTPases. However, the localization of mTORC1 at the lysosome stems multiple questions. Where are mTORC1 substrates phosphorylated? Some known substrates are not localized to the lysosome. How is mTORC1 trafficked to the lysosome, and where is mTORC1 located when it&#x02019;s not at the lysosome? One possibility could be the regulation of mTORC1 by other small GTPases, many of which are associated with cellular trafficking. Additionally, other small GTPases could regulate mTORC1 at different subcellular locations. How these small GTPases function in accordance with amino acid and growth factor signaling will provide more insight into mTORC1 regulation.</p></sec></body><back><ack><title>Acknowledgments</title><p>We thank the Jewell Lab for insightful comments.</p></ack><notes><title>Author Contributions</title><p>C.H.M. and J.L.J. wrote the manuscript. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This work was supported by grants from Cancer Prevention Research Institute of Texas (CPRIT) Scholar Recruitment of First-Time, Tenure-Track Faculty Member (RR150032), Cancer Prevention Research Institute of Texas (CPRIT) High-Impact/High-Risk Research Award (RP160713), The Welch Foundation (I-1927-20170325), 2017 UT Southwestern President&#x02019;s Research Council Distinguished Researcher Award, American Cancer Society Institutional Research Grants (ACS-IRG-17-174-13 and 133894-RSG-19-162-01-TBE), and National Institutes of Health (R01GM129097-01) to J.L.J.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-genes-11-00989"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>V&#x000e9;zina</surname><given-names>C.</given-names></name><name><surname>Kudelski</surname><given-names>A.</given-names></name><name><surname>Sehgal</surname><given-names>S.N.</given-names></name></person-group><article-title>Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle</article-title><source>J. Antibiot.</source><year>1975</year><volume>28</volume><fpage>721</fpage><lpage>726</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.28.721</pub-id></element-citation></ref><ref id="B2-genes-11-00989"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eng</surname><given-names>C.P.</given-names></name><name><surname>Sehgal</surname><given-names>S.N.</given-names></name><name><surname>V&#x000e9;zina</surname><given-names>C.</given-names></name></person-group><article-title>Activity of rapamycin (AY-22,989) against transplanted tumors</article-title><source>J. Antibiot.</source><year>1984</year><volume>37</volume><fpage>1231</fpage><lpage>1237</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.37.1231</pub-id><pub-id pub-id-type="pmid">6501094</pub-id></element-citation></ref><ref id="B3-genes-11-00989"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martel</surname><given-names>R.R.</given-names></name><name><surname>Klicius</surname><given-names>J.</given-names></name><name><surname>Galet</surname><given-names>S.</given-names></name></person-group><article-title>Inhibition of the immune response by rapamycin, a new antifungal antibiotic</article-title><source>Can. J. Physiol. Pharmacol.</source><year>1977</year><volume>55</volume><fpage>48</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1139/y77-007</pub-id><pub-id pub-id-type="pmid">843990</pub-id></element-citation></ref><ref id="B4-genes-11-00989"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>J.</given-names></name><name><surname>Kuo</surname><given-names>C.J.</given-names></name><name><surname>Crabtree</surname><given-names>G.R.</given-names></name><name><surname>Blenis</surname><given-names>J.</given-names></name></person-group><article-title>Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases</article-title><source>Cell</source><year>1992</year><volume>69</volume><fpage>1227</fpage><lpage>1236</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(92)90643-Q</pub-id><pub-id pub-id-type="pmid">1377606</pub-id></element-citation></ref><ref id="B5-genes-11-00989"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heitman</surname><given-names>J.</given-names></name><name><surname>Movva</surname><given-names>N.R.</given-names></name><name><surname>Hall</surname><given-names>M.N.</given-names></name></person-group><article-title>Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast</article-title><source>Science</source><year>1991</year><volume>253</volume><fpage>905</fpage><lpage>909</lpage><pub-id pub-id-type="doi">10.1126/science.1715094</pub-id><pub-id pub-id-type="pmid">1715094</pub-id></element-citation></ref><ref id="B6-genes-11-00989"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kunz</surname><given-names>J.</given-names></name><name><surname>Henriquez</surname><given-names>R.</given-names></name><name><surname>Schneider</surname><given-names>U.</given-names></name><name><surname>Deuter-Reinhard</surname><given-names>M.</given-names></name><name><surname>Movva</surname><given-names>N.</given-names></name><name><surname>Hall</surname><given-names>M.N.</given-names></name></person-group><article-title>Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression</article-title><source>Cell</source><year>1993</year><volume>73</volume><fpage>585</fpage><lpage>596</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(93)90144-F</pub-id><pub-id pub-id-type="pmid">8387896</pub-id></element-citation></ref><ref id="B7-genes-11-00989"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cafferkey</surname><given-names>R.</given-names></name><name><surname>Young</surname><given-names>P.R.</given-names></name><name><surname>McLaughlin</surname><given-names>M.M.</given-names></name><name><surname>Bergsma</surname><given-names>D.J.</given-names></name><name><surname>Koltin</surname><given-names>Y.</given-names></name><name><surname>Sathe</surname><given-names>G.M.</given-names></name><name><surname>Faucette</surname><given-names>L.</given-names></name><name><surname>Eng</surname><given-names>W.K.</given-names></name><name><surname>Johnson</surname><given-names>R.K.</given-names></name><name><surname>Livi</surname><given-names>G.P.</given-names></name></person-group><article-title>Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity</article-title><source>Mol. Cell. Biol.</source><year>1993</year><volume>13</volume><fpage>6012</fpage><lpage>6023</lpage><pub-id pub-id-type="doi">10.1128/MCB.13.10.6012</pub-id><pub-id pub-id-type="pmid">8413204</pub-id></element-citation></ref><ref id="B8-genes-11-00989"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>E.J.</given-names></name><name><surname>Albers</surname><given-names>M.W.</given-names></name><name><surname>Shin</surname><given-names>T.B.</given-names></name><name><surname>Ichikawa</surname><given-names>K.</given-names></name><name><surname>Keith</surname><given-names>C.T.</given-names></name><name><surname>Lane</surname><given-names>W.S.</given-names></name><name><surname>Schreiber</surname><given-names>S.L.</given-names></name></person-group><article-title>A mammalian protein targeted by G1-arresting rapamycin&#x02013;receptor complex</article-title><source>Nature</source><year>1994</year><volume>369</volume><fpage>756</fpage><lpage>758</lpage><pub-id pub-id-type="doi">10.1038/369756a0</pub-id><pub-id pub-id-type="pmid">8008069</pub-id></element-citation></ref><ref id="B9-genes-11-00989"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabatini</surname><given-names>D.M.</given-names></name><name><surname>Erdjument-Bromage</surname><given-names>H.</given-names></name><name><surname>Lui</surname><given-names>M.</given-names></name><name><surname>Tempst</surname><given-names>P.</given-names></name><name><surname>Snyder</surname><given-names>S.H.</given-names></name></person-group><article-title>RAFT1: A mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs</article-title><source>Cell</source><year>1994</year><volume>78</volume><fpage>35</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(94)90570-3</pub-id><pub-id pub-id-type="pmid">7518356</pub-id></element-citation></ref><ref id="B10-genes-11-00989"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabers</surname><given-names>C.J.</given-names></name><name><surname>Martin</surname><given-names>M.M.</given-names></name><name><surname>Brunn</surname><given-names>G.J.</given-names></name><name><surname>Williams</surname><given-names>J.M.</given-names></name><name><surname>Dumont</surname><given-names>F.J.</given-names></name><name><surname>Wiederrecht</surname><given-names>G.</given-names></name><name><surname>Abraham</surname><given-names>R.T.</given-names></name></person-group><article-title>Isolation of a Protein Target of the FKBP12-Rapamycin Complex in Mammalian Cells</article-title><source>J. Biol. Chem.</source><year>1995</year><volume>270</volume><fpage>815</fpage><lpage>822</lpage><pub-id pub-id-type="doi">10.1074/jbc.270.2.815</pub-id><pub-id pub-id-type="pmid">7822316</pub-id></element-citation></ref><ref id="B11-genes-11-00989"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loewith</surname><given-names>R.</given-names></name><name><surname>Jacinto</surname><given-names>E.</given-names></name><name><surname>Wullschleger</surname><given-names>S.</given-names></name><name><surname>Lorberg</surname><given-names>A.</given-names></name><name><surname>Crespo</surname><given-names>J.L.</given-names></name><name><surname>Bonenfant</surname><given-names>D.</given-names></name><name><surname>Oppliger</surname><given-names>W.</given-names></name><name><surname>Jenoe</surname><given-names>P.</given-names></name><name><surname>Hall</surname><given-names>M.N.</given-names></name></person-group><article-title>Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control</article-title><source>Mol. Cell</source><year>2002</year><volume>10</volume><fpage>457</fpage><lpage>468</lpage><pub-id pub-id-type="doi">10.1016/S1097-2765(02)00636-6</pub-id><pub-id pub-id-type="pmid">12408816</pub-id></element-citation></ref><ref id="B12-genes-11-00989"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacinto</surname><given-names>E.</given-names></name><name><surname>Loewith</surname><given-names>R.</given-names></name><name><surname>Schmidt</surname><given-names>A.</given-names></name><name><surname>Lin</surname><given-names>S.</given-names></name><name><surname>R&#x000fc;egg</surname><given-names>M.A.</given-names></name><name><surname>Hall</surname><given-names>A.</given-names></name><name><surname>Hall</surname><given-names>M.N.</given-names></name></person-group><article-title>Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive</article-title><source>Nat. Cell Biol.</source><year>2004</year><volume>6</volume><fpage>1122</fpage><lpage>1128</lpage><pub-id pub-id-type="doi">10.1038/ncb1183</pub-id><pub-id pub-id-type="pmid">15467718</pub-id></element-citation></ref><ref id="B13-genes-11-00989"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarbassov</surname><given-names>D.D.</given-names></name><name><surname>Ali</surname><given-names>S.M.</given-names></name><name><surname>Kim</surname><given-names>D.-H.</given-names></name><name><surname>Guertin</surname><given-names>D.A.</given-names></name><name><surname>Latek</surname><given-names>R.R.</given-names></name><name><surname>Erdjument-Bromage</surname><given-names>H.</given-names></name><name><surname>Tempst</surname><given-names>P.</given-names></name><name><surname>Sabatini</surname><given-names>D.M.</given-names></name></person-group><article-title>Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton</article-title><source>Curr. Biol.</source><year>2004</year><volume>14</volume><fpage>1296</fpage><lpage>1302</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2004.06.054</pub-id><pub-id pub-id-type="pmid">15268862</pub-id></element-citation></ref><ref id="B14-genes-11-00989"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarbassov</surname><given-names>D.D.</given-names></name><name><surname>Ali</surname><given-names>S.M.</given-names></name><name><surname>Sengupta</surname><given-names>S.</given-names></name><name><surname>Sheen</surname><given-names>J.-H.</given-names></name><name><surname>Hsu</surname><given-names>P.P.</given-names></name><name><surname>Bagley</surname><given-names>A.F.</given-names></name><name><surname>Markhard</surname><given-names>A.L.</given-names></name><name><surname>Sabatini</surname><given-names>D.M.</given-names></name></person-group><article-title>Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB</article-title><source>Mol. Cell</source><year>2006</year><volume>22</volume><fpage>159</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2006.03.029</pub-id><pub-id pub-id-type="pmid">16603397</pub-id></element-citation></ref><ref id="B15-genes-11-00989"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phung</surname><given-names>T.L.</given-names></name><name><surname>Ziv</surname><given-names>K.</given-names></name><name><surname>Dabydeen</surname><given-names>D.</given-names></name><name><surname>Eyiah-Mensah</surname><given-names>G.</given-names></name><name><surname>Riveros</surname><given-names>M.</given-names></name><name><surname>Perruzzi</surname><given-names>C.</given-names></name><name><surname>Sun</surname><given-names>J.</given-names></name><name><surname>Monahan-Earley</surname><given-names>R.A.</given-names></name><name><surname>Shiojima</surname><given-names>I.</given-names></name><name><surname>Nagy</surname><given-names>J.A.</given-names></name><etal/></person-group><article-title>Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin</article-title><source>Cancer Cell</source><year>2006</year><volume>10</volume><fpage>159</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1016/j.ccr.2006.07.003</pub-id><pub-id pub-id-type="pmid">16904613</pub-id></element-citation></ref><ref id="B16-genes-11-00989"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thoreen</surname><given-names>C.C.</given-names></name><name><surname>Kang</surname><given-names>S.A.</given-names></name><name><surname>Chang</surname><given-names>J.W.</given-names></name><name><surname>Liu</surname><given-names>Q.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Gao</surname><given-names>Y.</given-names></name><name><surname>Reichling</surname><given-names>L.J.</given-names></name><name><surname>Sim</surname><given-names>T.</given-names></name><name><surname>Sabatini</surname><given-names>D.M.</given-names></name><name><surname>Gray</surname><given-names>N.S.</given-names></name></person-group><article-title>An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1</article-title><source>J. Biol. Chem.</source><year>2009</year><volume>284</volume><fpage>8023</fpage><lpage>8032</lpage><pub-id pub-id-type="doi">10.1074/jbc.M900301200</pub-id><pub-id pub-id-type="pmid">19150980</pub-id></element-citation></ref><ref id="B17-genes-11-00989"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>D.-H.</given-names></name><name><surname>Sarbassov</surname><given-names>D.D.</given-names></name><name><surname>Ali</surname><given-names>S.M.</given-names></name><name><surname>King</surname><given-names>J.E.</given-names></name><name><surname>Latek</surname><given-names>R.R.</given-names></name><name><surname>Erdjument-Bromage</surname><given-names>H.</given-names></name><name><surname>Tempst</surname><given-names>P.</given-names></name><name><surname>Sabatini</surname><given-names>D.M.</given-names></name></person-group><article-title>mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth Machinery</article-title><source>Cell</source><year>2002</year><volume>110</volume><fpage>163</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(02)00808-5</pub-id><pub-id pub-id-type="pmid">12150925</pub-id></element-citation></ref><ref id="B18-genes-11-00989"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hara</surname><given-names>K.</given-names></name><name><surname>Maruki</surname><given-names>Y.</given-names></name><name><surname>Long</surname><given-names>X.</given-names></name><name><surname>Yoshino</surname><given-names>K.-I.</given-names></name><name><surname>Oshiro</surname><given-names>N.</given-names></name><name><surname>Hidayat</surname><given-names>S.</given-names></name><name><surname>Tokunaga</surname><given-names>C.</given-names></name><name><surname>Avruch</surname><given-names>J.</given-names></name><name><surname>Yonezawa</surname><given-names>K.</given-names></name></person-group><article-title>Raptor, a Binding Partner of Target of Rapamycin (TOR), Mediates TOR Action</article-title><source>Cell</source><year>2002</year><volume>110</volume><fpage>177</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(02)00833-4</pub-id><pub-id pub-id-type="pmid">12150926</pub-id></element-citation></ref><ref id="B19-genes-11-00989"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>D.-H.</given-names></name><name><surname>Sarbassov</surname><given-names>D.D.</given-names></name><name><surname>Ali</surname><given-names>S.M.</given-names></name><name><surname>Latek</surname><given-names>R.R.</given-names></name><name><surname>Guntur</surname><given-names>K.V.P.</given-names></name><name><surname>Erdjument-Bromage</surname><given-names>H.</given-names></name><name><surname>Tempst</surname><given-names>P.</given-names></name><name><surname>Sabatini</surname><given-names>D.M.</given-names></name></person-group><article-title>GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR</article-title><source>Mol. Cell</source><year>2003</year><volume>11</volume><fpage>895</fpage><lpage>904</lpage><pub-id pub-id-type="doi">10.1016/S1097-2765(03)00114-X</pub-id><pub-id pub-id-type="pmid">12718876</pub-id></element-citation></ref><ref id="B20-genes-11-00989"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nojima</surname><given-names>H.</given-names></name><name><surname>Tokunaga</surname><given-names>C.</given-names></name><name><surname>Eguchi</surname><given-names>S.</given-names></name><name><surname>Oshiro</surname><given-names>N.</given-names></name><name><surname>Hidayat</surname><given-names>S.</given-names></name><name><surname>Yoshino</surname><given-names>K.-I.</given-names></name><name><surname>Hara</surname><given-names>K.</given-names></name><name><surname>Tanaka</surname><given-names>N.</given-names></name><name><surname>Avruch</surname><given-names>J.</given-names></name><name><surname>Yonezawa</surname><given-names>K.</given-names></name></person-group><article-title>The Mammalian Target of Rapamycin (mTOR) Partner, Raptor, Binds the mTOR Substrates p70 S6 Kinase and 4E-BP1 through Their TOR Signaling (TOS) Motif</article-title><source>J. Biol. Chem.</source><year>2003</year><volume>278</volume><fpage>15461</fpage><lpage>15464</lpage><pub-id pub-id-type="doi">10.1074/jbc.C200665200</pub-id><pub-id pub-id-type="pmid">12604610</pub-id></element-citation></ref><ref id="B21-genes-11-00989"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schalm</surname><given-names>S.S.</given-names></name><name><surname>Fingar</surname><given-names>D.C.</given-names></name><name><surname>Sabatini</surname><given-names>D.M.</given-names></name><name><surname>Blenis</surname><given-names>J.</given-names></name></person-group><article-title>TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function</article-title><source>Curr. Biol.</source><year>2003</year><volume>13</volume><fpage>797</fpage><lpage>806</lpage><pub-id pub-id-type="doi">10.1016/S0960-9822(03)00329-4</pub-id><pub-id pub-id-type="pmid">12747827</pub-id></element-citation></ref><ref id="B22-genes-11-00989"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schalm</surname><given-names>S.S.</given-names></name><name><surname>Blenis</surname><given-names>J.</given-names></name></person-group><article-title>Identification of a Conserved Motif Required for mTOR Signaling</article-title><source>Curr. Biol.</source><year>2002</year><volume>12</volume><fpage>632</fpage><lpage>639</lpage><pub-id pub-id-type="doi">10.1016/S0960-9822(02)00762-5</pub-id><pub-id pub-id-type="pmid">11967149</pub-id></element-citation></ref><ref id="B23-genes-11-00989"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haar</surname><given-names>E.V.</given-names></name><name><surname>Lee</surname><given-names>S.-I.</given-names></name><name><surname>Bandhakavi</surname><given-names>S.</given-names></name><name><surname>Griffin</surname><given-names>T.J.</given-names></name><name><surname>Kim</surname><given-names>D.-H.</given-names></name></person-group><article-title>Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40</article-title><source>Nat. Cell Biol.</source><year>2007</year><volume>9</volume><fpage>316</fpage><lpage>323</lpage><pub-id pub-id-type="doi">10.1038/ncb1547</pub-id><pub-id pub-id-type="pmid">17277771</pub-id></element-citation></ref><ref id="B24-genes-11-00989"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sancak</surname><given-names>Y.</given-names></name><name><surname>Thoreen</surname><given-names>C.C.</given-names></name><name><surname>Peterson</surname><given-names>T.R.</given-names></name><name><surname>Lindquist</surname><given-names>R.A.</given-names></name><name><surname>Kang</surname><given-names>S.A.</given-names></name><name><surname>Spooner</surname><given-names>E.</given-names></name><name><surname>Carr</surname><given-names>S.A.</given-names></name><name><surname>Sabatini</surname><given-names>D.M.</given-names></name></person-group><article-title>PRAS40 Is an Insulin-Regulated Inhibitor of the mTORC1 Protein Kinase</article-title><source>Mol. Cell</source><year>2007</year><volume>25</volume><fpage>903</fpage><lpage>915</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2007.03.003</pub-id><pub-id pub-id-type="pmid">17386266</pub-id></element-citation></ref><ref id="B25-genes-11-00989"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Harris</surname><given-names>T.E.</given-names></name><name><surname>Roth</surname><given-names>R.A.</given-names></name><name><surname>Lawrence</surname><given-names>J.C.</given-names></name></person-group><article-title>PRAS40 Regulates mTORC1 Kinase Activity by Functioning as a Direct Inhibitor of Substrate Binding</article-title><source>J. Biol. Chem.</source><year>2007</year><volume>282</volume><fpage>20036</fpage><lpage>20044</lpage><pub-id pub-id-type="doi">10.1074/jbc.M702376200</pub-id><pub-id pub-id-type="pmid">17510057</pub-id></element-citation></ref><ref id="B26-genes-11-00989"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>T.R.</given-names></name><name><surname>Laplante</surname><given-names>M.</given-names></name><name><surname>Thoreen</surname><given-names>C.C.</given-names></name><name><surname>Sancak</surname><given-names>Y.</given-names></name><name><surname>Kang</surname><given-names>S.A.</given-names></name><name><surname>Kuehl</surname><given-names>W.M.</given-names></name><name><surname>Gray</surname><given-names>N.S.</given-names></name><name><surname>Sabatini</surname><given-names>D.M.</given-names></name></person-group><article-title>DEPTOR Is an mTOR Inhibitor Frequently Overexpressed in Multiple Myeloma Cells and Required for Their Survival</article-title><source>Cell</source><year>2009</year><volume>137</volume><fpage>873</fpage><lpage>886</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2009.03.046</pub-id><pub-id pub-id-type="pmid">19446321</pub-id></element-citation></ref><ref id="B27-genes-11-00989"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Harris</surname><given-names>T.E.</given-names></name><name><surname>Lawrence</surname><given-names>J.C.</given-names></name></person-group><article-title>Regulation of Proline-rich Akt Substrate of 40 kDa (PRAS40) Function by Mammalian Target of Rapamycin Complex 1 (mTORC1)-mediated Phosphorylation</article-title><source>J. Biol. Chem.</source><year>2008</year><volume>283</volume><fpage>15619</fpage><lpage>15627</lpage><pub-id pub-id-type="doi">10.1074/jbc.M800723200</pub-id><pub-id pub-id-type="pmid">18372248</pub-id></element-citation></ref><ref id="B28-genes-11-00989"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duan</surname><given-names>S.</given-names></name><name><surname>Skaar</surname><given-names>J.R.</given-names></name><name><surname>Kuchay</surname><given-names>S.</given-names></name><name><surname>Toschi</surname><given-names>A.</given-names></name><name><surname>Kanarek</surname><given-names>N.</given-names></name><name><surname>Ben-Neriah</surname><given-names>Y.</given-names></name><name><surname>Pagano</surname><given-names>M.</given-names></name></person-group><article-title>mTOR generates an auto-amplification loop by triggering the betaTrCP- and CK1alpha-dependent degradation of DEPTOR</article-title><source>Mol. Cell</source><year>2011</year><volume>44</volume><fpage>317</fpage><lpage>324</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2011.09.005</pub-id><pub-id pub-id-type="pmid">22017877</pub-id></element-citation></ref><ref id="B29-genes-11-00989"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>D.</given-names></name><name><surname>Inuzuka</surname><given-names>H.</given-names></name><name><surname>Tan</surname><given-names>M.K.</given-names></name><name><surname>Fukushima</surname><given-names>H.</given-names></name><name><surname>Locasale</surname><given-names>J.W.</given-names></name><name><surname>Liu</surname><given-names>P.</given-names></name><name><surname>Wan</surname><given-names>L.</given-names></name><name><surname>Zhai</surname><given-names>B.</given-names></name><name><surname>Chin</surname><given-names>Y.R.</given-names></name><name><surname>Shaik</surname><given-names>S.</given-names></name><etal/></person-group><article-title>mTOR drives its own activation via SCF(betaTrCP)-dependent degradation of the mTOR inhibitor DEPTOR</article-title><source>Mol. Cell</source><year>2011</year><volume>44</volume><fpage>290</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2011.08.030</pub-id><pub-id pub-id-type="pmid">22017875</pub-id></element-citation></ref><ref id="B30-genes-11-00989"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Xiong</surname><given-names>X.</given-names></name><name><surname>Sun</surname><given-names>Y.</given-names></name></person-group><article-title>DEPTOR, an mTOR inhibitor, is a physiological substrate of SCF(betaTrCP) E3 ubiquitin ligase and regulates survival and autophagy</article-title><source>Mol. Cell</source><year>2011</year><volume>44</volume><fpage>304</fpage><lpage>316</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2011.08.029</pub-id><pub-id pub-id-type="pmid">22017876</pub-id></element-citation></ref><ref id="B31-genes-11-00989"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>X.</given-names></name><name><surname>Lin</surname><given-names>Y.</given-names></name><name><surname>Ortiz-Vega</surname><given-names>S.</given-names></name><name><surname>Yonezawa</surname><given-names>K.</given-names></name><name><surname>Avruch</surname><given-names>J.</given-names></name></person-group><article-title>Rheb Binds and Regulates the mTOR Kinase</article-title><source>Curr. Biol.</source><year>2005</year><volume>15</volume><fpage>702</fpage><lpage>713</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2005.02.053</pub-id><pub-id pub-id-type="pmid">15854902</pub-id></element-citation></ref><ref id="B32-genes-11-00989"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holz</surname><given-names>M.K.</given-names></name><name><surname>Ballif</surname><given-names>B.A.</given-names></name><name><surname>Gygi</surname><given-names>S.P.</given-names></name><name><surname>Blenis</surname><given-names>J.</given-names></name></person-group><article-title>mTOR and S6K1 Mediate Assembly of the Translation Preinitiation Complex through Dynamic Protein Interchange and Ordered Phosphorylation Events</article-title><source>Cell</source><year>2005</year><volume>123</volume><fpage>569</fpage><lpage>580</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2005.10.024</pub-id><pub-id pub-id-type="pmid">16286006</pub-id></element-citation></ref><ref id="B33-genes-11-00989"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paglin</surname><given-names>S.</given-names></name></person-group><article-title>Rapamycin-Sensitive Pathway Regulates Mitochondrial Membrane Potential, Autophagy, and Survival in Irradiated MCF-7 Cells</article-title><source>Cancer Res.</source><year>2005</year><volume>65</volume><fpage>11061</fpage><lpage>11070</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-05-1083</pub-id><pub-id pub-id-type="pmid">16322256</pub-id></element-citation></ref><ref id="B34-genes-11-00989"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thedieck</surname><given-names>K.</given-names></name><name><surname>Holzwarth</surname><given-names>B.</given-names></name><name><surname>Prentzell</surname><given-names>M.T.</given-names></name><name><surname>Boehlke</surname><given-names>C.</given-names></name><name><surname>Klasener</surname><given-names>K.</given-names></name><name><surname>Ruf</surname><given-names>S.</given-names></name><name><surname>Sonntag</surname><given-names>A.G.</given-names></name><name><surname>Maerz</surname><given-names>L.</given-names></name><name><surname>Grellscheid</surname><given-names>S.N.</given-names></name><name><surname>Kremmer</surname><given-names>E.</given-names></name><etal/></person-group><article-title>lInhibition of mTORC1 by astrin and stress granules prevents apoptosis in cancer cels</article-title><source>Cell</source><year>2013</year><volume>154</volume><fpage>859</fpage><lpage>874</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.07.031</pub-id><pub-id pub-id-type="pmid">23953116</pub-id></element-citation></ref><ref id="B35-genes-11-00989"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bridges</surname><given-names>D.</given-names></name><name><surname>Ma</surname><given-names>J.-T.</given-names></name><name><surname>Park</surname><given-names>S.</given-names></name><name><surname>Inoki</surname><given-names>K.</given-names></name><name><surname>Weisman</surname><given-names>L.S.</given-names></name><name><surname>Saltiel</surname><given-names>A.</given-names></name></person-group><article-title>Phosphatidylinositol 3,5-bisphosphate plays a role in the activation and subcellular localization of mechanistic target of rapamycin 1</article-title><source>Mol. Biol. Cell</source><year>2012</year><volume>23</volume><fpage>2955</fpage><lpage>2962</lpage><pub-id pub-id-type="doi">10.1091/mbc.e11-12-1034</pub-id><pub-id pub-id-type="pmid">22696681</pub-id></element-citation></ref><ref id="B36-genes-11-00989"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Betz</surname><given-names>C.</given-names></name><name><surname>Hall</surname><given-names>M.N.</given-names></name></person-group><article-title>Where is mTOR and what is it doing there?</article-title><source>J. Cell Biol.</source><year>2013</year><volume>203</volume><fpage>563</fpage><lpage>574</lpage><pub-id pub-id-type="doi">10.1083/jcb.201306041</pub-id><pub-id pub-id-type="pmid">24385483</pub-id></element-citation></ref><ref id="B37-genes-11-00989"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosner</surname><given-names>M.</given-names></name><name><surname>Hengstschl&#x000e4;ger</surname><given-names>M.</given-names></name></person-group><article-title>Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: Rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1</article-title><source>Hum. Mol. Genet.</source><year>2008</year><volume>17</volume><fpage>2934</fpage><lpage>2948</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddn192</pub-id><pub-id pub-id-type="pmid">18614546</pub-id></element-citation></ref><ref id="B38-genes-11-00989"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saxton</surname><given-names>R.A.</given-names></name><name><surname>Sabatini</surname><given-names>D.M.</given-names></name></person-group><article-title>mTOR Signaling in Growth, Metabolism, and Disease</article-title><source>Cell</source><year>2017</year><volume>169</volume><fpage>361</fpage><lpage>371</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.03.035</pub-id></element-citation></ref><ref id="B39-genes-11-00989"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>X.M.</given-names></name><name><surname>Blenis</surname><given-names>J.</given-names></name></person-group><article-title>Molecular mechanisms of mTOR-mediated translational control</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2009</year><volume>10</volume><fpage>307</fpage><lpage>318</lpage><pub-id pub-id-type="doi">10.1038/nrm2672</pub-id><pub-id pub-id-type="pmid">19339977</pub-id></element-citation></ref><ref id="B40-genes-11-00989"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gingras</surname><given-names>A.-C.</given-names></name><name><surname>Raught</surname><given-names>B.</given-names></name><name><surname>Gygi</surname><given-names>S.P.</given-names></name><name><surname>Nied&#x0017a;wiecka-Korna&#x0015b;</surname><given-names>A.</given-names></name><name><surname>Miron</surname><given-names>M.</given-names></name><name><surname>Burley</surname><given-names>S.K.</given-names></name><name><surname>Polakiewicz</surname><given-names>R.D.</given-names></name><name><surname>Wyslouch-Cieszynska</surname><given-names>A.</given-names></name><name><surname>Aebersold</surname><given-names>R.</given-names></name><name><surname>Sonenberg</surname><given-names>N.</given-names></name></person-group><article-title>Hierarchical phosphorylation of the translation inhibitor 4E-BP1</article-title><source>Genome Res.</source><year>2001</year><volume>15</volume><fpage>2852</fpage><lpage>2864</lpage></element-citation></ref><ref id="B41-genes-11-00989"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gingras</surname><given-names>A.-C.</given-names></name><name><surname>Raught</surname><given-names>B.</given-names></name><name><surname>Sonenberg</surname><given-names>N.</given-names></name></person-group><article-title>eIF4 Initiation Factors: Effectors of mRNA Recruitment to Ribosomes and Regulators of Translation</article-title><source>Annu. Rev. Biochem.</source><year>1999</year><volume>68</volume><fpage>913</fpage><lpage>963</lpage><pub-id pub-id-type="doi">10.1146/annurev.biochem.68.1.913</pub-id><pub-id pub-id-type="pmid">10872469</pub-id></element-citation></ref><ref id="B42-genes-11-00989"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Kundu</surname><given-names>M.</given-names></name><name><surname>Viollet</surname><given-names>B.</given-names></name><name><surname>Guan</surname><given-names>K.-L.</given-names></name></person-group><article-title>AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1</article-title><source>Nat. Cell Biol.</source><year>2011</year><volume>13</volume><fpage>132</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1038/ncb2152</pub-id><pub-id pub-id-type="pmid">21258367</pub-id></element-citation></ref><ref id="B43-genes-11-00989"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porstmann</surname><given-names>T.</given-names></name><name><surname>Santos</surname><given-names>C.R.</given-names></name><name><surname>Griffiths</surname><given-names>B.</given-names></name><name><surname>Cully</surname><given-names>M.</given-names></name><name><surname>Wu</surname><given-names>M.</given-names></name><name><surname>Leevers</surname><given-names>S.</given-names></name><name><surname>Griffiths</surname><given-names>J.R.</given-names></name><name><surname>Chung</surname><given-names>Y.-L.</given-names></name><name><surname>Schulze</surname><given-names>A.</given-names></name></person-group><article-title>SREBP Activity Is Regulated by mTORC1 and Contributes to Akt-Dependent Cell Growth</article-title><source>Cell Metab.</source><year>2008</year><volume>8</volume><fpage>224</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2008.07.007</pub-id><pub-id pub-id-type="pmid">18762023</pub-id></element-citation></ref><ref id="B44-genes-11-00989"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>T.R.</given-names></name><name><surname>Sengupta</surname><given-names>S.S.</given-names></name><name><surname>Harris</surname><given-names>T.E.</given-names></name><name><surname>Carmack</surname><given-names>A.E.</given-names></name><name><surname>Kang</surname><given-names>S.A.</given-names></name><name><surname>Balderas</surname><given-names>E.</given-names></name><name><surname>Guertin</surname><given-names>D.A.</given-names></name><name><surname>Madden</surname><given-names>K.L.</given-names></name><name><surname>Carpenter</surname><given-names>A.E.</given-names></name><name><surname>Finck</surname><given-names>B.N.</given-names></name><etal/></person-group><article-title>mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway</article-title><source>Cell</source><year>2011</year><volume>146</volume><fpage>408</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.06.034</pub-id><pub-id pub-id-type="pmid">21816276</pub-id></element-citation></ref><ref id="B45-genes-11-00989"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x000fc;vel</surname><given-names>K.</given-names></name><name><surname>Yecies</surname><given-names>J.L.</given-names></name><name><surname>Menon</surname><given-names>S.</given-names></name><name><surname>Raman</surname><given-names>P.</given-names></name><name><surname>Lipovsky</surname><given-names>A.I.</given-names></name><name><surname>Souza</surname><given-names>A.L.</given-names></name><name><surname>Triantafellow</surname><given-names>E.</given-names></name><name><surname>Ma</surname><given-names>Q.</given-names></name><name><surname>Gorski</surname><given-names>R.</given-names></name><name><surname>Cleaver</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1</article-title><source>Mol. Cell</source><year>2010</year><volume>39</volume><fpage>171</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2010.06.022</pub-id><pub-id pub-id-type="pmid">20670887</pub-id></element-citation></ref><ref id="B46-genes-11-00989"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Settembre</surname><given-names>C.</given-names></name><name><surname>Zoncu</surname><given-names>R.</given-names></name><name><surname>Medina</surname><given-names>D.L.</given-names></name><name><surname>Vetrini</surname><given-names>F.</given-names></name><name><surname>Erdin</surname><given-names>S.</given-names></name><name><surname>Erdin</surname><given-names>S.</given-names></name><name><surname>Huynh</surname><given-names>T.</given-names></name><name><surname>Ferron</surname><given-names>M.</given-names></name><name><surname>Karsenty</surname><given-names>G.</given-names></name><name><surname>Vellard</surname><given-names>M.C.</given-names></name><etal/></person-group><article-title>A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB</article-title><source>EMBO J.</source><year>2012</year><volume>31</volume><fpage>1095</fpage><lpage>1108</lpage><pub-id pub-id-type="doi">10.1038/emboj.2012.32</pub-id><pub-id pub-id-type="pmid">22343943</pub-id></element-citation></ref><ref id="B47-genes-11-00989"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martina</surname><given-names>J.A.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Gucek</surname><given-names>M.</given-names></name><name><surname>Puertollano</surname><given-names>R.</given-names></name></person-group><article-title>MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB</article-title><source>Autophagy</source><year>2012</year><volume>8</volume><fpage>903</fpage><lpage>914</lpage><pub-id pub-id-type="doi">10.4161/auto.19653</pub-id><pub-id pub-id-type="pmid">22576015</pub-id></element-citation></ref><ref id="B48-genes-11-00989"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roczniak-Ferguson</surname><given-names>A.</given-names></name><name><surname>Petit</surname><given-names>C.S.</given-names></name><name><surname>Froehlich</surname><given-names>F.</given-names></name><name><surname>Qian</surname><given-names>S.</given-names></name><name><surname>Ky</surname><given-names>J.</given-names></name><name><surname>Angarola</surname><given-names>B.</given-names></name><name><surname>Walther</surname><given-names>T.C.</given-names></name><name><surname>Ferguson</surname><given-names>S.M.</given-names></name></person-group><article-title>The Transcription Factor TFEB Links mTORC1 Signaling to Transcriptional Control of Lysosome Homeostasis</article-title><source>Sci. Signal.</source><year>2012</year><volume>5</volume><fpage>ra42</fpage><pub-id pub-id-type="doi">10.1126/scisignal.2002790</pub-id><pub-id pub-id-type="pmid">22692423</pub-id></element-citation></ref><ref id="B49-genes-11-00989"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>P.P.</given-names></name><name><surname>Kang</surname><given-names>S.A.</given-names></name><name><surname>Rameseder</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Ottina</surname><given-names>K.A.</given-names></name><name><surname>Lim</surname><given-names>D.</given-names></name><name><surname>Peterson</surname><given-names>T.R.</given-names></name><name><surname>Choi</surname><given-names>Y.</given-names></name><name><surname>Gray</surname><given-names>N.S.</given-names></name><name><surname>Yaffe</surname><given-names>M.B.</given-names></name><etal/></person-group><article-title>The mTOR-Regulated Phosphoproteome Reveals a Mechanism of mTORC1-Mediated Inhibition of Growth Factor Signaling</article-title><source>Science</source><year>2011</year><volume>332</volume><fpage>1317</fpage><lpage>1322</lpage><pub-id pub-id-type="doi">10.1126/science.1199498</pub-id><pub-id pub-id-type="pmid">21659604</pub-id></element-citation></ref><ref id="B50-genes-11-00989"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>Y.</given-names></name><name><surname>Yoon</surname><given-names>S.-O.</given-names></name><name><surname>Poulogiannis</surname><given-names>G.</given-names></name><name><surname>Yang</surname><given-names>Q.</given-names></name><name><surname>Ma</surname><given-names>X.M.</given-names></name><name><surname>Vill&#x000e9;n</surname><given-names>J.</given-names></name><name><surname>Kubica</surname><given-names>N.</given-names></name><name><surname>Hoffman</surname><given-names>G.R.</given-names></name><name><surname>Cantley</surname><given-names>L.C.</given-names></name><name><surname>Gygi</surname><given-names>S.P.</given-names></name><etal/></person-group><article-title>Phosphoproteomic Analysis Identifies Grb10 as an mTORC1 Substrate That Negatively Regulates Insulin Signaling</article-title><source>Science</source><year>2011</year><volume>332</volume><fpage>1322</fpage><lpage>1326</lpage><pub-id pub-id-type="doi">10.1126/science.1199484</pub-id><pub-id pub-id-type="pmid">21659605</pub-id></element-citation></ref><ref id="B51-genes-11-00989"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>G.Y.</given-names></name><name><surname>Sabatini</surname><given-names>D.M.</given-names></name></person-group><article-title>mTOR at the nexus of nutrition, growth, ageing and disease</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2020</year><volume>21</volume><fpage>183</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.1038/s41580-019-0199-y</pub-id><pub-id pub-id-type="pmid">31937935</pub-id></element-citation></ref><ref id="B52-genes-11-00989"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Q.</given-names></name><name><surname>Inoki</surname><given-names>K.</given-names></name><name><surname>Ikenoue</surname><given-names>T.</given-names></name><name><surname>Guan</surname><given-names>K.-L.</given-names></name></person-group><article-title>Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity</article-title><source>Genes Dev.</source><year>2006</year><volume>20</volume><fpage>2820</fpage><lpage>2832</lpage><pub-id pub-id-type="doi">10.1101/gad.1461206</pub-id><pub-id pub-id-type="pmid">17043309</pub-id></element-citation></ref><ref id="B53-genes-11-00989"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fr&#x000ed;as</surname><given-names>M.A.</given-names></name><name><surname>Thoreen</surname><given-names>C.C.</given-names></name><name><surname>Jaffe</surname><given-names>J.D.</given-names></name><name><surname>Schroder</surname><given-names>W.</given-names></name><name><surname>Sculley</surname><given-names>T.</given-names></name><name><surname>Carr</surname><given-names>S.A.</given-names></name><name><surname>Sabatini</surname><given-names>D.M.</given-names></name></person-group><article-title>mSin1 Is Necessary for Akt/PKB Phosphorylation, and Its Isoforms Define Three Distinct mTORC2s</article-title><source>Curr. Biol.</source><year>2006</year><volume>16</volume><fpage>1865</fpage><lpage>1870</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2006.08.001</pub-id><pub-id pub-id-type="pmid">16919458</pub-id></element-citation></ref><ref id="B54-genes-11-00989"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacinto</surname><given-names>E.</given-names></name><name><surname>Facchinetti</surname><given-names>V.</given-names></name><name><surname>Liu</surname><given-names>D.</given-names></name><name><surname>Soto</surname><given-names>N.</given-names></name><name><surname>Wei</surname><given-names>S.</given-names></name><name><surname>Jung</surname><given-names>S.Y.</given-names></name><name><surname>Huang</surname><given-names>Q.</given-names></name><name><surname>Qin</surname><given-names>J.</given-names></name><name><surname>Su</surname><given-names>B.</given-names></name></person-group><article-title>SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity</article-title><source>Cell</source><year>2006</year><volume>127</volume><fpage>125</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2006.08.033</pub-id><pub-id pub-id-type="pmid">16962653</pub-id></element-citation></ref><ref id="B55-genes-11-00989"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>H.-X.</given-names></name><name><surname>Guan</surname><given-names>K.-L.</given-names></name></person-group><article-title>The SIN1-PH Domain Connects mTORC2 to PI3K</article-title><source>Cancer Discov.</source><year>2015</year><volume>5</volume><fpage>1127</fpage><lpage>1129</lpage><pub-id pub-id-type="doi">10.1158/2159-8290.CD-15-1125</pub-id><pub-id pub-id-type="pmid">26526694</pub-id></element-citation></ref><ref id="B56-genes-11-00989"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>P.</given-names></name><name><surname>Gan</surname><given-names>W.</given-names></name><name><surname>Chin</surname><given-names>Y.R.</given-names></name><name><surname>Ogura</surname><given-names>K.</given-names></name><name><surname>Guo</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>B.</given-names></name><name><surname>Blenis</surname><given-names>J.</given-names></name><name><surname>Cantley</surname><given-names>L.C.</given-names></name><name><surname>Toker</surname><given-names>A.</given-names></name><etal/></person-group><article-title>PtdIns(3,4,5)P3-Dependent Activation of the mTORC2 Kinase Complex</article-title><source>Cancer Discov.</source><year>2015</year><volume>5</volume><fpage>1194</fpage><lpage>1209</lpage><pub-id pub-id-type="doi">10.1158/2159-8290.CD-15-0460</pub-id><pub-id pub-id-type="pmid">26293922</pub-id></element-citation></ref><ref id="B57-genes-11-00989"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pearce</surname><given-names>L.R.</given-names></name><name><surname>Huang</surname><given-names>X.</given-names></name><name><surname>Boudeau</surname><given-names>J.</given-names></name><name><surname>Paw&#x00142;owski</surname><given-names>R.</given-names></name><name><surname>Wullschleger</surname><given-names>S.</given-names></name><name><surname>Deak</surname><given-names>M.</given-names></name><name><surname>Ibrahim</surname><given-names>A.F.M.</given-names></name><name><surname>Gourlay</surname><given-names>R.</given-names></name><name><surname>Magnuson</surname><given-names>M.A.</given-names></name><name><surname>Alessi</surname><given-names>D.R.</given-names></name></person-group><article-title>Identification of Protor as a novel Rictor-binding component of mTOR complex-2</article-title><source>Biochem. J.</source><year>2007</year><volume>405</volume><fpage>513</fpage><lpage>522</lpage><pub-id pub-id-type="doi">10.1042/BJ20070540</pub-id><pub-id pub-id-type="pmid">17461779</pub-id></element-citation></ref><ref id="B58-genes-11-00989"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebner</surname><given-names>M.</given-names></name><name><surname>Sinkovics</surname><given-names>B.</given-names></name><name><surname>Szczygie&#x00142;</surname><given-names>M.</given-names></name><name><surname>Ribeiro</surname><given-names>D.W.</given-names></name><name><surname>Yudushkin</surname><given-names>I.A.</given-names></name></person-group><article-title>Localization of mTORC2 activity inside cells</article-title><source>J. Cell Biol.</source><year>2017</year><volume>216</volume><fpage>343</fpage><lpage>353</lpage><pub-id pub-id-type="doi">10.1083/jcb.201610060</pub-id><pub-id pub-id-type="pmid">28143890</pub-id></element-citation></ref><ref id="B59-genes-11-00989"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Betz</surname><given-names>C.</given-names></name><name><surname>Stracka</surname><given-names>D.</given-names></name><name><surname>Prescianotto-Baschong</surname><given-names>C.</given-names></name><name><surname>Frieden</surname><given-names>M.</given-names></name><name><surname>Demaurex</surname><given-names>N.</given-names></name><name><surname>Hall</surname><given-names>M.N.</given-names></name></person-group><article-title>Feature Article: mTOR complex 2-Akt signaling at mitochondria-associated endoplasmic reticulum membranes (MAM) regulates mitochondrial physiology</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2013</year><volume>110</volume><fpage>12526</fpage><lpage>12534</lpage><pub-id pub-id-type="doi">10.1073/pnas.1302455110</pub-id><pub-id pub-id-type="pmid">23852728</pub-id></element-citation></ref><ref id="B60-genes-11-00989"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gan</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Sommer</surname><given-names>E.</given-names></name><name><surname>Kozasa</surname><given-names>T.</given-names></name><name><surname>Srinivasula</surname><given-names>S.</given-names></name><name><surname>Alessi</surname><given-names>D.</given-names></name><name><surname>Offermanns</surname><given-names>S.</given-names></name><name><surname>Simon</surname><given-names>M.I.</given-names></name><name><surname>Wu</surname><given-names>D.</given-names></name></person-group><article-title>PRR5L degradation promotes mTORC2-mediated PKC-delta phosphorylation and cell migration downstream of Galpha12</article-title><source>Nat. Cell Biol.</source><year>2012</year><volume>14</volume><fpage>686</fpage><lpage>696</lpage><pub-id pub-id-type="doi">10.1038/ncb2507</pub-id><pub-id pub-id-type="pmid">22609986</pub-id></element-citation></ref><ref id="B61-genes-11-00989"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Gao</surname><given-names>T.</given-names></name></person-group><article-title>mTORC2 phosphorylates protein kinase Czeta to regulate its stability and activity</article-title><source>EMBO Rep.</source><year>2014</year><volume>15</volume><fpage>191</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1002/embr.201338119</pub-id><pub-id pub-id-type="pmid">24375676</pub-id></element-citation></ref><ref id="B62-genes-11-00989"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomanetz</surname><given-names>V.</given-names></name><name><surname>Angliker</surname><given-names>N.</given-names></name><name><surname>Clo&#x000eb;tta</surname><given-names>D.</given-names></name><name><surname>Lustenberger</surname><given-names>R.M.</given-names></name><name><surname>Schweighauser</surname><given-names>M.</given-names></name><name><surname>Oliveri</surname><given-names>F.</given-names></name><name><surname>Suzuki</surname><given-names>N.</given-names></name><name><surname>R&#x000fc;egg</surname><given-names>M.A.</given-names></name></person-group><article-title>Ablation of the mTORC2 component rictor in brain or Purkinje cells affects size and neuron morphology</article-title><source>J. Cell Biol.</source><year>2013</year><volume>201</volume><fpage>293</fpage><lpage>308</lpage><pub-id pub-id-type="doi">10.1083/jcb.201205030</pub-id><pub-id pub-id-type="pmid">23569215</pub-id></element-citation></ref><ref id="B63-genes-11-00989"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarbassov</surname><given-names>D.D.</given-names></name><name><surname>Guertin</surname><given-names>D.A.</given-names></name><name><surname>Ali</surname><given-names>S.M.</given-names></name><name><surname>Sabatini</surname><given-names>D.M.</given-names></name></person-group><article-title>Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex</article-title><source>Science</source><year>2005</year><volume>307</volume><fpage>1098</fpage><lpage>1101</lpage><pub-id pub-id-type="doi">10.1126/science.1106148</pub-id><pub-id pub-id-type="pmid">15718470</pub-id></element-citation></ref><ref id="B64-genes-11-00989"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guertin</surname><given-names>D.A.</given-names></name><name><surname>Stevens</surname><given-names>D.M.</given-names></name><name><surname>Thoreen</surname><given-names>C.C.</given-names></name><name><surname>Burds</surname><given-names>A.A.</given-names></name><name><surname>Kalaany</surname><given-names>N.Y.</given-names></name><name><surname>Moffat</surname><given-names>J.</given-names></name><name><surname>Brown</surname><given-names>M.</given-names></name><name><surname>Fitzgerald</surname><given-names>K.J.</given-names></name><name><surname>Sabatini</surname><given-names>D.M.</given-names></name></person-group><article-title>Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1</article-title><source>Dev. Cell</source><year>2006</year><volume>11</volume><fpage>859</fpage><lpage>871</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2006.10.007</pub-id><pub-id pub-id-type="pmid">17141160</pub-id></element-citation></ref><ref id="B65-genes-11-00989"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunet</surname><given-names>A.</given-names></name><name><surname>Bonni</surname><given-names>A.</given-names></name><name><surname>Zigmond</surname><given-names>M.J.</given-names></name><name><surname>Lin</surname><given-names>M.Z.</given-names></name><name><surname>Juo</surname><given-names>P.</given-names></name><name><surname>Hu</surname><given-names>L.S.</given-names></name><name><surname>Anderson</surname><given-names>M.J.</given-names></name><name><surname>Arden</surname><given-names>K.C.</given-names></name><name><surname>Blenis</surname><given-names>J.</given-names></name><name><surname>Greenberg</surname><given-names>M.E.</given-names></name></person-group><article-title>Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor</article-title><source>Cell</source><year>1999</year><volume>96</volume><fpage>857</fpage><lpage>868</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)80595-4</pub-id><pub-id pub-id-type="pmid">10102273</pub-id></element-citation></ref><ref id="B66-genes-11-00989"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manning</surname><given-names>B.D.</given-names></name><name><surname>Tee</surname><given-names>A.R.</given-names></name><name><surname>Logsdon</surname><given-names>M.N.</given-names></name><name><surname>Blenis</surname><given-names>J.</given-names></name><name><surname>Cantley</surname><given-names>L.C.</given-names></name></person-group><article-title>Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway</article-title><source>Mol. Cell</source><year>2002</year><volume>10</volume><fpage>151</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1016/S1097-2765(02)00568-3</pub-id><pub-id pub-id-type="pmid">12150915</pub-id></element-citation></ref><ref id="B67-genes-11-00989"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a-Mart&#x000ed;nez</surname><given-names>J.M.</given-names></name><name><surname>Alessi</surname><given-names>D.R.</given-names></name></person-group><article-title>mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1)</article-title><source>Biochem. J.</source><year>2008</year><volume>416</volume><fpage>375</fpage><lpage>385</lpage><pub-id pub-id-type="doi">10.1042/BJ20081668</pub-id><pub-id pub-id-type="pmid">18925875</pub-id></element-citation></ref><ref id="B68-genes-11-00989"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>W.J.</given-names></name><name><surname>Jacinto</surname><given-names>E.</given-names></name></person-group><article-title>mTOR complex 2 signaling and functions</article-title><source>Cell Cycle</source><year>2011</year><volume>10</volume><fpage>2305</fpage><lpage>2316</lpage><pub-id pub-id-type="doi">10.4161/cc.10.14.16586</pub-id><pub-id pub-id-type="pmid">21670596</pub-id></element-citation></ref><ref id="B69-genes-11-00989"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dibble</surname><given-names>C.C.</given-names></name><name><surname>Elis</surname><given-names>W.</given-names></name><name><surname>Menon</surname><given-names>S.</given-names></name><name><surname>Qin</surname><given-names>W.</given-names></name><name><surname>Klekota</surname><given-names>J.</given-names></name><name><surname>Asara</surname><given-names>J.M.</given-names></name><name><surname>Finan</surname><given-names>P.M.</given-names></name><name><surname>Kwiatkowski</surname><given-names>D.J.</given-names></name><name><surname>Murphy</surname><given-names>L.O.</given-names></name><name><surname>Manning</surname><given-names>B.D.</given-names></name></person-group><article-title>TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1</article-title><source>Mol. Cell</source><year>2012</year><volume>47</volume><fpage>535</fpage><lpage>546</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2012.06.009</pub-id><pub-id pub-id-type="pmid">22795129</pub-id></element-citation></ref><ref id="B70-genes-11-00989"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inoki</surname><given-names>K.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>T.</given-names></name><name><surname>Guan</surname><given-names>K.-L.</given-names></name></person-group><article-title>Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling</article-title><source>Genes Dev.</source><year>2003</year><volume>17</volume><fpage>1829</fpage><lpage>1834</lpage><pub-id pub-id-type="doi">10.1101/gad.1110003</pub-id><pub-id pub-id-type="pmid">12869586</pub-id></element-citation></ref><ref id="B71-genes-11-00989"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tee</surname><given-names>A.R.</given-names></name><name><surname>Manning</surname><given-names>B.D.</given-names></name><name><surname>Roux</surname><given-names>P.P.</given-names></name><name><surname>Cantley</surname><given-names>L.C.</given-names></name><name><surname>Blenis</surname><given-names>J.</given-names></name></person-group><article-title>Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb</article-title><source>Curr. Biol.</source><year>2003</year><volume>13</volume><fpage>1259</fpage><lpage>1268</lpage><pub-id pub-id-type="doi">10.1016/S0960-9822(03)00506-2</pub-id><pub-id pub-id-type="pmid">12906785</pub-id></element-citation></ref><ref id="B72-genes-11-00989"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Jiang</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Yang</surname><given-names>H.J.</given-names></name><name><surname>Miller</surname><given-names>M.</given-names></name><name><surname>Yang</surname><given-names>A.</given-names></name><name><surname>Dhar</surname><given-names>A.</given-names></name><name><surname>Pavletich</surname><given-names>N.P.</given-names></name></person-group><article-title>Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40</article-title><source>Nature</source><year>2017</year><volume>552</volume><fpage>368</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.1038/nature25023</pub-id><pub-id pub-id-type="pmid">29236692</pub-id></element-citation></ref><ref id="B73-genes-11-00989"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potter</surname><given-names>C.J.</given-names></name><name><surname>Pedraza</surname><given-names>L.G.</given-names></name><name><surname>Xu</surname><given-names>T.</given-names></name></person-group><article-title>Akt regulates growth by directly phosphorylating Tsc2</article-title><source>Nat. Cell Biol.</source><year>2002</year><volume>4</volume><fpage>658</fpage><lpage>665</lpage><pub-id pub-id-type="doi">10.1038/ncb840</pub-id><pub-id pub-id-type="pmid">12172554</pub-id></element-citation></ref><ref id="B74-genes-11-00989"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Erdjument-Bromage</surname><given-names>H.</given-names></name><name><surname>Tempst</surname><given-names>P.</given-names></name><name><surname>Pandolfi</surname><given-names>P.P.</given-names></name></person-group><article-title>Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis</article-title><source>Cell</source><year>2005</year><volume>121</volume><fpage>179</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2005.02.031</pub-id><pub-id pub-id-type="pmid">15851026</pub-id></element-citation></ref><ref id="B75-genes-11-00989"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roux</surname><given-names>P.P.</given-names></name><name><surname>Ballif</surname><given-names>B.A.</given-names></name><name><surname>Anjum</surname><given-names>R.</given-names></name><name><surname>Gygi</surname><given-names>S.P.</given-names></name><name><surname>Blenis</surname><given-names>J.</given-names></name></person-group><article-title>Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2004</year><volume>101</volume><fpage>13489</fpage><lpage>13494</lpage><pub-id pub-id-type="doi">10.1073/pnas.0405659101</pub-id><pub-id pub-id-type="pmid">15342917</pub-id></element-citation></ref><ref id="B76-genes-11-00989"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>D.F.</given-names></name><name><surname>Kuo</surname><given-names>H.P.</given-names></name><name><surname>Chen</surname><given-names>C.T.</given-names></name><name><surname>Hsu</surname><given-names>J.M.</given-names></name><name><surname>Chou</surname><given-names>C.K.</given-names></name><name><surname>Wei</surname><given-names>Y.</given-names></name><name><surname>Sun</surname><given-names>H.L.</given-names></name><name><surname>Li</surname><given-names>L.Y.</given-names></name><name><surname>Ping</surname><given-names>B.</given-names></name><name><surname>Huang</surname><given-names>W.C.</given-names></name><etal/></person-group><article-title>IKK &#x003b2; suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway</article-title><source>Cell</source><year>2007</year><volume>130</volume><fpage>440</fpage><lpage>455</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.05.058</pub-id><pub-id pub-id-type="pmid">17693255</pub-id></element-citation></ref><ref id="B77-genes-11-00989"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Inoki</surname><given-names>K.</given-names></name><name><surname>Vacratsis</surname><given-names>P.</given-names></name><name><surname>Guan</surname><given-names>K.-L.</given-names></name></person-group><article-title>The p38 and MK2 Kinase Cascade Phosphorylates Tuberin, the Tuberous Sclerosis 2 Gene Product, and Enhances Its Interaction with 14-3-3</article-title><source>J. Biol. Chem.</source><year>2003</year><volume>278</volume><fpage>13663</fpage><lpage>13671</lpage><pub-id pub-id-type="doi">10.1074/jbc.M300862200</pub-id><pub-id pub-id-type="pmid">12582162</pub-id></element-citation></ref><ref id="B78-genes-11-00989"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tee</surname><given-names>A.R.</given-names></name><name><surname>Anjum</surname><given-names>R.</given-names></name><name><surname>Blenis</surname><given-names>J.</given-names></name></person-group><article-title>Inactivation of the Tuberous Sclerosis Complex-1 and -2 Gene Products Occurs by Phosphoinositide 3-Kinase/Akt-dependent and -independent Phosphorylation of Tuberin</article-title><source>J. Biol. Chem.</source><year>2003</year><volume>278</volume><fpage>37288</fpage><lpage>37296</lpage><pub-id pub-id-type="doi">10.1074/jbc.M303257200</pub-id><pub-id pub-id-type="pmid">12867426</pub-id></element-citation></ref><ref id="B79-genes-11-00989"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kopera</surname><given-names>H.C.</given-names></name><name><surname>Inoki</surname><given-names>K.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Zhu</surname><given-names>T.</given-names></name><name><surname>Garcia-Gonzalo</surname><given-names>F.R.</given-names></name><name><surname>Rosa</surname><given-names>J.L.</given-names></name><name><surname>Guan</surname><given-names>K.-L.</given-names></name></person-group><article-title>TSC1 Stabilizes TSC2 by Inhibiting the Interaction between TSC2 and the HERC1 Ubiquitin Ligase</article-title><source>J. Biol. Chem.</source><year>2006</year><volume>281</volume><fpage>8313</fpage><lpage>8316</lpage><pub-id pub-id-type="doi">10.1074/jbc.C500451200</pub-id><pub-id pub-id-type="pmid">16464865</pub-id></element-citation></ref><ref id="B80-genes-11-00989"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benvenuto</surname><given-names>G.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Brown</surname><given-names>S.J.</given-names></name><name><surname>Braverman</surname><given-names>R.</given-names></name><name><surname>Vass</surname><given-names>W.C.</given-names></name><name><surname>Cheadle</surname><given-names>J.P.</given-names></name><name><surname>Halley</surname><given-names>D.J.</given-names></name><name><surname>Sampson</surname><given-names>J.R.</given-names></name><name><surname>Wienecke</surname><given-names>R.</given-names></name><name><surname>DeClue</surname><given-names>J.E.</given-names></name></person-group><article-title>The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination</article-title><source>Oncogene</source><year>2000</year><volume>19</volume><fpage>6306</fpage><lpage>6316</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1204009</pub-id><pub-id pub-id-type="pmid">11175345</pub-id></element-citation></ref><ref id="B81-genes-11-00989"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghislat</surname><given-names>G.</given-names></name><name><surname>Patron</surname><given-names>M.</given-names></name><name><surname>Rizzuto</surname><given-names>R.</given-names></name><name><surname>Knecht</surname><given-names>E.</given-names></name></person-group><article-title>Withdrawal of essential amino acids increases autophagy by a pathway involving Ca2+/calmodulin-dependent kinase kinase-&#x003b2; (CaMKK-&#x003b2;)</article-title><source>J. Biol. Chem.</source><year>2012</year><volume>287</volume><fpage>38625</fpage><lpage>38636</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.365767</pub-id><pub-id pub-id-type="pmid">23027865</pub-id></element-citation></ref><ref id="B82-genes-11-00989"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Efeyan</surname><given-names>A.</given-names></name><name><surname>Zoncu</surname><given-names>R.</given-names></name><name><surname>Chang</surname><given-names>S.</given-names></name><name><surname>Gumper</surname><given-names>I.</given-names></name><name><surname>Snitkin</surname><given-names>H.</given-names></name><name><surname>Wolfson</surname><given-names>R.L.</given-names></name><name><surname>Kirak</surname><given-names>O.</given-names></name><name><surname>Sabatini</surname><given-names>D.D.</given-names></name><name><surname>Sabatini</surname><given-names>D.M.</given-names></name></person-group><article-title>Regulation of mTORC1 by the Rag GTPases is necessary for neonatal autophagy and survival</article-title><source>Nature</source><year>2012</year><volume>493</volume><fpage>679</fpage><lpage>683</lpage><pub-id pub-id-type="doi">10.1038/nature11745</pub-id><pub-id pub-id-type="pmid">23263183</pub-id></element-citation></ref><ref id="B83-genes-11-00989"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pezze</surname><given-names>P.D.</given-names></name><name><surname>Ruf</surname><given-names>S.</given-names></name><name><surname>Sonntag</surname><given-names>A.G.</given-names></name><name><surname>Langelaar-Makkinje</surname><given-names>M.</given-names></name><name><surname>Hall</surname><given-names>P.</given-names></name><name><surname>Heberle</surname><given-names>A.M.</given-names></name><name><surname>Navas</surname><given-names>P.R.</given-names></name><name><surname>Van Eunen</surname><given-names>K.</given-names></name><name><surname>T&#x000f6;lle</surname><given-names>R.C.</given-names></name><name><surname>Schwarz</surname><given-names>J.J.</given-names></name><etal/></person-group><article-title>A systems study reveals concurrent activation of AMPK and mTOR by amino acids</article-title><source>Nat. Commun.</source><year>2016</year><volume>7</volume><fpage>13254</fpage><pub-id pub-id-type="doi">10.1038/ncomms13254</pub-id><pub-id pub-id-type="pmid">27869123</pub-id></element-citation></ref><ref id="B84-genes-11-00989"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanders</surname><given-names>M.J.</given-names></name><name><surname>Grondin</surname><given-names>P.O.</given-names></name><name><surname>Hegarty</surname><given-names>B.D.</given-names></name><name><surname>Snowden</surname><given-names>M.A.</given-names></name><name><surname>Carling</surname><given-names>D.</given-names></name></person-group><article-title>Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade</article-title><source>Biochem. J.</source><year>2007</year><volume>403</volume><fpage>139</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1042/BJ20061520</pub-id><pub-id pub-id-type="pmid">17147517</pub-id></element-citation></ref><ref id="B85-genes-11-00989"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corradetti</surname><given-names>M.N.</given-names></name><name><surname>Inoki</surname><given-names>K.</given-names></name><name><surname>Bardeesy</surname><given-names>N.</given-names></name><name><surname>Depinho</surname><given-names>R.A.</given-names></name><name><surname>Guan</surname><given-names>K.-L.</given-names></name></person-group><article-title>Regulation of the TSC pathway by LKB1: Evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome</article-title><source>Genes Dev.</source><year>2004</year><volume>18</volume><fpage>1533</fpage><lpage>1538</lpage><pub-id pub-id-type="doi">10.1101/gad.1199104</pub-id><pub-id pub-id-type="pmid">15231735</pub-id></element-citation></ref><ref id="B86-genes-11-00989"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gwinn</surname><given-names>D.M.</given-names></name><name><surname>Shackelford</surname><given-names>D.B.</given-names></name><name><surname>Egan</surname><given-names>D.F.</given-names></name><name><surname>Mihaylova</surname><given-names>M.M.</given-names></name><name><surname>M&#x000e9;ry</surname><given-names>A.</given-names></name><name><surname>Vasquez</surname><given-names>D.S.</given-names></name><name><surname>Turk</surname><given-names>B.E.</given-names></name><name><surname>Shaw</surname><given-names>R.J.</given-names></name></person-group><article-title>AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint</article-title><source>Mol. Cell</source><year>2008</year><volume>30</volume><fpage>214</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2008.03.003</pub-id><pub-id pub-id-type="pmid">18439900</pub-id></element-citation></ref><ref id="B87-genes-11-00989"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>Z.</given-names></name><name><surname>Hu</surname><given-names>W.</given-names></name><name><surname>De Stanchina</surname><given-names>E.</given-names></name><name><surname>Teresky</surname><given-names>A.K.</given-names></name><name><surname>Jin</surname><given-names>S.</given-names></name><name><surname>Lowe</surname><given-names>S.</given-names></name><name><surname>Levine</surname><given-names>A.J.</given-names></name></person-group><article-title>The Regulation of AMPK &#x003b2;1, TSC2, and PTEN Expression by p53: Stress, Cell and Tissue Specificity, and the Role of These Gene Products in Modulating the IGF-1-AKT-mTOR Pathways</article-title><source>Cancer Res.</source><year>2007</year><volume>67</volume><fpage>3043</fpage><lpage>3053</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-06-4149</pub-id><pub-id pub-id-type="pmid">17409411</pub-id></element-citation></ref><ref id="B88-genes-11-00989"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brugarolas</surname><given-names>J.</given-names></name><name><surname>Lei</surname><given-names>K.</given-names></name><name><surname>Hurley</surname><given-names>R.L.</given-names></name><name><surname>Manning</surname><given-names>B.D.</given-names></name><name><surname>Reiling</surname><given-names>J.H.</given-names></name><name><surname>Hafen</surname><given-names>E.</given-names></name><name><surname>Witters</surname><given-names>L.A.</given-names></name><name><surname>Ellisen</surname><given-names>L.W.</given-names></name><name><surname>Kaelin</surname><given-names>W.G.</given-names></name></person-group><article-title>Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex</article-title><source>Genes Dev.</source><year>2004</year><volume>18</volume><fpage>2893</fpage><lpage>2904</lpage><pub-id pub-id-type="doi">10.1101/gad.1256804</pub-id><pub-id pub-id-type="pmid">15545625</pub-id></element-citation></ref><ref id="B89-genes-11-00989"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reiling</surname><given-names>J.H.</given-names></name><name><surname>Hafen</surname><given-names>E.</given-names></name></person-group><article-title>The hypoxia-induced paralogs Scylla and Charybdis inhibit growth by down-regulating S6K activity upstream of TSC in Drosophila</article-title><source>Genes Dev.</source><year>2004</year><volume>18</volume><fpage>2879</fpage><lpage>2892</lpage><pub-id pub-id-type="doi">10.1101/gad.322704</pub-id><pub-id pub-id-type="pmid">15545626</pub-id></element-citation></ref><ref id="B90-genes-11-00989"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sancak</surname><given-names>Y.</given-names></name><name><surname>Peterson</surname><given-names>T.R.</given-names></name><name><surname>Shaul</surname><given-names>Y.D.</given-names></name><name><surname>Lindquist</surname><given-names>R.A.</given-names></name><name><surname>Thoreen</surname><given-names>C.C.</given-names></name><name><surname>Bar-Peled</surname><given-names>L.</given-names></name><name><surname>Sabatini</surname><given-names>D.M.</given-names></name></person-group><article-title>The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1</article-title><source>Science</source><year>2008</year><volume>320</volume><fpage>1496</fpage><lpage>1501</lpage><pub-id pub-id-type="doi">10.1126/science.1157535</pub-id><pub-id pub-id-type="pmid">18497260</pub-id></element-citation></ref><ref id="B91-genes-11-00989"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sancak</surname><given-names>Y.</given-names></name><name><surname>Bar-Peled</surname><given-names>L.</given-names></name><name><surname>Zoncu</surname><given-names>R.</given-names></name><name><surname>Markhard</surname><given-names>A.L.</given-names></name><name><surname>Nada</surname><given-names>S.</given-names></name><name><surname>Sabatini</surname><given-names>D.M.</given-names></name></person-group><article-title>Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids</article-title><source>Cell</source><year>2010</year><volume>141</volume><fpage>290</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.02.024</pub-id><pub-id pub-id-type="pmid">20381137</pub-id></element-citation></ref><ref id="B92-genes-11-00989"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hara</surname><given-names>K.</given-names></name><name><surname>Yonezawa</surname><given-names>K.</given-names></name><name><surname>Weng</surname><given-names>Q.-P.</given-names></name><name><surname>Kozlowski</surname><given-names>M.T.</given-names></name><name><surname>Belham</surname><given-names>C.</given-names></name><name><surname>Avruch</surname><given-names>J.</given-names></name></person-group><article-title>Amino Acid Sufficiency and mTOR Regulate p70 S6 Kinase and eIF-4E BP1 through a Common Effector Mechanism</article-title><source>J. Biol. Chem.</source><year>1998</year><volume>273</volume><fpage>14484</fpage><lpage>14494</lpage><pub-id pub-id-type="doi">10.1074/jbc.273.23.14484</pub-id><pub-id pub-id-type="pmid">9603962</pub-id></element-citation></ref><ref id="B93-genes-11-00989"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>X.</given-names></name><name><surname>Ortiz-Vega</surname><given-names>S.</given-names></name><name><surname>Lin</surname><given-names>Y.</given-names></name><name><surname>Avruch</surname><given-names>J.</given-names></name></person-group><article-title>Rheb Binding to Mammalian Target of Rapamycin (mTOR) Is Regulated by Amino Acid Sufficiency</article-title><source>J. Biol. Chem.</source><year>2005</year><volume>280</volume><fpage>23433</fpage><lpage>23436</lpage><pub-id pub-id-type="doi">10.1074/jbc.C500169200</pub-id><pub-id pub-id-type="pmid">15878852</pub-id></element-citation></ref><ref id="B94-genes-11-00989"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Byfield</surname><given-names>M.P.</given-names></name><name><surname>Murray</surname><given-names>J.T.</given-names></name><name><surname>Backer</surname><given-names>J.M.</given-names></name></person-group><article-title>hVps34 Is a Nutrient-regulated Lipid Kinase Required for Activation of p70 S6 Kinase</article-title><source>J. Biol. Chem.</source><year>2005</year><volume>280</volume><fpage>33076</fpage><lpage>33082</lpage><pub-id pub-id-type="doi">10.1074/jbc.M507201200</pub-id><pub-id pub-id-type="pmid">16049009</pub-id></element-citation></ref><ref id="B95-genes-11-00989"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nobukuni</surname><given-names>T.</given-names></name><name><surname>Joaquin</surname><given-names>M.</given-names></name><name><surname>Roccio</surname><given-names>M.</given-names></name><name><surname>Dann</surname><given-names>S.G.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name><name><surname>Gulati</surname><given-names>P.</given-names></name><name><surname>Byfield</surname><given-names>M.P.</given-names></name><name><surname>Backer</surname><given-names>J.M.</given-names></name><name><surname>Natt</surname><given-names>F.</given-names></name><name><surname>Bos</surname><given-names>J.L.</given-names></name><etal/></person-group><article-title>Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2005</year><volume>102</volume><fpage>14238</fpage><lpage>14243</lpage><pub-id pub-id-type="doi">10.1073/pnas.0506925102</pub-id><pub-id pub-id-type="pmid">16176982</pub-id></element-citation></ref><ref id="B96-genes-11-00989"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>E.M.</given-names></name><name><surname>Finn</surname><given-names>S.G.</given-names></name><name><surname>Tee</surname><given-names>A.R.</given-names></name><name><surname>Browne</surname><given-names>G.J.</given-names></name><name><surname>Proud</surname><given-names>C.</given-names></name></person-group><article-title>The Tuberous Sclerosis Protein TSC2 Is Not Required for the Regulation of the Mammalian Target of Rapamycin by Amino Acids and Certain Cellular Stresses</article-title><source>J. Biol. Chem.</source><year>2005</year><volume>280</volume><fpage>18717</fpage><lpage>18727</lpage><pub-id pub-id-type="doi">10.1074/jbc.M414499200</pub-id><pub-id pub-id-type="pmid">15772076</pub-id></element-citation></ref><ref id="B97-genes-11-00989"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>E.</given-names></name><name><surname>Goraksha-Hicks</surname><given-names>P.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Neufeld</surname><given-names>T.P.</given-names></name><name><surname>Guan</surname><given-names>K.-L.</given-names></name></person-group><article-title>Regulation of TORC1 by Rag GTPases in nutrient response</article-title><source>Nat. Cell Biol.</source><year>2008</year><volume>10</volume><fpage>935</fpage><lpage>945</lpage><pub-id pub-id-type="doi">10.1038/ncb1753</pub-id><pub-id pub-id-type="pmid">18604198</pub-id></element-citation></ref><ref id="B98-genes-11-00989"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sekiguchi</surname><given-names>T.</given-names></name><name><surname>Hirose</surname><given-names>E.</given-names></name><name><surname>Nakashima</surname><given-names>N.</given-names></name><name><surname>Ii</surname><given-names>M.</given-names></name><name><surname>Nishimoto</surname><given-names>T.</given-names></name></person-group><article-title>Novel G Proteins, Rag C and Rag D, Interact with GTP-binding Proteins, Rag A and Rag B</article-title><source>J. Biol. Chem.</source><year>2000</year><volume>276</volume><fpage>7246</fpage><lpage>7257</lpage><pub-id pub-id-type="doi">10.1074/jbc.M004389200</pub-id><pub-id pub-id-type="pmid">11073942</pub-id></element-citation></ref><ref id="B99-genes-11-00989"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jewell</surname><given-names>J.L.</given-names></name><name><surname>Kim</surname><given-names>Y.C.</given-names></name><name><surname>Russell</surname><given-names>R.C.</given-names></name><name><surname>Yu</surname><given-names>F.-X.</given-names></name><name><surname>Park</surname><given-names>H.W.</given-names></name><name><surname>Plouffe</surname><given-names>S.W.</given-names></name><name><surname>Tagliabracci</surname><given-names>V.S.</given-names></name><name><surname>Guan</surname><given-names>K.-L.</given-names></name></person-group><article-title>Differential regulation of mTORC1 by leucine and glutamine</article-title><source>Science</source><year>2015</year><volume>347</volume><fpage>194</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1126/science.1259472</pub-id><pub-id pub-id-type="pmid">25567907</pub-id></element-citation></ref><ref id="B100-genes-11-00989"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bar-Peled</surname><given-names>L.</given-names></name><name><surname>Schweitzer</surname><given-names>L.D.</given-names></name><name><surname>Zoncu</surname><given-names>R.</given-names></name><name><surname>Sabatini</surname><given-names>D.M.</given-names></name></person-group><article-title>Ragulator Is a GEF for the Rag GTPases that Signal Amino Acid Levels to mTORC1</article-title><source>Cell</source><year>2012</year><volume>150</volume><fpage>1196</fpage><lpage>1208</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2012.07.032</pub-id><pub-id pub-id-type="pmid">22980980</pub-id></element-citation></ref><ref id="B101-genes-11-00989"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nada</surname><given-names>S.</given-names></name><name><surname>Hondo</surname><given-names>A.</given-names></name><name><surname>Kasai</surname><given-names>A.</given-names></name><name><surname>Koike</surname><given-names>M.</given-names></name><name><surname>Saito</surname><given-names>K.</given-names></name><name><surname>Uchiyama</surname><given-names>Y.</given-names></name><name><surname>Okada</surname><given-names>M.</given-names></name></person-group><article-title>The novel lipid raft adaptor p18 controls endosome dynamics by anchoring the MEK&#x02013;ERK pathway to late endosomes</article-title><source>EMBO J.</source><year>2009</year><volume>28</volume><fpage>477</fpage><lpage>489</lpage><pub-id pub-id-type="doi">10.1038/emboj.2008.308</pub-id><pub-id pub-id-type="pmid">19177150</pub-id></element-citation></ref><ref id="B102-genes-11-00989"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>K.</given-names></name><name><surname>Sabatini</surname><given-names>D.M.</given-names></name></person-group><article-title>Ragulator and SLC38A9 activate the Rag GTPases through noncanonical GEF mechanisms</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2018</year><volume>115</volume><fpage>9545</fpage><lpage>9550</lpage><pub-id pub-id-type="doi">10.1073/pnas.1811727115</pub-id><pub-id pub-id-type="pmid">30181260</pub-id></element-citation></ref><ref id="B103-genes-11-00989"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jewell</surname><given-names>J.L.</given-names></name><name><surname>Russell</surname><given-names>R.C.</given-names></name><name><surname>Guan</surname><given-names>K.-L.</given-names></name></person-group><article-title>Amino acid signalling upstream of mTOR</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2013</year><volume>14</volume><fpage>133</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.1038/nrm3522</pub-id><pub-id pub-id-type="pmid">23361334</pub-id></element-citation></ref><ref id="B104-genes-11-00989"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zoncu</surname><given-names>R.</given-names></name><name><surname>Bar-Peled</surname><given-names>L.</given-names></name><name><surname>Efeyan</surname><given-names>A.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Sancak</surname><given-names>Y.</given-names></name><name><surname>Sabatini</surname><given-names>D.M.</given-names></name></person-group><article-title>mTORC1 Senses Lysosomal Amino Acids Through an Inside-Out Mechanism That Requires the Vacuolar H+-ATPase</article-title><source>Science</source><year>2011</year><volume>334</volume><fpage>678</fpage><lpage>683</lpage><pub-id pub-id-type="doi">10.1126/science.1207056</pub-id><pub-id pub-id-type="pmid">22053050</pub-id></element-citation></ref><ref id="B105-genes-11-00989"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wyant</surname><given-names>G.A.</given-names></name><name><surname>Abu-Remaileh</surname><given-names>M.</given-names></name><name><surname>Wolfson</surname><given-names>R.L.</given-names></name><name><surname>Chen</surname><given-names>W.W.</given-names></name><name><surname>Freinkman</surname><given-names>E.</given-names></name><name><surname>Danai</surname><given-names>L.V.</given-names></name><name><surname>Heiden</surname><given-names>M.G.V.</given-names></name><name><surname>Sabatini</surname><given-names>D.M.</given-names></name></person-group><article-title>mTORC1 Activator SLC38A9 Is Required to Efflux Essential Amino Acids from Lysosomes and Use Protein as a Nutrient</article-title><source>Cell</source><year>2017</year><volume>171</volume><fpage>642</fpage><lpage>654</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.09.046</pub-id><pub-id pub-id-type="pmid">29053970</pub-id></element-citation></ref><ref id="B106-genes-11-00989"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bar-Peled</surname><given-names>L.</given-names></name><name><surname>Chantranupong</surname><given-names>L.</given-names></name><name><surname>Cherniack</surname><given-names>A.D.</given-names></name><name><surname>Chen</surname><given-names>W.W.</given-names></name><name><surname>Ottina</surname><given-names>K.A.</given-names></name><name><surname>Grabiner</surname><given-names>B.C.</given-names></name><name><surname>Spear</surname><given-names>E.D.</given-names></name><name><surname>Carter</surname><given-names>S.L.</given-names></name><name><surname>Meyerson</surname><given-names>M.</given-names></name><name><surname>Sabatini</surname><given-names>D.M.</given-names></name></person-group><article-title>A Tumor Suppressor Complex with GAP Activity for the Rag GTPases That Signal Amino Acid Sufficiency to mTORC1</article-title><source>Science</source><year>2013</year><volume>340</volume><fpage>1100</fpage><lpage>1106</lpage><pub-id pub-id-type="doi">10.1126/science.1232044</pub-id><pub-id pub-id-type="pmid">23723238</pub-id></element-citation></ref><ref id="B107-genes-11-00989"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>K.</given-names></name><name><surname>Huang</surname><given-names>R.K.</given-names></name><name><surname>Brignole</surname><given-names>E.J.</given-names></name><name><surname>Condon</surname><given-names>K.J.</given-names></name><name><surname>Valenstein</surname><given-names>M.L.</given-names></name><name><surname>Chantranupong</surname><given-names>L.</given-names></name><name><surname>Bomaliyamu</surname><given-names>A.</given-names></name><name><surname>Choe</surname><given-names>A.</given-names></name><name><surname>Hong</surname><given-names>C.</given-names></name><name><surname>Yu</surname><given-names>Z.</given-names></name><etal/></person-group><article-title>Architecture of the human GATOR1 and GATOR1&#x02013;Rag GTPases complexes</article-title><source>Nature</source><year>2018</year><volume>556</volume><fpage>64</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1038/nature26158</pub-id><pub-id pub-id-type="pmid">29590090</pub-id></element-citation></ref><ref id="B108-genes-11-00989"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolfson</surname><given-names>R.L.</given-names></name><name><surname>Chantranupong</surname><given-names>L.</given-names></name><name><surname>Wyant</surname><given-names>G.A.</given-names></name><name><surname>Gu</surname><given-names>X.</given-names></name><name><surname>Orozco</surname><given-names>J.M.</given-names></name><name><surname>Shen</surname><given-names>K.</given-names></name><name><surname>Condon</surname><given-names>K.J.</given-names></name><name><surname>Petri</surname><given-names>S.</given-names></name><name><surname>Kedir</surname><given-names>J.</given-names></name><name><surname>Scaria</surname><given-names>S.M.</given-names></name><etal/></person-group><article-title>KICSTOR recruits GATOR1 to the lysosome and is necessary for nutrients to regulate mTORC1</article-title><source>Nature</source><year>2017</year><volume>543</volume><fpage>438</fpage><lpage>442</lpage><pub-id pub-id-type="doi">10.1038/nature21423</pub-id><pub-id pub-id-type="pmid">28199306</pub-id></element-citation></ref><ref id="B109-genes-11-00989"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>M.</given-names></name><name><surname>Yin</surname><given-names>N.</given-names></name><name><surname>Li</surname><given-names>M.O.</given-names></name></person-group><article-title>SZT2 dictates GATOR control of mTORC1 signalling</article-title><source>Nature</source><year>2017</year><volume>543</volume><fpage>433</fpage><lpage>437</lpage><pub-id pub-id-type="doi">10.1038/nature21378</pub-id><pub-id pub-id-type="pmid">28199315</pub-id></element-citation></ref><ref id="B110-genes-11-00989"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petit</surname><given-names>C.S.</given-names></name><name><surname>Roczniak-Ferguson</surname><given-names>A.</given-names></name><name><surname>Ferguson</surname><given-names>S.M.</given-names></name></person-group><article-title>Recruitment of folliculin to lysosomes supports the amino acid&#x02013;dependent activation of Rag GTPases</article-title><source>J. Cell Biol.</source><year>2013</year><volume>202</volume><fpage>1107</fpage><lpage>1122</lpage><pub-id pub-id-type="doi">10.1083/jcb.201307084</pub-id><pub-id pub-id-type="pmid">24081491</pub-id></element-citation></ref><ref id="B111-genes-11-00989"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsun</surname><given-names>Z.-Y.</given-names></name><name><surname>Bar-Peled</surname><given-names>L.</given-names></name><name><surname>Chantranupong</surname><given-names>L.</given-names></name><name><surname>Zoncu</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>T.C.</given-names></name><name><surname>Kim</surname><given-names>C.</given-names></name><name><surname>Spooner</surname><given-names>E.</given-names></name><name><surname>Sabatini</surname><given-names>D.M.</given-names></name></person-group><article-title>The folliculin tumor suppressor is a GAP for the RagC/D GTPases that signal amino acid levels to mTORC1</article-title><source>Mol. Cell</source><year>2013</year><volume>52</volume><fpage>495</fpage><lpage>505</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2013.09.016</pub-id><pub-id pub-id-type="pmid">24095279</pub-id></element-citation></ref><ref id="B112-genes-11-00989"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chantranupong</surname><given-names>L.</given-names></name><name><surname>Scaria</surname><given-names>S.M.</given-names></name><name><surname>Saxton</surname><given-names>R.A.</given-names></name><name><surname>Gygi</surname><given-names>M.P.</given-names></name><name><surname>Shen</surname><given-names>K.</given-names></name><name><surname>Wyant</surname><given-names>G.A.</given-names></name><name><surname>Wang</surname><given-names>T.C.</given-names></name><name><surname>Harper</surname><given-names>J.W.</given-names></name><name><surname>Gygi</surname><given-names>S.P.</given-names></name><name><surname>Sabatini</surname><given-names>D.M.</given-names></name></person-group><article-title>The CASTOR Proteins Are Arginine Sensors for the mTORC1 Pathway</article-title><source>Cell</source><year>2016</year><volume>165</volume><fpage>153</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.02.035</pub-id><pub-id pub-id-type="pmid">26972053</pub-id></element-citation></ref><ref id="B113-genes-11-00989"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>J.</given-names></name><name><surname>Genau</surname><given-names>H.M.</given-names></name><name><surname>Behrends</surname><given-names>C.</given-names></name></person-group><article-title>Amino Acid-Dependent mTORC1 Regulation by the Lysosomal Membrane Protein SLC38A9</article-title><source>Mol. Cell. Biol.</source><year>2015</year><volume>35</volume><fpage>2479</fpage><lpage>2494</lpage><pub-id pub-id-type="doi">10.1128/MCB.00125-15</pub-id><pub-id pub-id-type="pmid">25963655</pub-id></element-citation></ref><ref id="B114-genes-11-00989"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rebsamen</surname><given-names>M.</given-names></name><name><surname>Pochini</surname><given-names>L.</given-names></name><name><surname>Stasyk</surname><given-names>T.</given-names></name><name><surname>De Araujo</surname><given-names>M.E.G.</given-names></name><name><surname>Galluccio</surname><given-names>M.</given-names></name><name><surname>Kandasamy</surname><given-names>K.</given-names></name><name><surname>Snijder</surname><given-names>B.</given-names></name><name><surname>Fauster</surname><given-names>A.</given-names></name><name><surname>Rudashevskaya</surname><given-names>E.L.</given-names></name><name><surname>Bruckner</surname><given-names>M.</given-names></name><etal/></person-group><article-title>SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1</article-title><source>Nature</source><year>2015</year><volume>519</volume><fpage>477</fpage><lpage>481</lpage><pub-id pub-id-type="doi">10.1038/nature14107</pub-id><pub-id pub-id-type="pmid">25561175</pub-id></element-citation></ref><ref id="B115-genes-11-00989"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saxton</surname><given-names>R.A.</given-names></name><name><surname>Chantranupong</surname><given-names>L.</given-names></name><name><surname>Knockenhauer</surname><given-names>K.E.</given-names></name><name><surname>Schwartz</surname><given-names>T.U.</given-names></name><name><surname>Sabatini</surname><given-names>D.M.</given-names></name></person-group><article-title>Mechanism of arginine sensing by CASTOR1 upstream of mTORC1</article-title><source>Nature</source><year>2016</year><volume>536</volume><fpage>229</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1038/nature19079</pub-id><pub-id pub-id-type="pmid">27487210</pub-id></element-citation></ref><ref id="B116-genes-11-00989"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Tsun</surname><given-names>Z.-Y.</given-names></name><name><surname>Wolfson</surname><given-names>R.L.</given-names></name><name><surname>Shen</surname><given-names>K.</given-names></name><name><surname>Wyant</surname><given-names>G.A.</given-names></name><name><surname>Plovanich</surname><given-names>M.E.</given-names></name><name><surname>Yuan</surname><given-names>E.D.</given-names></name><name><surname>Jones</surname><given-names>T.D.</given-names></name><name><surname>Chantranupong</surname><given-names>L.</given-names></name><name><surname>Comb</surname><given-names>W.</given-names></name><etal/></person-group><article-title>Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1</article-title><source>Science</source><year>2015</year><volume>347</volume><fpage>188</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1126/science.1257132</pub-id><pub-id pub-id-type="pmid">25567906</pub-id></element-citation></ref><ref id="B117-genes-11-00989"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castellano</surname><given-names>B.M.</given-names></name><name><surname>Thelen</surname><given-names>A.M.</given-names></name><name><surname>Moldavski</surname><given-names>O.</given-names></name><name><surname>Feltes</surname><given-names>M.</given-names></name><name><surname>Van Der Welle</surname><given-names>R.E.N.</given-names></name><name><surname>Mydock-McGrane</surname><given-names>L.</given-names></name><name><surname>Jiang</surname><given-names>X.</given-names></name><name><surname>Van Eijkeren</surname><given-names>R.J.</given-names></name><name><surname>Davis</surname><given-names>O.B.</given-names></name><name><surname>Louie</surname><given-names>S.M.</given-names></name><etal/></person-group><article-title>Lysosomal cholesterol activates mTORC1 via an SLC38A9&#x02013;Niemann-Pick C1 signaling complex</article-title><source>Science</source><year>2017</year><volume>355</volume><fpage>1306</fpage><lpage>1311</lpage><pub-id pub-id-type="doi">10.1126/science.aag1417</pub-id><pub-id pub-id-type="pmid">28336668</pub-id></element-citation></ref><ref id="B118-genes-11-00989"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saxton</surname><given-names>R.A.</given-names></name><name><surname>Knockenhauer</surname><given-names>K.E.</given-names></name><name><surname>Wolfson</surname><given-names>R.L.</given-names></name><name><surname>Chantranupong</surname><given-names>L.</given-names></name><name><surname>Pacold</surname><given-names>M.E.</given-names></name><name><surname>Wang</surname><given-names>T.C.</given-names></name><name><surname>Schwartz</surname><given-names>T.U.</given-names></name><name><surname>Sabatini</surname><given-names>D.M.</given-names></name></person-group><article-title>Structural basis for leucine sensing by the Sestrin2-mTORC1 pathway</article-title><source>Science</source><year>2015</year><volume>351</volume><fpage>53</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1126/science.aad2087</pub-id><pub-id pub-id-type="pmid">26586190</pub-id></element-citation></ref><ref id="B119-genes-11-00989"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.H.</given-names></name><name><surname>Cho</surname><given-names>U.-S.</given-names></name><name><surname>Karin</surname><given-names>M.</given-names></name></person-group><article-title>Sestrin regulation of TORC1: Is Sestrin a leucine sensor?</article-title><source>Sci. Signal.</source><year>2016</year><volume>9</volume><fpage>re5</fpage><pub-id pub-id-type="doi">10.1126/scisignal.aaf2885</pub-id><pub-id pub-id-type="pmid">27273098</pub-id></element-citation></ref><ref id="B120-genes-11-00989"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolfson</surname><given-names>R.L.</given-names></name><name><surname>Chantranupong</surname><given-names>L.</given-names></name><name><surname>Saxton</surname><given-names>R.A.</given-names></name><name><surname>Shen</surname><given-names>K.</given-names></name><name><surname>Scaria</surname><given-names>S.M.</given-names></name><name><surname>Cantor</surname><given-names>J.R.</given-names></name><name><surname>Sabatini</surname><given-names>D.M.</given-names></name></person-group><article-title>Sestrin2 is a leucine sensor for the mTORC1 pathway</article-title><source>Science</source><year>2015</year><volume>351</volume><fpage>43</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1126/science.aab2674</pub-id><pub-id pub-id-type="pmid">26449471</pub-id></element-citation></ref><ref id="B121-genes-11-00989"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>X.</given-names></name><name><surname>Orozco</surname><given-names>J.M.</given-names></name><name><surname>Saxton</surname><given-names>R.A.</given-names></name><name><surname>Condon</surname><given-names>K.J.</given-names></name><name><surname>Liu</surname><given-names>G.Y.</given-names></name><name><surname>Krawczyk</surname><given-names>P.A.</given-names></name><name><surname>Scaria</surname><given-names>S.M.</given-names></name><name><surname>Harper</surname><given-names>J.W.</given-names></name><name><surname>Gygi</surname><given-names>S.P.</given-names></name><name><surname>Sabatini</surname><given-names>D.M.</given-names></name></person-group><article-title>SAMTOR is anS-adenosylmethionine sensor for the mTORC1 pathway</article-title><source>Science</source><year>2017</year><volume>358</volume><fpage>813</fpage><lpage>818</lpage><pub-id pub-id-type="doi">10.1126/science.aao3265</pub-id><pub-id pub-id-type="pmid">29123071</pub-id></element-citation></ref><ref id="B122-genes-11-00989"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>T.</given-names></name><name><surname>Shimabukuro-Demoto</surname><given-names>S.</given-names></name><name><surname>Yoshida-Sugitani</surname><given-names>R.</given-names></name><name><surname>Furuyama-Tanaka</surname><given-names>K.</given-names></name><name><surname>Karyu</surname><given-names>H.</given-names></name><name><surname>Sugiura</surname><given-names>Y.</given-names></name><name><surname>Shimizu</surname><given-names>Y.</given-names></name><name><surname>Hosaka</surname><given-names>T.</given-names></name><name><surname>Goto</surname><given-names>M.</given-names></name><name><surname>Kato</surname><given-names>N.</given-names></name><etal/></person-group><article-title>The Histidine Transporter SLC15A4 Coordinates mTOR-Dependent Inflammatory Responses and Pathogenic Antibody Production</article-title><source>Immunity</source><year>2014</year><volume>41</volume><fpage>375</fpage><lpage>388</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2014.08.011</pub-id><pub-id pub-id-type="pmid">25238095</pub-id></element-citation></ref><ref id="B123-genes-11-00989"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almutairi</surname><given-names>S.M.</given-names></name><name><surname>Ali</surname><given-names>A.K.</given-names></name><name><surname>He</surname><given-names>W.</given-names></name><name><surname>Yang</surname><given-names>D.</given-names></name><name><surname>Ghorbani</surname><given-names>P.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Fullerton</surname><given-names>M.D.</given-names></name><name><surname>Lee</surname><given-names>S.-H.</given-names></name></person-group><article-title>Interleukin-18 up-regulates amino acid transporters and facilitates amino acid&#x02013;induced mTORC1 activation in natural killer cells</article-title><source>J. Biol. Chem.</source><year>2019</year><volume>294</volume><fpage>4644</fpage><lpage>4655</lpage><pub-id pub-id-type="doi">10.1074/jbc.RA118.005892</pub-id><pub-id pub-id-type="pmid">30696773</pub-id></element-citation></ref><ref id="B124-genes-11-00989"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meier</surname><given-names>C.</given-names></name><name><surname>Ristic</surname><given-names>Z.</given-names></name><name><surname>Klauser</surname><given-names>S.</given-names></name><name><surname>Verrey</surname><given-names>F.</given-names></name></person-group><article-title>Activation of system L heterodimeric amino acid exchangers by intracellular substrates</article-title><source>EMBO J.</source><year>2002</year><volume>21</volume><fpage>580</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1093/emboj/21.4.580</pub-id><pub-id pub-id-type="pmid">11847106</pub-id></element-citation></ref><ref id="B125-genes-11-00989"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yanagida</surname><given-names>O.</given-names></name><name><surname>Kanai</surname><given-names>Y.</given-names></name><name><surname>Chairoungdua</surname><given-names>A.</given-names></name><name><surname>Kim</surname><given-names>D.K.</given-names></name><name><surname>Segawa</surname><given-names>H.</given-names></name><name><surname>Nii</surname><given-names>T.</given-names></name><name><surname>Cha</surname><given-names>S.H.</given-names></name><name><surname>Matsuo</surname><given-names>H.</given-names></name><name><surname>Fukushima</surname><given-names>J.-I.</given-names></name><name><surname>Fukasawa</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Human L-type amino acid transporter 1 (LAT1): Characterization of function and expression in tumor cell lines</article-title><source>Biochim. Biophys. Acta BBA Biomembr.</source><year>2001</year><volume>1514</volume><fpage>291</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1016/S0005-2736(01)00384-4</pub-id></element-citation></ref><ref id="B126-genes-11-00989"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicklin</surname><given-names>P.</given-names></name><name><surname>Bergman</surname><given-names>P.</given-names></name><name><surname>Zhang</surname><given-names>B.</given-names></name><name><surname>Triantafellow</surname><given-names>E.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Nyfeler</surname><given-names>B.</given-names></name><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Hild</surname><given-names>M.</given-names></name><name><surname>Kung</surname><given-names>C.</given-names></name><name><surname>Wilson</surname><given-names>C.J.</given-names></name><etal/></person-group><article-title>Bidirectional transport of amino acids regulates mTOR and autophagy</article-title><source>Cell</source><year>2009</year><volume>136</volume><fpage>521</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.11.044</pub-id><pub-id pub-id-type="pmid">19203585</pub-id></element-citation></ref><ref id="B127-genes-11-00989"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>A.</given-names></name><name><surname>Bu</surname><given-names>Y.</given-names></name><name><surname>Qie</surname><given-names>S.</given-names></name><name><surname>Wrangle</surname><given-names>J.</given-names></name><name><surname>Camp</surname><given-names>E.R.</given-names></name><name><surname>Hazard</surname><given-names>E.S.</given-names></name><name><surname>Hardiman</surname><given-names>G.</given-names></name><name><surname>de Leeuw</surname><given-names>R.</given-names></name><name><surname>Knudsen</surname><given-names>K.E.</given-names></name><name><surname>Diehl</surname><given-names>J.A.</given-names></name></person-group><article-title>SLC36A1-mTORC1 signaling drives acquired resistance to CDK4/6 inhibitors</article-title><source>Sci. Adv.</source><year>2019</year><volume>5</volume><fpage>eaax6352</fpage><pub-id pub-id-type="doi">10.1126/sciadv.aax6352</pub-id><pub-id pub-id-type="pmid">31555743</pub-id></element-citation></ref><ref id="B128-genes-11-00989"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heublein</surname><given-names>S.</given-names></name><name><surname>Kazi</surname><given-names>S.</given-names></name><name><surname>&#x000d6;gmundsd&#x000f3;ttir</surname><given-names>M.H.</given-names></name><name><surname>Attwood</surname><given-names>E.V.</given-names></name><name><surname>Kala</surname><given-names>S.</given-names></name><name><surname>Boyd</surname><given-names>C.A.R.</given-names></name><name><surname>Wilson</surname><given-names>C.</given-names></name><name><surname>Goberdhan</surname><given-names>D.C.</given-names></name></person-group><article-title>Proton-assisted amino-acid transporters are conserved regulators of proliferation and amino-acid-dependent mTORC1 activation</article-title><source>Oncogene</source><year>2010</year><volume>29</volume><fpage>4068</fpage><lpage>4079</lpage><pub-id pub-id-type="doi">10.1038/onc.2010.177</pub-id><pub-id pub-id-type="pmid">20498635</pub-id></element-citation></ref><ref id="B129-genes-11-00989"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>C&#x000e9;sar-Razquin</surname><given-names>A.</given-names></name><name><surname>Snijder</surname><given-names>B.</given-names></name><name><surname>Frappier-Brinton</surname><given-names>T.</given-names></name><name><surname>Isserlin</surname><given-names>R.</given-names></name><name><surname>Gyimesi</surname><given-names>G.</given-names></name><name><surname>Bai</surname><given-names>X.</given-names></name><name><surname>Reithmeier</surname><given-names>R.A.F.</given-names></name><name><surname>Hepworth</surname><given-names>D.</given-names></name><name><surname>Hediger</surname><given-names>M.A.</given-names></name><name><surname>Edwards</surname><given-names>A.M.</given-names></name><etal/></person-group><article-title>A Call for Systematic Research on Solute Carriers</article-title><source>Cell</source><year>2015</year><volume>162</volume><fpage>478</fpage><lpage>487</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.07.022</pub-id><pub-id pub-id-type="pmid">26232220</pub-id></element-citation></ref><ref id="B130-genes-11-00989"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>Y.C.</given-names></name><name><surname>Park</surname><given-names>H.W.</given-names></name><name><surname>Sciarretta</surname><given-names>S.</given-names></name><name><surname>Mo</surname><given-names>J.-S.</given-names></name><name><surname>Jewell</surname><given-names>J.L.</given-names></name><name><surname>Russell</surname><given-names>R.C.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Sadoshima</surname><given-names>J.</given-names></name><name><surname>Guan</surname><given-names>K.-L.</given-names></name></person-group><article-title>Rag GTPases are cardioprotective by regulating lysosomal function</article-title><source>Nat. Commun.</source><year>2014</year><volume>5</volume><fpage>4241</fpage><pub-id pub-id-type="doi">10.1038/ncomms5241</pub-id><pub-id pub-id-type="pmid">24980141</pub-id></element-citation></ref><ref id="B131-genes-11-00989"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krall</surname><given-names>A.S.</given-names></name><name><surname>Xu</surname><given-names>S.</given-names></name><name><surname>Graeber</surname><given-names>T.G.</given-names></name><name><surname>Braas</surname><given-names>D.</given-names></name><name><surname>Christofk</surname><given-names>H.R.</given-names></name></person-group><article-title>Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor</article-title><source>Nat. Commun.</source><year>2016</year><volume>7</volume><fpage>11457</fpage><pub-id pub-id-type="doi">10.1038/ncomms11457</pub-id><pub-id pub-id-type="pmid">27126896</pub-id></element-citation></ref><ref id="B132-genes-11-00989"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>D.</given-names></name><name><surname>Yang</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Melick</surname><given-names>C.H.</given-names></name><name><surname>Navlani</surname><given-names>R.</given-names></name><name><surname>Frank</surname><given-names>A.R.</given-names></name><name><surname>Jewell</surname><given-names>J.L.</given-names></name></person-group><article-title>Glutamine and asparagine activate mTORC1 independently of Rag GTPases</article-title><source>J. Biol. Chem.</source><year>2020</year><volume>295</volume><fpage>2890</fpage><lpage>2899</lpage><pub-id pub-id-type="doi">10.1074/jbc.AC119.011578</pub-id><pub-id pub-id-type="pmid">32019866</pub-id></element-citation></ref><ref id="B133-genes-11-00989"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dyachok</surname><given-names>J.</given-names></name><name><surname>Earnest</surname><given-names>S.</given-names></name><name><surname>Iturraran</surname><given-names>E.N.</given-names></name><name><surname>Cobb</surname><given-names>M.H.</given-names></name><name><surname>Ross</surname><given-names>E.M.</given-names></name></person-group><article-title>Amino Acids Regulate mTORC1 by an Obligate Two-step Mechanism</article-title><source>J. Biol. Chem.</source><year>2016</year><volume>291</volume><fpage>22414</fpage><lpage>22426</lpage><pub-id pub-id-type="doi">10.1074/jbc.M116.732511</pub-id><pub-id pub-id-type="pmid">27587390</pub-id></element-citation></ref><ref id="B134-genes-11-00989"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>H.W.S.</given-names></name><name><surname>Sim</surname><given-names>A.Y.L.</given-names></name><name><surname>Long</surname><given-names>Y.C.</given-names></name></person-group><article-title>Glutamine metabolism regulates autophagy-dependent mTORC1 reactivation during amino acid starvation</article-title><source>Nat. Commun.</source><year>2017</year><volume>8</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1038/s41467-017-00369-y</pub-id><pub-id pub-id-type="pmid">28232747</pub-id></element-citation></ref><ref id="B135-genes-11-00989"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carroll</surname><given-names>B.</given-names></name><name><surname>Maetzel</surname><given-names>D.</given-names></name><name><surname>Maddocks</surname><given-names>O.D.K.</given-names></name><name><surname>Otten</surname><given-names>E.G.</given-names></name><name><surname>Ratcliff</surname><given-names>M.</given-names></name><name><surname>Smith</surname><given-names>G.R.</given-names></name><name><surname>Dunlop</surname><given-names>E.A.</given-names></name><name><surname>Passos</surname><given-names>J.F.</given-names></name><name><surname>Davies</surname><given-names>O.R.</given-names></name><name><surname>Jaenisch</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Control of TSC2-Rheb signaling axis by arginine regulates mTORC1 activity</article-title><source>eLife</source><year>2016</year><volume>5</volume><fpage>e11058</fpage><pub-id pub-id-type="doi">10.7554/eLife.11058</pub-id><pub-id pub-id-type="pmid">26742086</pub-id></element-citation></ref><ref id="B136-genes-11-00989"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Ren</surname><given-names>J.</given-names></name><name><surname>Song</surname><given-names>T.</given-names></name><name><surname>Peng</surname><given-names>J.</given-names></name><name><surname>Wei</surname><given-names>H.</given-names></name></person-group><article-title>Methionine Regulates mTORC1 via the T1R1/T1R3-PLCbeta-Ca(2+)-ERK1/2 Signal Transduction Process in C2C12 Cells</article-title><source>Int. J. Mol. Sci.</source><year>2016</year><volume>17</volume><elocation-id>1684</elocation-id><pub-id pub-id-type="doi">10.3390/ijms17101684</pub-id></element-citation></ref><ref id="B137-genes-11-00989"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S.G.</given-names></name><name><surname>Hoffman</surname><given-names>G.R.</given-names></name><name><surname>Poulogiannis</surname><given-names>G.</given-names></name><name><surname>Buel</surname><given-names>G.R.</given-names></name><name><surname>Jang</surname><given-names>Y.J.</given-names></name><name><surname>Lee</surname><given-names>K.W.</given-names></name><name><surname>Kim</surname><given-names>B.Y.</given-names></name><name><surname>Erikson</surname><given-names>R.L.</given-names></name><name><surname>Cantley</surname><given-names>L.C.</given-names></name><name><surname>Choo</surname><given-names>A.Y.</given-names></name><etal/></person-group><article-title>Metabolic stress controls mTORC1 lysosomal localization and dimerization by regulating the TTT-RUVBL1/2 complex</article-title><source>Mol. Cell</source><year>2013</year><volume>49</volume><fpage>172</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2012.10.003</pub-id><pub-id pub-id-type="pmid">23142078</pub-id></element-citation></ref><ref id="B138-genes-11-00989"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stracka</surname><given-names>D.</given-names></name><name><surname>Jozefczuk</surname><given-names>S.</given-names></name><name><surname>Rudroff</surname><given-names>F.</given-names></name><name><surname>Sauer</surname><given-names>U.</given-names></name><name><surname>Hall</surname><given-names>M.N.</given-names></name></person-group><article-title>Nitrogen Source Activates TOR (Target of Rapamycin) Complex 1 via Glutamine and Independently of Gtr/Rag Proteins</article-title><source>J. Biol. Chem.</source><year>2014</year><volume>289</volume><fpage>25010</fpage><lpage>25020</lpage><pub-id pub-id-type="doi">10.1074/jbc.M114.574335</pub-id><pub-id pub-id-type="pmid">25063813</pub-id></element-citation></ref><ref id="B139-genes-11-00989"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernfeld</surname><given-names>E.</given-names></name><name><surname>Menon</surname><given-names>D.</given-names></name><name><surname>Vaghela</surname><given-names>V.</given-names></name><name><surname>Zerin</surname><given-names>I.</given-names></name><name><surname>Faruque</surname><given-names>P.</given-names></name><name><surname>Frias</surname><given-names>M.A.</given-names></name><name><surname>Foster</surname><given-names>D.A.</given-names></name></person-group><article-title>Phospholipase D&#x02013;dependent mTOR complex 1 (mTORC1) activation by glutamine</article-title><source>J. Biol. Chem.</source><year>2018</year><volume>293</volume><fpage>16390</fpage><lpage>16401</lpage><pub-id pub-id-type="doi">10.1074/jbc.RA118.004972</pub-id><pub-id pub-id-type="pmid">30194281</pub-id></element-citation></ref><ref id="B140-genes-11-00989"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishi</surname><given-names>T.</given-names></name><name><surname>Forgac</surname><given-names>M.</given-names></name></person-group><article-title>The vacuolar (H+)-ATPases&#x02014;Nature&#x02019;s most versatile proton pumps</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2002</year><volume>3</volume><fpage>94</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1038/nrm729</pub-id><pub-id pub-id-type="pmid">11836511</pub-id></element-citation></ref><ref id="B141-genes-11-00989"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aylett</surname><given-names>C.H.S.</given-names></name><name><surname>Sauer</surname><given-names>E.</given-names></name><name><surname>Imseng</surname><given-names>S.</given-names></name><name><surname>Boehringer</surname><given-names>D.</given-names></name><name><surname>Hall</surname><given-names>M.N.</given-names></name><name><surname>Ban</surname><given-names>N.</given-names></name><name><surname>Maier</surname><given-names>T.</given-names></name></person-group><article-title>Architecture of human mTOR complex 1</article-title><source>Science</source><year>2015</year><volume>351</volume><fpage>48</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1126/science.aaa3870</pub-id><pub-id pub-id-type="pmid">26678875</pub-id></element-citation></ref><ref id="B142-genes-11-00989"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Huang</surname><given-names>M.</given-names></name><name><surname>Tan</surname><given-names>D.</given-names></name><name><surname>Dong</surname><given-names>M.-Q.</given-names></name><name><surname>Wong</surname><given-names>C.C.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>4.4 &#x000c5; Resolution Cryo-EM structure of human mTOR Complex 1</article-title><source>Protein Cell</source><year>2016</year><volume>7</volume><fpage>878</fpage><lpage>887</lpage><pub-id pub-id-type="doi">10.1007/s13238-016-0346-6</pub-id><pub-id pub-id-type="pmid">27909983</pub-id></element-citation></ref><ref id="B143-genes-11-00989"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anandapadamanaban</surname><given-names>M.</given-names></name><name><surname>Masson</surname><given-names>G.R.</given-names></name><name><surname>Perisic</surname><given-names>O.</given-names></name><name><surname>Berndt</surname><given-names>A.</given-names></name><name><surname>Kaufman</surname><given-names>J.</given-names></name><name><surname>Johnson</surname><given-names>C.M.</given-names></name><name><surname>Santhanam</surname><given-names>B.</given-names></name><name><surname>Rogala</surname><given-names>K.B.</given-names></name><name><surname>Sabatini</surname><given-names>D.M.</given-names></name><name><surname>Williams</surname><given-names>R.L.</given-names></name></person-group><article-title>Architecture of human Rag GTPase heterodimers and their complex with mTORC1</article-title><source>Science</source><year>2019</year><volume>366</volume><fpage>203</fpage><lpage>210</lpage><pub-id pub-id-type="doi">10.1126/science.aax3939</pub-id><pub-id pub-id-type="pmid">31601764</pub-id></element-citation></ref><ref id="B144-genes-11-00989"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogala</surname><given-names>K.B.</given-names></name><name><surname>Gu</surname><given-names>X.</given-names></name><name><surname>Kedir</surname><given-names>J.F.</given-names></name><name><surname>Abu-Remaileh</surname><given-names>M.</given-names></name><name><surname>Bianchi</surname><given-names>L.F.</given-names></name><name><surname>Bottino</surname><given-names>A.M.S.</given-names></name><name><surname>Dueholm</surname><given-names>R.</given-names></name><name><surname>Niehaus</surname><given-names>A.</given-names></name><name><surname>Overwijn</surname><given-names>D.</given-names></name><name><surname>Fils</surname><given-names>A.-C.P.</given-names></name><etal/></person-group><article-title>Structural basis for the docking of mTORC1 on the lysosomal surface</article-title><source>Science</source><year>2019</year><volume>366</volume><fpage>468</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.1126/science.aay0166</pub-id><pub-id pub-id-type="pmid">31601708</pub-id></element-citation></ref><ref id="B145-genes-11-00989"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hilger</surname><given-names>D.</given-names></name><name><surname>Masureel</surname><given-names>M.</given-names></name><name><surname>Kobilka</surname><given-names>B.K.</given-names></name></person-group><article-title>Structure and dynamics of GPCR signaling complexes</article-title><source>Nat. Struct. Mol. Biol.</source><year>2018</year><volume>25</volume><fpage>4</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1038/s41594-017-0011-7</pub-id><pub-id pub-id-type="pmid">29323277</pub-id></element-citation></ref><ref id="B146-genes-11-00989"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fredriksson</surname><given-names>R.</given-names></name><name><surname>Schi&#x000f6;th</surname><given-names>H.B.</given-names></name></person-group><article-title>The Repertoire of G-Protein&#x02013;Coupled Receptors in Fully Sequenced Genomes</article-title><source>Mol. Pharmacol.</source><year>2005</year><volume>67</volume><fpage>1414</fpage><lpage>1425</lpage><pub-id pub-id-type="doi">10.1124/mol.104.009001</pub-id><pub-id pub-id-type="pmid">15687224</pub-id></element-citation></ref><ref id="B147-genes-11-00989"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>V&#x000f6;gler</surname><given-names>O.</given-names></name><name><surname>Barcelo</surname><given-names>J.M.</given-names></name><name><surname>Ribas</surname><given-names>C.</given-names></name><name><surname>Escrib&#x000e1;</surname><given-names>P.V.</given-names></name></person-group><article-title>Membrane interactions of G proteins and other related proteins</article-title><source>Biochim. Biophys. Acta BBA Biomembr.</source><year>2008</year><volume>1778</volume><fpage>1640</fpage><lpage>1652</lpage><pub-id pub-id-type="doi">10.1016/j.bbamem.2008.03.008</pub-id><pub-id pub-id-type="pmid">18402765</pub-id></element-citation></ref><ref id="B148-genes-11-00989"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohan</surname><given-names>M.L.</given-names></name><name><surname>Vasudevan</surname><given-names>N.T.</given-names></name><name><surname>Gupta</surname><given-names>M.K.</given-names></name><name><surname>Martelli</surname><given-names>E.E.</given-names></name><name><surname>Prasad</surname><given-names>S.V.N.</given-names></name></person-group><article-title>G-protein coupled receptor resensitization-appreciating the balancing act of receptor function</article-title><source>Curr. Mol. Pharmacol.</source><year>2012</year><volume>5</volume><fpage>350</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.2174/1874467211205030004</pub-id></element-citation></ref><ref id="B149-genes-11-00989"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wettschureck</surname><given-names>N.</given-names></name><name><surname>Offermanns</surname><given-names>S.</given-names></name></person-group><article-title>Mammalian G Proteins and Their Cell Type Specific Functions</article-title><source>Physiol. Rev.</source><year>2005</year><volume>85</volume><fpage>1159</fpage><lpage>1204</lpage><pub-id pub-id-type="doi">10.1152/physrev.00003.2005</pub-id><pub-id pub-id-type="pmid">16183910</pub-id></element-citation></ref><ref id="B150-genes-11-00989"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sassone-Corsi</surname><given-names>P.</given-names></name></person-group><article-title>The Cyclic AMP Pathway</article-title><source>Cold Spring Harb. Perspect. Biol.</source><year>2012</year><volume>4</volume><fpage>a011148</fpage><pub-id pub-id-type="doi">10.1101/cshperspect.a011148</pub-id><pub-id pub-id-type="pmid">23209152</pub-id></element-citation></ref><ref id="B151-genes-11-00989"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kadamur</surname><given-names>G.</given-names></name><name><surname>Ross</surname><given-names>E.M.</given-names></name></person-group><article-title>Mammalian Phospholipase C</article-title><source>Annu. Rev. Physiol.</source><year>2013</year><volume>75</volume><fpage>127</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.1146/annurev-physiol-030212-183750</pub-id><pub-id pub-id-type="pmid">23140367</pub-id></element-citation></ref><ref id="B152-genes-11-00989"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>N.</given-names></name><name><surname>Hajicek</surname><given-names>N.</given-names></name><name><surname>Kozasa</surname><given-names>T.</given-names></name></person-group><article-title>Regulation and physiological functions of G12/13-mediated signaling pathways</article-title><source>Neurosignals</source><year>2009</year><volume>17</volume><fpage>55</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1159/000186690</pub-id><pub-id pub-id-type="pmid">19212140</pub-id></element-citation></ref><ref id="B153-genes-11-00989"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanlon</surname><given-names>C.D.</given-names></name><name><surname>Andrew</surname><given-names>D.J.</given-names></name></person-group><article-title>Outside-in signaling--a brief review of GPCR signaling with a focus on the Drosophila GPCR family</article-title><source>J. Cell Sci.</source><year>2015</year><volume>128</volume><fpage>3533</fpage><lpage>3542</lpage><pub-id pub-id-type="doi">10.1242/jcs.175158</pub-id><pub-id pub-id-type="pmid">26345366</pub-id></element-citation></ref><ref id="B154-genes-11-00989"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pavlos</surname><given-names>N.J.</given-names></name><name><surname>Friedman</surname><given-names>P.A.</given-names></name></person-group><article-title>GPCR Signaling and Trafficking: The Long and Short of It</article-title><source>Trends Endocrinol. Metab.</source><year>2016</year><volume>28</volume><fpage>213</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1016/j.tem.2016.10.007</pub-id><pub-id pub-id-type="pmid">27889227</pub-id></element-citation></ref><ref id="B155-genes-11-00989"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>W.</given-names></name><name><surname>Scott</surname><given-names>J.D.</given-names></name></person-group><article-title>AKAP signalling complexes: Focal points in space and time</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2004</year><volume>5</volume><fpage>959</fpage><lpage>970</lpage><pub-id pub-id-type="doi">10.1038/nrm1527</pub-id><pub-id pub-id-type="pmid">15573134</pub-id></element-citation></ref><ref id="B156-genes-11-00989"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapiloff</surname><given-names>M.S.</given-names></name><name><surname>Rigatti</surname><given-names>M.</given-names></name><name><surname>Dodge-Kafka</surname><given-names>K.L.</given-names></name></person-group><article-title>Architectural and functional roles of A kinase&#x02013;anchoring proteins in cAMP microdomains</article-title><source>J. Gen. Physiol.</source><year>2013</year><volume>143</volume><fpage>9</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1085/jgp.201311020</pub-id></element-citation></ref><ref id="B157-genes-11-00989"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x000f8;skeland</surname><given-names>S.O.</given-names></name><name><surname>Maronde</surname><given-names>E.</given-names></name><name><surname>Gjertsen</surname><given-names>B.T.</given-names></name></person-group><article-title>The genetic subtypes of cAMP-dependent protein kinase&#x02014;Functionally different or redundant?</article-title><source>Biochim. Biophys. Acta BBA Bioenerg.</source><year>1993</year><volume>1178</volume><fpage>249</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1016/0167-4889(93)90201-Y</pub-id></element-citation></ref><ref id="B158-genes-11-00989"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ilouz</surname><given-names>R.</given-names></name><name><surname>Bubis</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Yim</surname><given-names>Y.Y.</given-names></name><name><surname>Deal</surname><given-names>M.S.</given-names></name><name><surname>Kornev</surname><given-names>A.P.</given-names></name><name><surname>Ma</surname><given-names>Y.</given-names></name><name><surname>Blumenthal</surname><given-names>D.K.</given-names></name><name><surname>Taylor</surname><given-names>S.S.</given-names></name></person-group><article-title>Localization and quaternary structure of the PKA RIbeta holoenzyme</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2012</year><volume>109</volume><fpage>12443</fpage><lpage>12448</lpage><pub-id pub-id-type="doi">10.1073/pnas.1209538109</pub-id><pub-id pub-id-type="pmid">22797896</pub-id></element-citation></ref><ref id="B159-genes-11-00989"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jewell</surname><given-names>J.L.</given-names></name><name><surname>Fu</surname><given-names>V.</given-names></name><name><surname>Hong</surname><given-names>A.W.</given-names></name><name><surname>Yu</surname><given-names>F.-X.</given-names></name><name><surname>Meng</surname><given-names>D.</given-names></name><name><surname>Melick</surname><given-names>C.H.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Lam</surname><given-names>W.-L.M.</given-names></name><name><surname>Yuan</surname><given-names>H.-X.</given-names></name><name><surname>Taylor</surname><given-names>S.S.</given-names></name><etal/></person-group><article-title>GPCR signaling inhibits mTORC1 via PKA phosphorylation of Raptor</article-title><source>eLife</source><year>2019</year><volume>8</volume><pub-id pub-id-type="doi">10.7554/eLife.43038</pub-id></element-citation></ref><ref id="B160-genes-11-00989"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>D.</given-names></name><name><surname>Bordicchia</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Fang</surname><given-names>H.</given-names></name><name><surname>Wei</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>J.L.</given-names></name><name><surname>Guilherme</surname><given-names>A.</given-names></name><name><surname>Guntur</surname><given-names>K.</given-names></name><name><surname>Czech</surname><given-names>M.P.</given-names></name><name><surname>Collins</surname><given-names>S.</given-names></name></person-group><article-title>Activation of mTORC1 is essential for &#x003b2;-adrenergic stimulation of adipose browning</article-title><source>J. Clin. Investig.</source><year>2016</year><volume>126</volume><fpage>1704</fpage><lpage>1716</lpage><pub-id pub-id-type="doi">10.1172/JCI83532</pub-id><pub-id pub-id-type="pmid">27018708</pub-id></element-citation></ref><ref id="B161-genes-11-00989"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soliman</surname><given-names>G.A.</given-names></name><name><surname>Acosta-Jaquez</surname><given-names>H.A.</given-names></name><name><surname>Fingar</surname><given-names>D.C.</given-names></name></person-group><article-title>mTORC1 Inhibition via Rapamycin Promotes Triacylglycerol Lipolysis and Release of Free Fatty Acids in 3T3-L1 Adipocytes</article-title><source>Lipids</source><year>2010</year><volume>45</volume><fpage>1089</fpage><lpage>1100</lpage><pub-id pub-id-type="doi">10.1007/s11745-010-3488-y</pub-id><pub-id pub-id-type="pmid">21042876</pub-id></element-citation></ref><ref id="B162-genes-11-00989"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>G.</given-names></name><name><surname>Marshall</surname><given-names>C.A.</given-names></name><name><surname>Pappan</surname><given-names>K.L.</given-names></name><name><surname>Remedi</surname><given-names>M.S.</given-names></name><name><surname>McDaniel</surname><given-names>M.L.</given-names></name></person-group><article-title>Signaling elements involved in the metabolic regulation of mTOR by nutrients, incretins, and growth factors in islets</article-title><source>Diabetes</source><year>2004</year><volume>53</volume><fpage>S225</fpage><lpage>S232</lpage><pub-id pub-id-type="doi">10.2337/diabetes.53.suppl_3.S225</pub-id><pub-id pub-id-type="pmid">15561916</pub-id></element-citation></ref><ref id="B163-genes-11-00989"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brennesvik</surname><given-names>E.O.</given-names></name><name><surname>Ktori</surname><given-names>C.</given-names></name><name><surname>Ruzzin</surname><given-names>J.</given-names></name><name><surname>Jebens</surname><given-names>E.</given-names></name><name><surname>Shepherd</surname><given-names>P.R.</given-names></name><name><surname>Jensen</surname><given-names>J.</given-names></name></person-group><article-title>Adrenaline potentiates insulin-stimulated PKB activation via cAMP and Epac: Implications for cross talk between insulin and adrenaline</article-title><source>Cell. Signal.</source><year>2005</year><volume>17</volume><fpage>1551</fpage><lpage>1559</lpage><pub-id pub-id-type="doi">10.1016/j.cellsig.2005.03.011</pub-id><pub-id pub-id-type="pmid">15908181</pub-id></element-citation></ref><ref id="B164-genes-11-00989"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>C.E.</given-names></name><name><surname>Xie</surname><given-names>J.</given-names></name><name><surname>Gomez</surname><given-names>E.</given-names></name><name><surname>Herbert</surname><given-names>T.P.</given-names></name></person-group><article-title>Identification of cAMP-dependent kinase as a third in vivo ribosomal protein S6 kinase in pancreatic &#x003b2;-cells</article-title><source>J. Mol. Biol.</source><year>2009</year><volume>389</volume><fpage>480</fpage><lpage>494</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2009.04.020</pub-id><pub-id pub-id-type="pmid">19376132</pub-id></element-citation></ref><ref id="B165-genes-11-00989"><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blancquaert</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Paternot</surname><given-names>S.</given-names></name><name><surname>Coulonval</surname><given-names>K.</given-names></name><name><surname>Dumont</surname><given-names>J.E.</given-names></name><name><surname>Harris</surname><given-names>T.E.</given-names></name><name><surname>Roger</surname><given-names>P.P.</given-names></name></person-group><article-title>cAMP-dependent activation of mammalian target of rapamycin (mTOR) in thyroid cells. Implication in mitogenesis and activation of CDK4</article-title><source>Mol. Endocrinol.</source><year>2010</year><volume>24</volume><fpage>1453</fpage><lpage>1468</lpage><pub-id pub-id-type="doi">10.1210/me.2010-0087</pub-id><pub-id pub-id-type="pmid">20484410</pub-id></element-citation></ref><ref id="B166-genes-11-00989"><label>166.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H.W.</given-names></name><name><surname>Ha</surname><given-names>S.H.</given-names></name><name><surname>Lee</surname><given-names>M.N.</given-names></name><name><surname>Huston</surname><given-names>E.</given-names></name><name><surname>Kim</surname><given-names>D.-H.</given-names></name><name><surname>Jang</surname><given-names>S.K.</given-names></name><name><surname>Suh</surname><given-names>P.-G.</given-names></name><name><surname>Houslay</surname><given-names>M.D.</given-names></name><name><surname>Ryu</surname><given-names>S.H.</given-names></name></person-group><article-title>Cyclic AMP Controls mTOR through Regulation of the Dynamic Interaction between Rheb and Phosphodiesterase 4D</article-title><source>Mol. Cell. Biol.</source><year>2010</year><volume>30</volume><fpage>5406</fpage><lpage>5420</lpage><pub-id pub-id-type="doi">10.1128/MCB.00217-10</pub-id><pub-id pub-id-type="pmid">20837708</pub-id></element-citation></ref><ref id="B167-genes-11-00989"><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>P.H.</given-names></name><name><surname>Lawrence</surname><given-names>J.C.</given-names></name></person-group><article-title>Attenuation of Mammalian Target of Rapamycin Activity by Increased cAMP in 3T3-L1 Adipocytes</article-title><source>J. Biol. Chem.</source><year>1998</year><volume>273</volume><fpage>34496</fpage><lpage>34501</lpage><pub-id pub-id-type="doi">10.1074/jbc.273.51.34496</pub-id><pub-id pub-id-type="pmid">9852118</pub-id></element-citation></ref><ref id="B168-genes-11-00989"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mothe-Satney</surname><given-names>I.</given-names></name><name><surname>Gautier</surname><given-names>N.</given-names></name><name><surname>Hinault</surname><given-names>C.</given-names></name><name><surname>Lawrence</surname><given-names>J.C.</given-names></name><name><surname>Van Obberghen</surname><given-names>E.</given-names></name></person-group><article-title>In Rat Hepatocytes Glucagon Increases Mammalian Target of Rapamycin Phosphorylation on Serine 2448 but Antagonizes the Phosphorylation of Its Downstream Targets Induced by Insulin and Amino Acids</article-title><source>J. Biol. Chem.</source><year>2004</year><volume>279</volume><fpage>42628</fpage><lpage>42637</lpage><pub-id pub-id-type="doi">10.1074/jbc.M405173200</pub-id><pub-id pub-id-type="pmid">15292249</pub-id></element-citation></ref><ref id="B169-genes-11-00989"><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimball</surname><given-names>S.R.</given-names></name><name><surname>Siegfried</surname><given-names>B.A.</given-names></name><name><surname>Jefferson</surname><given-names>L.S.</given-names></name></person-group><article-title>Glucagon Represses Signaling through the Mammalian Target of Rapamycin in Rat Liver by Activating AMP-activated Protein Kinase</article-title><source>J. Biol. Chem.</source><year>2004</year><volume>279</volume><fpage>54103</fpage><lpage>54109</lpage><pub-id pub-id-type="doi">10.1074/jbc.M410755200</pub-id><pub-id pub-id-type="pmid">15494402</pub-id></element-citation></ref><ref id="B170-genes-11-00989"><label>170.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rocha</surname><given-names>A.S.</given-names></name><name><surname>Paternot</surname><given-names>S.</given-names></name><name><surname>Coulonval</surname><given-names>K.</given-names></name><name><surname>Dumont</surname><given-names>J.E.</given-names></name><name><surname>Soares</surname><given-names>P.</given-names></name><name><surname>Roger</surname><given-names>P.P.</given-names></name></person-group><article-title>Cyclic AMP Inhibits the Proliferation of Thyroid Carcinoma Cell Lines through Regulation of CDK4 Phosphorylation</article-title><source>Mol. Biol. Cell</source><year>2008</year><volume>19</volume><fpage>4814</fpage><lpage>4825</lpage><pub-id pub-id-type="doi">10.1091/mbc.e08-06-0617</pub-id><pub-id pub-id-type="pmid">18799615</pub-id></element-citation></ref><ref id="B171-genes-11-00989"><label>171.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baum</surname><given-names>J.I.</given-names></name><name><surname>Kimball</surname><given-names>S.R.</given-names></name><name><surname>Jefferson</surname><given-names>L.S.</given-names></name></person-group><article-title>Glucagon acts in a dominant manner to repress insulin-induced mammalian target of rapamycin complex 1 signaling in perfused rat liver</article-title><source>Am. J. Physiol. Metab.</source><year>2009</year><volume>297</volume><fpage>E410</fpage><lpage>E415</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00042.2009</pub-id><pub-id pub-id-type="pmid">19509187</pub-id></element-citation></ref><ref id="B172-genes-11-00989"><label>172.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Jee</surname><given-names>K.</given-names></name><name><surname>Kim</surname><given-names>D.</given-names></name><name><surname>Koh</surname><given-names>H.</given-names></name><name><surname>Chung</surname><given-names>J.-K.</given-names></name></person-group><article-title>Cyclic AMP Inhibits Akt Activity by Blocking the Membrane Localization of PDK1</article-title><source>J. Biol. Chem.</source><year>2001</year><volume>276</volume><fpage>12864</fpage><lpage>12870</lpage><pub-id pub-id-type="doi">10.1074/jbc.M001492200</pub-id><pub-id pub-id-type="pmid">11278269</pub-id></element-citation></ref><ref id="B173-genes-11-00989"><label>173.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palaniappan</surname><given-names>M.</given-names></name><name><surname>Menon</surname><given-names>K.</given-names></name></person-group><article-title>Human chorionic gonadotropin stimulates theca-interstitial cell proliferation and cell cycle regulatory proteins by a cAMP-dependent activation of AKT/mTORC1 signaling pathway</article-title><source>Mol. Endocrinol.</source><year>2010</year><volume>24</volume><fpage>1782</fpage><lpage>1793</lpage><pub-id pub-id-type="doi">10.1210/me.2010-0044</pub-id><pub-id pub-id-type="pmid">20660299</pub-id></element-citation></ref><ref id="B174-genes-11-00989"><label>174.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>J.</given-names></name><name><surname>Ponuwei</surname><given-names>G.A.</given-names></name><name><surname>Moore</surname><given-names>C.E.</given-names></name><name><surname>Willars</surname><given-names>G.B.</given-names></name><name><surname>Tee</surname><given-names>A.R.</given-names></name><name><surname>Herbert</surname><given-names>T.P.</given-names></name></person-group><article-title>cAMP inhibits mammalian target of rapamycin complex-1 and -2 (mTORC1 and 2) by promoting complex dissociation and inhibiting mTOR kinase activity</article-title><source>Cell. Signal.</source><year>2011</year><volume>23</volume><fpage>1927</fpage><lpage>1935</lpage><pub-id pub-id-type="doi">10.1016/j.cellsig.2011.06.025</pub-id><pub-id pub-id-type="pmid">21763421</pub-id></element-citation></ref><ref id="B175-genes-11-00989"><label>175.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>W.B.</given-names></name><name><surname>Starck</surname><given-names>S.R.</given-names></name><name><surname>Roberts</surname><given-names>R.W.</given-names></name><name><surname>Schuman</surname><given-names>E.M.</given-names></name></person-group><article-title>Dopaminergic Stimulation of Local Protein Synthesis Enhances Surface Expression of GluR1 and Synaptic Transmission in Hippocampal Neurons</article-title><source>Neuron</source><year>2005</year><volume>45</volume><fpage>765</fpage><lpage>779</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2005.01.015</pub-id><pub-id pub-id-type="pmid">15748851</pub-id></element-citation></ref><ref id="B176-genes-11-00989"><label>176.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santini</surname><given-names>E.</given-names></name><name><surname>Feyder</surname><given-names>M.</given-names></name><name><surname>Gangarossa</surname><given-names>G.</given-names></name><name><surname>Bateup</surname><given-names>H.S.</given-names></name><name><surname>Greengard</surname><given-names>P.</given-names></name><name><surname>Fisone</surname><given-names>G.</given-names></name></person-group><article-title>Dopamine- and cAMP-regulated Phosphoprotein of 32-kDa (DARPP-32)-dependent Activation of Extracellular Signal-regulated Kinase (ERK) and Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling in Experimental Parkinsonism</article-title><source>J. Biol. Chem.</source><year>2012</year><volume>287</volume><fpage>27806</fpage><lpage>27812</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.388413</pub-id><pub-id pub-id-type="pmid">22753408</pub-id></element-citation></ref><ref id="B177-genes-11-00989"><label>177.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Joussineau</surname><given-names>C.</given-names></name><name><surname>Sahut-Barnola</surname><given-names>I.</given-names></name><name><surname>Tissier</surname><given-names>F.</given-names></name><name><surname>Dumontet</surname><given-names>T.</given-names></name><name><surname>Drelon</surname><given-names>C.</given-names></name><name><surname>Batisse-Lignier</surname><given-names>M.</given-names></name><name><surname>Tauveron</surname><given-names>I.</given-names></name><name><surname>Pointud</surname><given-names>J.-C.</given-names></name><name><surname>Lefran&#x000e7;ois-Martinez</surname><given-names>A.-M.</given-names></name><name><surname>Stratakis</surname><given-names>C.A.</given-names></name><etal/></person-group><article-title>mTOR pathway is activated by PKA in adrenocortical cells and participates in vivo to apoptosis resistance in primary pigmented nodular adrenocortical disease (PPNAD)</article-title><source>Hum. Mol. Genet.</source><year>2014</year><volume>23</volume><fpage>5418</fpage><lpage>5428</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddu265</pub-id><pub-id pub-id-type="pmid">24865460</pub-id></element-citation></ref><ref id="B178-genes-11-00989"><label>178.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>H.H.</given-names></name><name><surname>Young</surname><given-names>S.H.</given-names></name><name><surname>Sinnett-Smith</surname><given-names>J.</given-names></name><name><surname>Chou</surname><given-names>C.E.</given-names></name><name><surname>Moro</surname><given-names>A.</given-names></name><name><surname>Hertzer</surname><given-names>K.M.</given-names></name><name><surname>Hines</surname><given-names>O.J.</given-names></name><name><surname>Rozengurt</surname><given-names>E.</given-names></name><name><surname>Eibl</surname><given-names>G.</given-names></name></person-group><article-title>Prostaglandin E2 activates the mTORC1 pathway through an EP4/cAMP/PKA- and EP1/Ca2+-mediated mechanism in the human pancreatic carcinoma cell line PANC-1</article-title><source>Am. J. Physiol. Cell Physiol.</source><year>2015</year><volume>309</volume><fpage>C639</fpage><lpage>C649</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00417.2014</pub-id><pub-id pub-id-type="pmid">26310818</pub-id></element-citation></ref><ref id="B179-genes-11-00989"><label>179.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Insel</surname><given-names>P.A.</given-names></name><name><surname>Snead</surname><given-names>A.</given-names></name><name><surname>Murray</surname><given-names>F.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Yokouchi</surname><given-names>H.</given-names></name><name><surname>Katakia</surname><given-names>T.</given-names></name><name><surname>Kwon</surname><given-names>O.</given-names></name><name><surname>Dimucci</surname><given-names>D.</given-names></name><name><surname>Wilderman</surname><given-names>A.</given-names></name></person-group><article-title>GPCR expression in tissues and cells: Are the optimal receptors being used as drug targets?</article-title><source>Br. J. Pharmacol.</source><year>2012</year><volume>165</volume><fpage>1613</fpage><lpage>1616</lpage><pub-id pub-id-type="doi">10.1111/j.1476-5381.2011.01434.x</pub-id><pub-id pub-id-type="pmid">21488863</pub-id></element-citation></ref><ref id="B180-genes-11-00989"><label>180.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>B&#x000f6;hme</surname><given-names>I.</given-names></name><name><surname>Beck-Sickinger</surname><given-names>A.G.</given-names></name></person-group><article-title>Illuminating the life of GPCRs</article-title><source>Cell Commun. Signal.</source><year>2009</year><volume>7</volume><fpage>16</fpage><pub-id pub-id-type="doi">10.1186/1478-811X-7-16</pub-id><pub-id pub-id-type="pmid">19602276</pub-id></element-citation></ref><ref id="B181-genes-11-00989"><label>181.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hakak</surname><given-names>Y.</given-names></name><name><surname>Shrestha</surname><given-names>D.</given-names></name><name><surname>Goegel</surname><given-names>M.C.</given-names></name><name><surname>Behan</surname><given-names>D.P.</given-names></name><name><surname>Chalmers</surname><given-names>D.T.</given-names></name></person-group><article-title>Global analysis of G-protein-coupled receptor signaling in human tissues</article-title><source>FEBS Lett.</source><year>2003</year><volume>550</volume><fpage>11</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1016/S0014-5793(03)00762-2</pub-id><pub-id pub-id-type="pmid">12935878</pub-id></element-citation></ref><ref id="B182-genes-11-00989"><label>182.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Regard</surname><given-names>J.B.</given-names></name><name><surname>Sato</surname><given-names>I.T.</given-names></name><name><surname>Coughlin</surname><given-names>S.R.</given-names></name></person-group><article-title>Anatomical Profiling of G Protein-Coupled Receptor Expression</article-title><source>Cell</source><year>2008</year><volume>135</volume><fpage>561</fpage><lpage>571</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.08.040</pub-id><pub-id pub-id-type="pmid">18984166</pub-id></element-citation></ref><ref id="B183-genes-11-00989"><label>183.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Lee</surname><given-names>J.W.</given-names></name><name><surname>Chou</surname><given-names>C.-L.</given-names></name><name><surname>Nair</surname><given-names>A.V.</given-names></name><name><surname>Battistone</surname><given-names>M.A.</given-names></name><name><surname>P&#x00103;unescu</surname><given-names>T.G.</given-names></name><name><surname>Merkulova</surname><given-names>M.</given-names></name><name><surname>Breton</surname><given-names>S.</given-names></name><name><surname>Verlander</surname><given-names>J.W.</given-names></name><name><surname>Wall</surname><given-names>S.M.</given-names></name><etal/></person-group><article-title>Transcriptomes of major renal collecting duct cell types in mouse identified by single-cell RNA-seq</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2017</year><volume>114</volume><fpage>E9989</fpage><lpage>E9998</lpage><pub-id pub-id-type="doi">10.1073/pnas.1710964114</pub-id><pub-id pub-id-type="pmid">29089413</pub-id></element-citation></ref><ref id="B184-genes-11-00989"><label>184.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hauser</surname><given-names>A.S.</given-names></name><name><surname>Attwood</surname><given-names>M.M.</given-names></name><name><surname>Rask-Andersen</surname><given-names>M.</given-names></name><name><surname>Schi&#x000f6;th</surname><given-names>H.B.</given-names></name><name><surname>Gloriam</surname><given-names>D.E.</given-names></name></person-group><article-title>Trends in GPCR drug discovery: New agents, targets and indications</article-title><source>Nat. Rev. Drug Discov.</source><year>2017</year><volume>16</volume><fpage>829</fpage><lpage>842</lpage><pub-id pub-id-type="doi">10.1038/nrd.2017.178</pub-id><pub-id pub-id-type="pmid">29075003</pub-id></element-citation></ref><ref id="B185-genes-11-00989"><label>185.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>E.H.T.</given-names></name><name><surname>Wong</surname><given-names>Y.H.</given-names></name></person-group><article-title>Involvement of Gi/o Proteins in Nerve Growth Factor-Stimulated Phosphorylation and Degradation of Tuberin in PC-12 Cells and Cortical Neurons</article-title><source>Mol. Pharmacol.</source><year>2004</year><volume>67</volume><fpage>1195</fpage><lpage>1205</lpage><pub-id pub-id-type="doi">10.1124/mol.104.007237</pub-id><pub-id pub-id-type="pmid">15626752</pub-id></element-citation></ref><ref id="B186-genes-11-00989"><label>186.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>E.H.</given-names></name><name><surname>Wong</surname><given-names>Y.H.</given-names></name></person-group><article-title>Activation of muscarinic M4 receptor augments NGF-induced pro-survival Akt signaling in PC12 cells</article-title><source>Cell. Signal.</source><year>2006</year><volume>18</volume><fpage>285</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1016/j.cellsig.2005.04.009</pub-id><pub-id pub-id-type="pmid">15979279</pub-id></element-citation></ref><ref id="B187-genes-11-00989"><label>187.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>P.M.</given-names></name><name><surname>Mikhailova</surname><given-names>M.</given-names></name><name><surname>Bedolla</surname><given-names>R.</given-names></name><name><surname>Kreisberg</surname><given-names>J.I.</given-names></name></person-group><article-title>Arginine vasopressin stimulates mesangial cell proliferation by activating the epidermal growth factor receptor</article-title><source>Am. J. Physiol. Physiol.</source><year>2001</year><volume>280</volume><fpage>F972</fpage><lpage>F979</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.2001.280.6.F972</pub-id></element-citation></ref><ref id="B188-genes-11-00989"><label>188.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suh</surname><given-names>J.M.</given-names></name><name><surname>Song</surname><given-names>J.H.</given-names></name><name><surname>Kim</surname><given-names>N.W.</given-names></name><name><surname>Kim</surname><given-names>H.</given-names></name><name><surname>Chung</surname><given-names>H.K.</given-names></name><name><surname>Hwang</surname><given-names>J.H.</given-names></name><name><surname>Kim</surname><given-names>J.-M.</given-names></name><name><surname>Hwang</surname><given-names>E.S.</given-names></name><name><surname>Chung</surname><given-names>J.</given-names></name><name><surname>Han</surname><given-names>J.-H.</given-names></name><etal/></person-group><article-title>Regulation of the Phosphatidylinositol 3-Kinase, Akt/Protein Kinase B, FRAP/Mammalian Target of Rapamycin, and Ribosomal S6 Kinase 1 Signaling Pathways by Thyroid-stimulating Hormone (TSH) and Stimulating type TSH Receptor Antibodies in the Thyroid Gland</article-title><source>J. Biol. Chem.</source><year>2003</year><volume>278</volume><fpage>21960</fpage><lpage>21971</lpage><pub-id pub-id-type="doi">10.1074/jbc.M300805200</pub-id><pub-id pub-id-type="pmid">12668683</pub-id></element-citation></ref><ref id="B189-genes-11-00989"><label>189.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arvisais</surname><given-names>E.W.</given-names></name><name><surname>Romanelli</surname><given-names>A.</given-names></name><name><surname>Hou</surname><given-names>X.</given-names></name><name><surname>Davis</surname><given-names>J.S.</given-names></name></person-group><article-title>AKT-independent Phosphorylation of TSC2 and Activation of mTOR and Ribosomal Protein S6 Kinase Signaling by Prostaglandin F2&#x003b1;</article-title><source>J. Biol. Chem.</source><year>2006</year><volume>281</volume><fpage>26904</fpage><lpage>26913</lpage><pub-id pub-id-type="doi">10.1074/jbc.M605371200</pub-id><pub-id pub-id-type="pmid">16816403</pub-id></element-citation></ref><ref id="B190-genes-11-00989"><label>190.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Kakizaki</surname><given-names>M.</given-names></name><name><surname>Hirose</surname><given-names>Y.</given-names></name><name><surname>Ishikawa</surname><given-names>Y.</given-names></name><name><surname>Funato</surname><given-names>H.</given-names></name><name><surname>Yanagisawa</surname><given-names>M.</given-names></name><name><surname>Yu</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>Q.</given-names></name></person-group><article-title>Orexin/Hypocretin Activates mTOR Complex 1 (mTORC1) via an Erk/Akt-independent and Calcium-stimulated Lysosome v-ATPase Pathway</article-title><source>J. Biol. Chem.</source><year>2014</year><volume>289</volume><fpage>31950</fpage><lpage>31959</lpage><pub-id pub-id-type="doi">10.1074/jbc.M114.600015</pub-id><pub-id pub-id-type="pmid">25278019</pub-id></element-citation></ref><ref id="B191-genes-11-00989"><label>191.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rozengurt</surname><given-names>E.</given-names></name></person-group><article-title>Mitogenic signaling pathways induced by G protein-coupled receptors</article-title><source>J. Cell. Physiol.</source><year>2007</year><volume>213</volume><fpage>589</fpage><lpage>602</lpage><pub-id pub-id-type="doi">10.1002/jcp.21246</pub-id><pub-id pub-id-type="pmid">17786953</pub-id></element-citation></ref><ref id="B192-genes-11-00989"><label>192.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robles-Molina</surname><given-names>E.</given-names></name><name><surname>Dionisio-Vicuna</surname><given-names>M.</given-names></name><name><surname>Guzman-Hernandez</surname><given-names>M.L.</given-names></name><name><surname>Reyes-Cruz</surname><given-names>G.</given-names></name><name><surname>Vazquez-Prado</surname><given-names>J.</given-names></name></person-group><article-title>Gbetagamma interacts with mTOR and promotes its activation</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2014</year><volume>444</volume><fpage>218</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2014.01.044</pub-id><pub-id pub-id-type="pmid">24462769</pub-id></element-citation></ref><ref id="B193-genes-11-00989"><label>193.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>T.</given-names></name><name><surname>Hoeffer</surname><given-names>C.A.</given-names></name><name><surname>Capetillo-Zarate</surname><given-names>E.</given-names></name><name><surname>Yu</surname><given-names>F.</given-names></name><name><surname>Wong</surname><given-names>H.</given-names></name><name><surname>Lin</surname><given-names>M.T.</given-names></name><name><surname>Tampellini</surname><given-names>D.</given-names></name><name><surname>Klann</surname><given-names>E.</given-names></name><name><surname>Blitzer</surname><given-names>R.D.</given-names></name><name><surname>Gouras</surname><given-names>G.K.</given-names></name></person-group><article-title>Dysregulation of the mTOR pathway mediates impairment of synaptic plasticity in a mouse model of Alzheimer&#x02019;s disease</article-title><source>PLoS ONE</source><year>2010</year><volume>5</volume><elocation-id>e12845</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0012845</pub-id><pub-id pub-id-type="pmid">20862226</pub-id></element-citation></ref><ref id="B194-genes-11-00989"><label>194.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peart</surname><given-names>J.N.</given-names></name><name><surname>Pepe</surname><given-names>S.</given-names></name><name><surname>Reichelt</surname><given-names>M.E.</given-names></name><name><surname>Beckett</surname><given-names>N.</given-names></name><name><surname>Hoe</surname><given-names>L.S.</given-names></name><name><surname>Ozberk</surname><given-names>V.</given-names></name><name><surname>Niesman</surname><given-names>I.R.</given-names></name><name><surname>Patel</surname><given-names>H.H.</given-names></name><name><surname>Headrick</surname><given-names>J.P.</given-names></name></person-group><article-title>Dysfunctional survival-signaling and stress-intolerance in aged murine and human myocardium</article-title><source>Exp. Gerontol.</source><year>2013</year><volume>50</volume><fpage>72</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1016/j.exger.2013.11.015</pub-id><pub-id pub-id-type="pmid">24316036</pub-id></element-citation></ref><ref id="B195-genes-11-00989"><label>195.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giovannini</surname><given-names>M.</given-names></name><name><surname>Lana</surname><given-names>D.</given-names></name><name><surname>Pepeu</surname><given-names>G.</given-names></name></person-group><article-title>The integrated role of ACh, ERK and mTOR in the mechanisms of hippocampal inhibitory avoidance memory</article-title><source>Neurobiol. Learn. Mem.</source><year>2015</year><volume>119</volume><fpage>18</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1016/j.nlm.2014.12.014</pub-id><pub-id pub-id-type="pmid">25595880</pub-id></element-citation></ref><ref id="B196-genes-11-00989"><label>196.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J.J.</given-names></name><name><surname>Chiu</surname><given-names>Y.-T.</given-names></name><name><surname>Dimattio</surname><given-names>K.M.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Huang</surname><given-names>P.</given-names></name><name><surname>Gentile</surname><given-names>T.A.</given-names></name><name><surname>Muschamp</surname><given-names>J.W.</given-names></name><name><surname>Cowan</surname><given-names>A.</given-names></name><name><surname>Mann</surname><given-names>M.</given-names></name><name><surname>Liu-Chen</surname><given-names>L.-Y.</given-names></name></person-group><article-title>Phosphoproteomic approach for agonist-specific signaling in mouse brains: mTOR pathway is involved in &#x003ba; opioid aversion</article-title><source>Neuropsychopharmacology</source><year>2018</year><volume>44</volume><fpage>939</fpage><lpage>949</lpage><pub-id pub-id-type="doi">10.1038/s41386-018-0155-0</pub-id><pub-id pub-id-type="pmid">30082888</pub-id></element-citation></ref><ref id="B197-genes-11-00989"><label>197.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wauson</surname><given-names>E.M.</given-names></name><name><surname>Zaganjor</surname><given-names>E.</given-names></name><name><surname>Lee</surname><given-names>A.Y.</given-names></name><name><surname>Guerra</surname><given-names>M.L.</given-names></name><name><surname>Ghosh</surname><given-names>A.B.</given-names></name><name><surname>Bookout</surname><given-names>A.L.</given-names></name><name><surname>Chambers</surname><given-names>C.P.</given-names></name><name><surname>Jivan</surname><given-names>A.</given-names></name><name><surname>McGlynn</surname><given-names>K.</given-names></name><name><surname>Hutchison</surname><given-names>M.R.</given-names></name><etal/></person-group><article-title>The G protein-coupled taste receptor T1R1/T1R3 regulates mTORC1 and autophagy</article-title><source>Mol. Cell</source><year>2012</year><volume>47</volume><fpage>851</fpage><lpage>862</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2012.08.001</pub-id><pub-id pub-id-type="pmid">22959271</pub-id></element-citation></ref><ref id="B198-genes-11-00989"><label>198.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michel</surname><given-names>G.</given-names></name><name><surname>Matthes</surname><given-names>H.W.D.</given-names></name><name><surname>Hachet-Haas</surname><given-names>M.</given-names></name><name><surname>El Baghdadi</surname><given-names>K.</given-names></name><name><surname>De Mey</surname><given-names>J.</given-names></name><name><surname>Pepperkok</surname><given-names>R.</given-names></name><name><surname>Simpson</surname><given-names>J.C.</given-names></name><name><surname>Galzi</surname><given-names>J.-L.</given-names></name><name><surname>Lecat</surname><given-names>S.</given-names></name></person-group><article-title>Plasma membrane translocation of REDD1 governed by GPCRs contributes to mTORC1 activation</article-title><source>J. Cell Sci.</source><year>2013</year><volume>127</volume><fpage>773</fpage><lpage>787</lpage><pub-id pub-id-type="doi">10.1242/jcs.136432</pub-id><pub-id pub-id-type="pmid">24338366</pub-id></element-citation></ref><ref id="B199-genes-11-00989"><label>199.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gan</surname><given-names>L.</given-names></name><name><surname>Seki</surname><given-names>A.</given-names></name><name><surname>Shen</surname><given-names>K.</given-names></name><name><surname>Iyer</surname><given-names>H.</given-names></name><name><surname>Han</surname><given-names>K.</given-names></name><name><surname>Hayer</surname><given-names>A.</given-names></name><name><surname>Wollman</surname><given-names>R.</given-names></name><name><surname>Ge</surname><given-names>X.</given-names></name><name><surname>Lin</surname><given-names>J.R.</given-names></name><name><surname>Dey</surname><given-names>G.</given-names></name><etal/></person-group><article-title>The lysosomal GPCR-like protein GPR137B regulates Rag and mTORC1 localization and activity</article-title><source>Nat. Cell Biol.</source><year>2019</year><volume>21</volume><fpage>614</fpage><lpage>626</lpage><pub-id pub-id-type="doi">10.1038/s41556-019-0321-6</pub-id><pub-id pub-id-type="pmid">31036939</pub-id></element-citation></ref><ref id="B200-genes-11-00989"><label>200.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlessi</surname><given-names>R.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Rowlands</surname><given-names>J.</given-names></name><name><surname>Cruzat</surname><given-names>V.F.</given-names></name><name><surname>Keane</surname><given-names>K.N.</given-names></name><name><surname>Egan</surname><given-names>L.</given-names></name><name><surname>Mamotte</surname><given-names>C.</given-names></name><name><surname>Stokes</surname><given-names>R.</given-names></name><name><surname>Gunton</surname><given-names>J.E.</given-names></name><name><surname>de Bittencourt</surname><given-names>P.I.</given-names></name><etal/></person-group><article-title>GLP-1 receptor signalling promotes &#x003b2;-cell glucose metabolism via mTOR-dependent HIF-1alpha activation</article-title><source>Sci. Rep.</source><year>2017</year><volume>7</volume><fpage>2661</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-02838-2</pub-id><pub-id pub-id-type="pmid">28572610</pub-id></element-citation></ref><ref id="B201-genes-11-00989"><label>201.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kritzer</surname><given-names>M.D.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Dodge-Kafka</surname><given-names>K.</given-names></name><name><surname>Kapiloff</surname><given-names>M.S.</given-names></name></person-group><article-title>AKAPs: The architectural underpinnings of local cAMP signaling</article-title><source>J. Mol. Cell. Cardiol.</source><year>2012</year><volume>52</volume><fpage>351</fpage><lpage>358</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2011.05.002</pub-id><pub-id pub-id-type="pmid">21600214</pub-id></element-citation></ref><ref id="B202-genes-11-00989"><label>202.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esseltine</surname><given-names>J.L.</given-names></name><name><surname>Scott</surname><given-names>J.D.</given-names></name></person-group><article-title>AKAP signaling complexes: Pointing towards the next generation of therapeutic targets?</article-title><source>Trends Pharmacol. Sci.</source><year>2013</year><volume>34</volume><fpage>648</fpage><lpage>655</lpage><pub-id pub-id-type="doi">10.1016/j.tips.2013.10.005</pub-id><pub-id pub-id-type="pmid">24239028</pub-id></element-citation></ref><ref id="B203-genes-11-00989"><label>203.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Yu</surname><given-names>Y.</given-names></name></person-group><article-title>Global Phosphoproteomic Analysis of Insulin/Akt/mTORC1/S6K Signaling in Rat Hepatocytes</article-title><source>J. Proteome Res.</source><year>2017</year><volume>16</volume><fpage>2825</fpage><lpage>2835</lpage><pub-id pub-id-type="doi">10.1021/acs.jproteome.7b00140</pub-id><pub-id pub-id-type="pmid">28689409</pub-id></element-citation></ref><ref id="B204-genes-11-00989"><label>204.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melick</surname><given-names>C.H.</given-names></name><name><surname>Meng</surname><given-names>D.</given-names></name><name><surname>Jewell</surname><given-names>J.L.</given-names></name></person-group><article-title>A-kinase anchoring protein 8L interacts with mTORC1 and promotes cell growth</article-title><source>J. Biol. Chem.</source><year>2020</year><volume>295</volume><pub-id pub-id-type="doi">10.1074/jbc.AC120.012595</pub-id><pub-id pub-id-type="pmid">32312749</pub-id></element-citation></ref><ref id="B205-genes-11-00989"><label>205.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rinaldi</surname><given-names>L.</given-names></name><name><surname>Sepe</surname><given-names>M.</given-names></name><name><surname>Donne</surname><given-names>R.D.</given-names></name><name><surname>Conte</surname><given-names>K.</given-names></name><name><surname>Arcella</surname><given-names>A.</given-names></name><name><surname>Borzacchiello</surname><given-names>D.</given-names></name><name><surname>Amente</surname><given-names>S.</given-names></name><name><surname>De Vita</surname><given-names>F.</given-names></name><name><surname>Porpora</surname><given-names>M.</given-names></name><name><surname>Garbi</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Mitochondrial AKAP1 supports mTOR pathway and tumor growth</article-title><source>Cell Death Dis.</source><year>2017</year><volume>8</volume><fpage>e2842</fpage><pub-id pub-id-type="doi">10.1038/cddis.2017.241</pub-id><pub-id pub-id-type="pmid">28569781</pub-id></element-citation></ref><ref id="B206-genes-11-00989"><label>206.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>P.H.</given-names></name><name><surname>Brunn</surname><given-names>G.J.</given-names></name><name><surname>Kohn</surname><given-names>A.D.</given-names></name><name><surname>Roth</surname><given-names>R.A.</given-names></name><name><surname>Lawrence</surname><given-names>J.C.</given-names></name></person-group><article-title>Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1998</year><volume>95</volume><fpage>7772</fpage><lpage>7777</lpage><pub-id pub-id-type="doi">10.1073/pnas.95.13.7772</pub-id><pub-id pub-id-type="pmid">9636226</pub-id></element-citation></ref><ref id="B207-genes-11-00989"><label>207.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nave</surname><given-names>B.T.</given-names></name><name><surname>Ouwens</surname><given-names>M.</given-names></name><name><surname>Withers</surname><given-names>D.J.</given-names></name><name><surname>Alessi</surname><given-names>D.R.</given-names></name><name><surname>Shepherd</surname><given-names>P.R.</given-names></name></person-group><article-title>Mammalian target of rapamycin is a direct target for protein kinase B: Identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation</article-title><source>Biochem. J.</source><year>1999</year><volume>344</volume><issue-part>Pt 2</issue-part><fpage>427</fpage><lpage>431</lpage><pub-id pub-id-type="doi">10.1042/bj3440427</pub-id><pub-id pub-id-type="pmid">10567225</pub-id></element-citation></ref><ref id="B208-genes-11-00989"><label>208.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sekuli&#x00107;</surname><given-names>A.</given-names></name><name><surname>Hudson</surname><given-names>C.C.</given-names></name><name><surname>Homme</surname><given-names>J.L.</given-names></name><name><surname>Yin</surname><given-names>P.</given-names></name><name><surname>Otterness</surname><given-names>D.M.</given-names></name><name><surname>Karnitz</surname><given-names>L.M.</given-names></name><name><surname>Abraham</surname><given-names>R.T.</given-names></name></person-group><article-title>A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells</article-title><source>Cancer Res.</source><year>2000</year><volume>60</volume><fpage>3504</fpage><lpage>3513</lpage><pub-id pub-id-type="pmid">10910062</pub-id></element-citation></ref><ref id="B209-genes-11-00989"><label>209.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiang</surname><given-names>G.G.</given-names></name><name><surname>Abraham</surname><given-names>R.T.</given-names></name></person-group><article-title>Phosphorylation of Mammalian Target of Rapamycin (mTOR) at Ser-2448 Is Mediated by p70S6 Kinase</article-title><source>J. Biol. Chem.</source><year>2005</year><volume>280</volume><fpage>25485</fpage><lpage>25490</lpage><pub-id pub-id-type="doi">10.1074/jbc.M501707200</pub-id><pub-id pub-id-type="pmid">15899889</pub-id></element-citation></ref><ref id="B210-genes-11-00989"><label>210.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>S.W.Y.</given-names></name><name><surname>Fryer</surname><given-names>L.G.D.</given-names></name><name><surname>Carling</surname><given-names>D.</given-names></name><name><surname>Shepherd</surname><given-names>P.R.</given-names></name></person-group><article-title>Thr2446Is a Novel Mammalian Target of Rapamycin (mTOR) Phosphorylation Site Regulated by Nutrient Status</article-title><source>J. Biol. Chem.</source><year>2004</year><volume>279</volume><fpage>15719</fpage><lpage>15722</lpage><pub-id pub-id-type="doi">10.1074/jbc.C300534200</pub-id><pub-id pub-id-type="pmid">14970221</pub-id></element-citation></ref><ref id="B211-genes-11-00989"><label>211.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Acosta-Jaquez</surname><given-names>H.A.</given-names></name><name><surname>Keller</surname><given-names>J.A.</given-names></name><name><surname>Foster</surname><given-names>K.G.</given-names></name><name><surname>Ekim</surname><given-names>B.</given-names></name><name><surname>Soliman</surname><given-names>G.A.</given-names></name><name><surname>Feener</surname><given-names>E.P.</given-names></name><name><surname>Ballif</surname><given-names>B.A.</given-names></name><name><surname>Fingar</surname><given-names>D.C.</given-names></name></person-group><article-title>Site-Specific mTOR Phosphorylation Promotes mTORC1-Mediated Signaling and Cell Growth</article-title><source>Mol. Cell. Biol.</source><year>2009</year><volume>29</volume><fpage>4308</fpage><lpage>4324</lpage><pub-id pub-id-type="doi">10.1128/MCB.01665-08</pub-id><pub-id pub-id-type="pmid">19487463</pub-id></element-citation></ref><ref id="B212-genes-11-00989"><label>212.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>R.T.</given-names></name><name><surname>Beal</surname><given-names>P.A.</given-names></name><name><surname>Comb</surname><given-names>M.J.</given-names></name><name><surname>Schreiber</surname><given-names>S.L.</given-names></name></person-group><article-title>FKBP12-Rapamycin-associated Protein (FRAP) Autophosphorylates at Serine 2481 under Translationally Repressive Conditions</article-title><source>J. Biol. Chem.</source><year>2000</year><volume>275</volume><fpage>7416</fpage><lpage>7423</lpage><pub-id pub-id-type="doi">10.1074/jbc.275.10.7416</pub-id><pub-id pub-id-type="pmid">10702316</pub-id></element-citation></ref><ref id="B213-genes-11-00989"><label>213.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soliman</surname><given-names>G.A.</given-names></name><name><surname>Acosta-Jaquez</surname><given-names>H.A.</given-names></name><name><surname>Dunlop</surname><given-names>E.A.</given-names></name><name><surname>Ekim</surname><given-names>B.</given-names></name><name><surname>Maj</surname><given-names>N.E.</given-names></name><name><surname>Tee</surname><given-names>A.R.</given-names></name><name><surname>Fingar</surname><given-names>D.C.</given-names></name></person-group><article-title>mTOR Ser-2481 Autophosphorylation Monitors mTORC-specific Catalytic Activity and Clarifies Rapamycin Mechanism of Action</article-title><source>J. Biol. Chem.</source><year>2009</year><volume>285</volume><fpage>7866</fpage><lpage>7879</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.096222</pub-id><pub-id pub-id-type="pmid">20022946</pub-id></element-citation></ref><ref id="B214-genes-11-00989"><label>214.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dan</surname><given-names>H.C.</given-names></name><name><surname>Ebbs</surname><given-names>A.</given-names></name><name><surname>Pasparakis</surname><given-names>M.</given-names></name><name><surname>Van Dyke</surname><given-names>T.</given-names></name><name><surname>Basseres</surname><given-names>D.S.</given-names></name><name><surname>Baldwin</surname><given-names>A.S.</given-names></name></person-group><article-title>Akt-dependent activation of mTORC1 complex involves phosphorylation of mTOR (mammalian target of rapamycin) by IkappaB kinase &#x003b1; (IKKalpha)</article-title><source>J. Biol. Chem.</source><year>2014</year><volume>289</volume><fpage>25227</fpage><lpage>25240</lpage><pub-id pub-id-type="doi">10.1074/jbc.M114.554881</pub-id><pub-id pub-id-type="pmid">24990947</pub-id></element-citation></ref><ref id="B215-genes-11-00989"><label>215.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ekim</surname><given-names>B.</given-names></name><name><surname>Magnuson</surname><given-names>B.</given-names></name><name><surname>Acosta-Jaquez</surname><given-names>H.A.</given-names></name><name><surname>Keller</surname><given-names>J.A.</given-names></name><name><surname>Feener</surname><given-names>E.P.</given-names></name><name><surname>Fingar</surname><given-names>D.C.</given-names></name></person-group><article-title>mTOR Kinase Domain Phosphorylation Promotes mTORC1 Signaling, Cell Growth, and Cell Cycle Progression</article-title><source>Mol. Cell. Biol.</source><year>2011</year><volume>31</volume><fpage>2787</fpage><lpage>2801</lpage><pub-id pub-id-type="doi">10.1128/MCB.05437-11</pub-id><pub-id pub-id-type="pmid">21576368</pub-id></element-citation></ref><ref id="B216-genes-11-00989"><label>216.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bodur</surname><given-names>C.</given-names></name><name><surname>Kazyken</surname><given-names>D.</given-names></name><name><surname>Huang</surname><given-names>K.</given-names></name><name><surname>Ustunel</surname><given-names>B.E.</given-names></name><name><surname>Siroky</surname><given-names>K.A.</given-names></name><name><surname>Tooley</surname><given-names>A.S.</given-names></name><name><surname>Gonzalez</surname><given-names>I.E.</given-names></name><name><surname>Foley</surname><given-names>D.H.</given-names></name><name><surname>Acosta-Jaquez</surname><given-names>H.A.</given-names></name><name><surname>Barnes</surname><given-names>T.M.</given-names></name><etal/></person-group><article-title>The IKK-related kinase TBK1 activates mTORC1 directly in response to growth factors and innate immune agonists</article-title><source>EMBO J.</source><year>2017</year><volume>37</volume><fpage>19</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.15252/embj.201696164</pub-id><pub-id pub-id-type="pmid">29150432</pub-id></element-citation></ref><ref id="B217-genes-11-00989"><label>217.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Lawrence</surname><given-names>J.C.</given-names></name><name><surname>Sturgill</surname><given-names>T.W.</given-names></name><name><surname>Harris</surname><given-names>T.E.</given-names></name></person-group><article-title>Mammalian Target of Rapamycin Complex 1 (mTORC1) Activity Is Associated with Phosphorylation of Raptor by mTOR</article-title><source>J. Biol. Chem.</source><year>2009</year><volume>284</volume><fpage>14693</fpage><lpage>14697</lpage><pub-id pub-id-type="doi">10.1074/jbc.C109.002907</pub-id><pub-id pub-id-type="pmid">19346248</pub-id></element-citation></ref><ref id="B218-genes-11-00989"><label>218.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foster</surname><given-names>K.G.</given-names></name><name><surname>Acosta-Jaquez</surname><given-names>H.A.</given-names></name><name><surname>Romeo</surname><given-names>Y.</given-names></name><name><surname>Ekim</surname><given-names>B.</given-names></name><name><surname>Soliman</surname><given-names>G.A.</given-names></name><name><surname>Carriere</surname><given-names>A.</given-names></name><name><surname>Roux</surname><given-names>P.P.</given-names></name><name><surname>Ballif</surname><given-names>B.A.</given-names></name><name><surname>Fingar</surname><given-names>D.C.</given-names></name></person-group><article-title>Regulation of mTOR Complex 1 (mTORC1) by Raptor Ser863and Multisite Phosphorylation</article-title><source>J. Biol. Chem.</source><year>2009</year><volume>285</volume><fpage>80</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.029637</pub-id><pub-id pub-id-type="pmid">19864431</pub-id></element-citation></ref><ref id="B219-genes-11-00989"><label>219.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frey</surname><given-names>J.W.</given-names></name><name><surname>Jacobs</surname><given-names>B.</given-names></name><name><surname>Goodman</surname><given-names>C.A.</given-names></name><name><surname>Hornberger</surname><given-names>T.A.</given-names></name></person-group><article-title>A role for Raptor phosphorylation in the mechanical activation of mTOR signaling</article-title><source>Cell. Signal.</source><year>2013</year><volume>26</volume><fpage>313</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1016/j.cellsig.2013.11.009</pub-id><pub-id pub-id-type="pmid">24239769</pub-id></element-citation></ref><ref id="B220-genes-11-00989"><label>220.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carriere</surname><given-names>A.</given-names></name><name><surname>Cargnello</surname><given-names>M.</given-names></name><name><surname>Julien</surname><given-names>L.-A.</given-names></name><name><surname>Gao</surname><given-names>H.</given-names></name><name><surname>Bonneil</surname><given-names>E.</given-names></name><name><surname>Thibault</surname><given-names>P.</given-names></name><name><surname>Roux</surname><given-names>P.P.</given-names></name></person-group><article-title>Oncogenic MAPK Signaling Stimulates mTORC1 Activity by Promoting RSK-Mediated Raptor Phosphorylation</article-title><source>Curr. Biol.</source><year>2008</year><volume>18</volume><fpage>1269</fpage><lpage>1277</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2008.07.078</pub-id><pub-id pub-id-type="pmid">18722121</pub-id></element-citation></ref><ref id="B221-genes-11-00989"><label>221.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carriere</surname><given-names>A.</given-names></name><name><surname>Romeo</surname><given-names>Y.</given-names></name><name><surname>Acosta-Jaquez</surname><given-names>H.A.</given-names></name><name><surname>Moreau</surname><given-names>J.</given-names></name><name><surname>Bonneil</surname><given-names>E.</given-names></name><name><surname>Thibault</surname><given-names>P.</given-names></name><name><surname>Fingar</surname><given-names>D.C.</given-names></name><name><surname>Roux</surname><given-names>P.P.</given-names></name></person-group><article-title>ERK1/2 phosphorylate Raptor to promote Ras-dependent activation of mTOR complex 1 (mTORC1)</article-title><source>J. Biol. Chem.</source><year>2011</year><volume>286</volume><fpage>567</fpage><lpage>577</lpage><pub-id pub-id-type="doi">10.1074/jbc.M110.159046</pub-id><pub-id pub-id-type="pmid">21071439</pub-id></element-citation></ref><ref id="B222-genes-11-00989"><label>222.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwak</surname><given-names>D.</given-names></name><name><surname>Choi</surname><given-names>S.</given-names></name><name><surname>Jeong</surname><given-names>H.</given-names></name><name><surname>Jang</surname><given-names>J.-H.</given-names></name><name><surname>Lee</surname><given-names>Y.</given-names></name><name><surname>Jeon</surname><given-names>H.</given-names></name><name><surname>Lee</surname><given-names>M.N.</given-names></name><name><surname>Noh</surname><given-names>J.</given-names></name><name><surname>Cho</surname><given-names>K.</given-names></name><name><surname>Yoo</surname><given-names>J.S.</given-names></name><etal/></person-group><article-title>Osmotic Stress Regulates Mammalian Target of Rapamycin (mTOR) Complex 1 via c-Jun N-terminal Kinase (JNK)-mediated Raptor Protein Phosphorylation</article-title><source>J. Biol. Chem.</source><year>2012</year><volume>287</volume><fpage>18398</fpage><lpage>18407</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.326538</pub-id><pub-id pub-id-type="pmid">22493283</pub-id></element-citation></ref><ref id="B223-genes-11-00989"><label>223.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujishita</surname><given-names>T.</given-names></name><name><surname>Aoki</surname><given-names>M.</given-names></name><name><surname>Taketo</surname><given-names>M.M.</given-names></name></person-group><article-title>JNK signaling promotes intestinal tumorigenesis through activation of mTOR complex 1 in Apc(Delta716) mice</article-title><source>Gastroenterology</source><year>2011</year><volume>140</volume><fpage>1556</fpage><lpage>1563</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2011.02.007</pub-id><pub-id pub-id-type="pmid">21320501</pub-id></element-citation></ref><ref id="B224-genes-11-00989"><label>224.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stretton</surname><given-names>C.</given-names></name><name><surname>Hoffmann</surname><given-names>T.M.</given-names></name><name><surname>Munson</surname><given-names>M.J.</given-names></name><name><surname>Prescott</surname><given-names>A.</given-names></name><name><surname>Taylor</surname><given-names>P.M.</given-names></name><name><surname>Ganley</surname><given-names>I.G.</given-names></name><name><surname>Hundal</surname><given-names>H.S.</given-names></name></person-group><article-title>GSK3-mediated raptor phosphorylation supports amino-acid-dependent mTORC1-directed signalling</article-title><source>Biochem. J.</source><year>2015</year><volume>470</volume><fpage>207</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1042/BJ20150404</pub-id><pub-id pub-id-type="pmid">26348909</pub-id></element-citation></ref><ref id="B225-genes-11-00989"><label>225.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>H.-X.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Yu</surname><given-names>F.-X.</given-names></name><name><surname>Li</surname><given-names>F.</given-names></name><name><surname>Russell</surname><given-names>R.C.</given-names></name><name><surname>Jewell</surname><given-names>J.L.</given-names></name><name><surname>Guan</surname><given-names>K.-L.</given-names></name></person-group><article-title>NLK phosphorylates Raptor to mediate stress-induced mTORC1 inhibition</article-title><source>Genes Dev.</source><year>2015</year><volume>29</volume><fpage>2362</fpage><lpage>2376</lpage><pub-id pub-id-type="doi">10.1101/gad.265116.115</pub-id><pub-id pub-id-type="pmid">26588989</pub-id></element-citation></ref><ref id="B226-genes-11-00989"><label>226.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gan</surname><given-names>W.</given-names></name><name><surname>Dai</surname><given-names>X.</given-names></name><name><surname>Dai</surname><given-names>X.</given-names></name><name><surname>Xie</surname><given-names>J.</given-names></name><name><surname>Yin</surname><given-names>S.</given-names></name><name><surname>Zhu</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Guo</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><etal/></person-group><article-title>LATS suppresses mTORC1 activity to directly coordinate Hippo and mTORC1 pathways in growth control</article-title><source>Nat. Cell Biol.</source><year>2020</year><volume>22</volume><fpage>246</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1038/s41556-020-0463-6</pub-id><pub-id pub-id-type="pmid">32015438</pub-id></element-citation></ref><ref id="B227-genes-11-00989"><label>227.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ram&#x0013a;rez-Valle</surname><given-names>F.</given-names></name><name><surname>Badura</surname><given-names>M.L.</given-names></name><name><surname>Braunstein</surname><given-names>S.</given-names></name><name><surname>Narasimhan</surname><given-names>M.</given-names></name><name><surname>Schneider</surname><given-names>R.J.</given-names></name></person-group><article-title>Mitotic Raptor Promotes mTORC1 Activity, G2/M Cell Cycle Progression, and Internal Ribosome Entry Site-Mediated mRNA Translation</article-title><source>Mol. Cell. Biol.</source><year>2010</year><volume>30</volume><fpage>3151</fpage><lpage>3164</lpage><pub-id pub-id-type="doi">10.1128/MCB.00322-09</pub-id><pub-id pub-id-type="pmid">20439490</pub-id></element-citation></ref><ref id="B228-genes-11-00989"><label>228.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gwinn</surname><given-names>D.M.</given-names></name><name><surname>Asara</surname><given-names>J.M.</given-names></name><name><surname>Shaw</surname><given-names>R.J.</given-names></name></person-group><article-title>Raptor is Phosphorylated by cdc2 during Mitosis</article-title><source>PLoS ONE</source><year>2010</year><volume>5</volume><elocation-id>e9197</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0009197</pub-id><pub-id pub-id-type="pmid">20169205</pub-id></element-citation></ref><ref id="B229-genes-11-00989"><label>229.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buerger</surname><given-names>C.</given-names></name><name><surname>Devries</surname><given-names>B.</given-names></name><name><surname>Stambolic</surname><given-names>V.</given-names></name></person-group><article-title>Localization of Rheb to the endomembrane is critical for its signaling function</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2006</year><volume>344</volume><fpage>869</fpage><lpage>880</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2006.03.220</pub-id><pub-id pub-id-type="pmid">16631613</pub-id></element-citation></ref><ref id="B230-genes-11-00989"><label>230.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanker</surname><given-names>A.B.</given-names></name><name><surname>Mitin</surname><given-names>N.</given-names></name><name><surname>Wilder</surname><given-names>R.S.</given-names></name><name><surname>Henske</surname><given-names>E.P.</given-names></name><name><surname>Tamanoi</surname><given-names>F.</given-names></name><name><surname>Cox</surname><given-names>A.D.</given-names></name><name><surname>Der</surname><given-names>C.J.</given-names></name></person-group><article-title>Differential requirement of CAAX-mediated posttranslational processing for Rheb localization and signaling</article-title><source>Oncogene</source><year>2009</year><volume>29</volume><fpage>380</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1038/onc.2009.336</pub-id><pub-id pub-id-type="pmid">19838215</pub-id></element-citation></ref><ref id="B231-genes-11-00989"><label>231.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>H.</given-names></name><name><surname>Vogt</surname><given-names>P.K.</given-names></name></person-group><article-title>Constitutively active Rheb induces oncogenic transformation</article-title><source>Oncogene</source><year>2008</year><volume>27</volume><fpage>5729</fpage><lpage>5740</lpage><pub-id pub-id-type="doi">10.1038/onc.2008.180</pub-id><pub-id pub-id-type="pmid">18521078</pub-id></element-citation></ref><ref id="B232-genes-11-00989"><label>232.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manifava</surname><given-names>M.</given-names></name><name><surname>Smith</surname><given-names>M.D.</given-names></name><name><surname>Rotondo</surname><given-names>S.</given-names></name><name><surname>Walker</surname><given-names>S.A.</given-names></name><name><surname>Niewczas</surname><given-names>I.</given-names></name><name><surname>Zoncu</surname><given-names>R.</given-names></name><name><surname>Clark</surname><given-names>J.</given-names></name><name><surname>Ktistakis</surname><given-names>N.</given-names></name></person-group><article-title>Dynamics of mTORC1 activation in response to amino acids</article-title><source>eLife</source><year>2016</year><volume>5</volume><fpage>142</fpage><pub-id pub-id-type="doi">10.7554/eLife.19960</pub-id><pub-id pub-id-type="pmid">27725083</pub-id></element-citation></ref><ref id="B233-genes-11-00989"><label>233.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>J.D.</given-names></name><name><surname>Zhang</surname><given-names>Y.-J.</given-names></name><name><surname>Wei</surname><given-names>Y.-H.</given-names></name><name><surname>Cho</surname><given-names>J.-H.</given-names></name><name><surname>Morris</surname><given-names>L.E.</given-names></name><name><surname>Wang</surname><given-names>H.-Y.</given-names></name><name><surname>Zheng</surname><given-names>X.S.</given-names></name></person-group><article-title>Rab1A is an mTORC1 activator and a colorectal oncogene</article-title><source>Cancer Cell</source><year>2014</year><volume>26</volume><fpage>754</fpage><lpage>769</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2014.09.008</pub-id><pub-id pub-id-type="pmid">25446900</pub-id></element-citation></ref><ref id="B234-genes-11-00989"><label>234.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Alexander</surname><given-names>A.</given-names></name><name><surname>Cai</surname><given-names>S.</given-names></name><name><surname>Tripathi</surname><given-names>D.N.</given-names></name><name><surname>Dere</surname><given-names>R.</given-names></name><name><surname>Tee</surname><given-names>A.R.</given-names></name><name><surname>Tait-Mulder</surname><given-names>J.</given-names></name><name><surname>Di Nardo</surname><given-names>A.</given-names></name><name><surname>Han</surname><given-names>J.M.</given-names></name><etal/></person-group><article-title>A tuberous sclerosis complex signalling node at the peroxisome regulates mTORC1 and autophagy in response to ROS</article-title><source>Nat. Cell Biol.</source><year>2013</year><volume>15</volume><fpage>1186</fpage><lpage>1196</lpage><pub-id pub-id-type="doi">10.1038/ncb2822</pub-id><pub-id pub-id-type="pmid">23955302</pub-id></element-citation></ref><ref id="B235-genes-11-00989"><label>235.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melser</surname><given-names>S.</given-names></name><name><surname>Hebert-Chatelain</surname><given-names>E.</given-names></name><name><surname>Lavie</surname><given-names>J.</given-names></name><name><surname>Mahfouf</surname><given-names>W.</given-names></name><name><surname>Jose</surname><given-names>C.</given-names></name><name><surname>Obre</surname><given-names>E.</given-names></name><name><surname>Goorden</surname><given-names>S.</given-names></name><name><surname>Priault</surname><given-names>M.</given-names></name><name><surname>Elgersma</surname><given-names>Y.</given-names></name><name><surname>Rezvani</surname><given-names>H.R.</given-names></name><etal/></person-group><article-title>Rheb Regulates Mitophagy Induced by Mitochondrial Energetic Status</article-title><source>Cell Metab.</source><year>2013</year><volume>17</volume><fpage>719</fpage><lpage>730</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2013.03.014</pub-id><pub-id pub-id-type="pmid">23602449</pub-id></element-citation></ref><ref id="B236-genes-11-00989"><label>236.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inoki</surname><given-names>K.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Zhu</surname><given-names>T.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Guan</surname><given-names>K.-L.</given-names></name></person-group><article-title>TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling</article-title><source>Nat. Cell Biol.</source><year>2002</year><volume>4</volume><fpage>648</fpage><lpage>657</lpage><pub-id pub-id-type="doi">10.1038/ncb839</pub-id><pub-id pub-id-type="pmid">12172553</pub-id></element-citation></ref><ref id="B237-genes-11-00989"><label>237.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plescher</surname><given-names>M.</given-names></name><name><surname>Teleman</surname><given-names>A.A.</given-names></name><name><surname>Demetriades</surname><given-names>C.</given-names></name></person-group><article-title>TSC2 mediates hyperosmotic stress-induced inactivation of mTORC1</article-title><source>Sci. Rep.</source><year>2015</year><volume>5</volume><fpage>13828</fpage><pub-id pub-id-type="doi">10.1038/srep13828</pub-id><pub-id pub-id-type="pmid">26345496</pub-id></element-citation></ref><ref id="B238-genes-11-00989"><label>238.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inoki</surname><given-names>K.</given-names></name><name><surname>Zhu</surname><given-names>T.</given-names></name><name><surname>Guan</surname><given-names>K.-L.</given-names></name></person-group><article-title>TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival</article-title><source>Cell</source><year>2003</year><volume>115</volume><fpage>577</fpage><lpage>590</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(03)00929-2</pub-id><pub-id pub-id-type="pmid">14651849</pub-id></element-citation></ref><ref id="B239-genes-11-00989"><label>239.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inoki</surname><given-names>K.</given-names></name><name><surname>Ouyang</surname><given-names>H.</given-names></name><name><surname>Zhu</surname><given-names>T.</given-names></name><name><surname>Lindvall</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>Q.</given-names></name><name><surname>Bennett</surname><given-names>C.</given-names></name><name><surname>Harada</surname><given-names>Y.</given-names></name><name><surname>Stankunas</surname><given-names>K.</given-names></name><etal/></person-group><article-title>TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth</article-title><source>Cell</source><year>2006</year><volume>126</volume><fpage>955</fpage><lpage>968</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2006.06.055</pub-id><pub-id pub-id-type="pmid">16959574</pub-id></element-citation></ref><ref id="B240-genes-11-00989"><label>240.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>C.-H.</given-names></name><name><surname>Inoki</surname><given-names>K.</given-names></name><name><surname>Karbowniczek</surname><given-names>M.</given-names></name><name><surname>Petroulakis</surname><given-names>E.</given-names></name><name><surname>Sonenberg</surname><given-names>N.</given-names></name><name><surname>Henske</surname><given-names>E.P.</given-names></name><name><surname>Guan</surname><given-names>K.-L.</given-names></name></person-group><article-title>Constitutive mTOR activation in TSC mutants sensitizes cells to energy starvation and genomic damage via p53</article-title><source>EMBO J.</source><year>2007</year><volume>26</volume><fpage>4812</fpage><lpage>4823</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7601900</pub-id><pub-id pub-id-type="pmid">17962806</pub-id></element-citation></ref><ref id="B241-genes-11-00989"><label>241.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maehama</surname><given-names>T.</given-names></name><name><surname>Tanaka</surname><given-names>M.</given-names></name><name><surname>Nishina</surname><given-names>H.</given-names></name><name><surname>Murakami</surname><given-names>M.</given-names></name><name><surname>Kanaho</surname><given-names>Y.</given-names></name><name><surname>Hanada</surname><given-names>K.</given-names></name></person-group><article-title>RalA Functions as an Indispensable Signal Mediator for the Nutrient-sensing System</article-title><source>J. Biol. Chem.</source><year>2008</year><volume>283</volume><fpage>35053</fpage><lpage>35059</lpage><pub-id pub-id-type="doi">10.1074/jbc.M805822200</pub-id><pub-id pub-id-type="pmid">18948269</pub-id></element-citation></ref><ref id="B242-genes-11-00989"><label>242.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Segev</surname><given-names>N.</given-names></name></person-group><article-title>Ypt/rab gtpases: Regulators of protein trafficking</article-title><source>Sci. STKE</source><year>2001</year><volume>2001</volume><fpage>re11</fpage><pub-id pub-id-type="doi">10.1126/stke.2001.100.re11</pub-id><pub-id pub-id-type="pmid">11579231</pub-id></element-citation></ref><ref id="B243-genes-11-00989"><label>243.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Kim</surname><given-names>E.</given-names></name><name><surname>Yuan</surname><given-names>H.</given-names></name><name><surname>Inoki</surname><given-names>K.</given-names></name><name><surname>Goraksha-Hicks</surname><given-names>P.</given-names></name><name><surname>Schiesher</surname><given-names>R.L.</given-names></name><name><surname>Neufeld</surname><given-names>T.P.</given-names></name><name><surname>Guan</surname><given-names>K.-L.</given-names></name></person-group><article-title>Regulation of mTORC1 by the Rab and Arf GTPases</article-title><source>J. Biol. Chem.</source><year>2010</year><volume>285</volume><fpage>19705</fpage><lpage>19709</lpage><pub-id pub-id-type="doi">10.1074/jbc.C110.102483</pub-id><pub-id pub-id-type="pmid">20457610</pub-id></element-citation></ref><ref id="B244-genes-11-00989"><label>244.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsui</surname><given-names>T.</given-names></name><name><surname>Fukuda</surname><given-names>M.</given-names></name></person-group><article-title>Rab12 regulates mTORC1 activity and autophagy through controlling the degradation of amino-acid transporter PAT4</article-title><source>EMBO Rep.</source><year>2013</year><volume>14</volume><fpage>450</fpage><lpage>457</lpage><pub-id pub-id-type="doi">10.1038/embor.2013.32</pub-id><pub-id pub-id-type="pmid">23478338</pub-id></element-citation></ref><ref id="B245-genes-11-00989"><label>245.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>L.</given-names></name><name><surname>Wall</surname><given-names>A.A.</given-names></name><name><surname>Yeo</surname><given-names>J.C.</given-names></name><name><surname>Condon</surname><given-names>N.D.</given-names></name><name><surname>Norwood</surname><given-names>S.J.</given-names></name><name><surname>Schoenwaelder</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>K.W.</given-names></name><name><surname>Jackson</surname><given-names>S.</given-names></name><name><surname>Jenkins</surname><given-names>B.J.</given-names></name><name><surname>Hartland</surname><given-names>E.L.</given-names></name><etal/></person-group><article-title>Rab8a interacts directly with PI3Kgamma to modulate TLR4-driven PI3K and mTOR signalling</article-title><source>Nat. Commun.</source><year>2014</year><volume>5</volume><fpage>4407</fpage><pub-id pub-id-type="doi">10.1038/ncomms5407</pub-id><pub-id pub-id-type="pmid">25022365</pub-id></element-citation></ref><ref id="B246-genes-11-00989"><label>246.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saci</surname><given-names>A.</given-names></name><name><surname>Cantley</surname><given-names>L.C.</given-names></name><name><surname>Carpenter</surname><given-names>C.L.</given-names></name></person-group><article-title>Rac1 regulates the activity of mTORC1 and mTORC2 and controls cellular size</article-title><source>Mol. Cell</source><year>2011</year><volume>42</volume><fpage>50</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2011.03.017</pub-id><pub-id pub-id-type="pmid">21474067</pub-id></element-citation></ref><ref id="B247-genes-11-00989"><label>247.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname><given-names>B.S.</given-names></name><name><surname>Kazi</surname><given-names>A.A.</given-names></name><name><surname>Coleman</surname><given-names>C.S.</given-names></name><name><surname>Dennis</surname><given-names>M.D.</given-names></name><name><surname>Chau</surname><given-names>V.</given-names></name><name><surname>Jefferson</surname><given-names>L.S.</given-names></name><name><surname>Kimball</surname><given-names>S.R.</given-names></name></person-group><article-title>RhoA modulates signaling through the mechanistic target of rapamycin complex 1 (mTORC1) in mammalian cells</article-title><source>Cell. Signal.</source><year>2014</year><volume>26</volume><fpage>461</fpage><lpage>467</lpage><pub-id pub-id-type="doi">10.1016/j.cellsig.2013.11.035</pub-id><pub-id pub-id-type="pmid">24316235</pub-id></element-citation></ref><ref id="B248-genes-11-00989"><label>248.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mutvei</surname><given-names>A.P.</given-names></name><name><surname>Nagiec</surname><given-names>M.J.</given-names></name><name><surname>Hamann</surname><given-names>J.C.</given-names></name><name><surname>Kim</surname><given-names>S.G.</given-names></name><name><surname>Vincent</surname><given-names>C.T.</given-names></name><name><surname>Blenis</surname><given-names>J.</given-names></name></person-group><article-title>Rap1-GTPases control mTORC1 activity by coordinating lysosome organization with amino acid availability</article-title><source>Nat. Commun.</source><year>2020</year><volume>11</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1038/s41467-020-15156-5</pub-id><pub-id pub-id-type="pmid">31911652</pub-id></element-citation></ref><ref id="B249-genes-11-00989"><label>249.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chien</surname><given-names>Y.</given-names></name><name><surname>White</surname><given-names>M.A.</given-names></name></person-group><article-title>RAL GTPases are linchpin modulators of human tumour-cell proliferation and survival</article-title><source>EMBO Rep.</source><year>2003</year><volume>4</volume><fpage>800</fpage><lpage>806</lpage><pub-id pub-id-type="doi">10.1038/sj.embor.embor899</pub-id><pub-id pub-id-type="pmid">12856001</pub-id></element-citation></ref><ref id="B250-genes-11-00989"><label>250.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bodemann</surname><given-names>B.O.</given-names></name><name><surname>White</surname><given-names>M.A.</given-names></name></person-group><article-title>Ral GTPases and cancer: Linchpin support of the tumorigenic platform</article-title><source>Nat. Rev. Cancer</source><year>2008</year><volume>8</volume><fpage>133</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1038/nrc2296</pub-id><pub-id pub-id-type="pmid">18219307</pub-id></element-citation></ref><ref id="B251-genes-11-00989"><label>251.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balasubramanian</surname><given-names>N.</given-names></name><name><surname>Meier</surname><given-names>J.A.</given-names></name><name><surname>Scott</surname><given-names>D.W.</given-names></name><name><surname>Norambuena</surname><given-names>A.</given-names></name><name><surname>White</surname><given-names>M.A.</given-names></name><name><surname>Schwartz</surname><given-names>M.A.</given-names></name></person-group><article-title>RalA-Exocyst Complex Regulates Integrin-Dependent Membrane Raft Exocytosis and Growth Signaling</article-title><source>Curr. Biol.</source><year>2010</year><volume>20</volume><fpage>75</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2009.11.016</pub-id><pub-id pub-id-type="pmid">20005108</pub-id></element-citation></ref><ref id="B252-genes-11-00989"><label>252.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inoue</surname><given-names>M.</given-names></name><name><surname>Chang</surname><given-names>L.</given-names></name><name><surname>Hwang</surname><given-names>J.</given-names></name><name><surname>Chiang</surname><given-names>S.-H.</given-names></name><name><surname>Saltiel</surname><given-names>A.</given-names></name></person-group><article-title>The exocyst complex is required for targeting of Glut4 to the plasma membrane by insulin</article-title><source>Nature</source><year>2003</year><volume>422</volume><fpage>629</fpage><lpage>633</lpage><pub-id pub-id-type="doi">10.1038/nature01533</pub-id><pub-id pub-id-type="pmid">12687004</pub-id></element-citation></ref><ref id="B253-genes-11-00989"><label>253.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X.-W.</given-names></name><name><surname>Leto</surname><given-names>D.</given-names></name><name><surname>Xiong</surname><given-names>T.</given-names></name><name><surname>Yu</surname><given-names>G.</given-names></name><name><surname>Cheng</surname><given-names>A.</given-names></name><name><surname>Decker</surname><given-names>S.</given-names></name><name><surname>Saltiel</surname><given-names>A.</given-names></name></person-group><article-title>A Ral GAP complex links PI 3-kinase/Akt signaling to RalA activation in insulin action</article-title><source>Mol. Biol. Cell</source><year>2011</year><volume>22</volume><fpage>141</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1091/mbc.e10-08-0665</pub-id><pub-id pub-id-type="pmid">21148297</pub-id></element-citation></ref><ref id="B254-genes-11-00989"><label>254.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parri</surname><given-names>M.</given-names></name><name><surname>Chiarugia</surname><given-names>P.</given-names></name></person-group><article-title>Rac and Rho GTPases in cancer cell motility control</article-title><source>Cell Commun. Signal.</source><year>2010</year><volume>8</volume><fpage>23</fpage><pub-id pub-id-type="doi">10.1186/1478-811X-8-23</pub-id><pub-id pub-id-type="pmid">20822528</pub-id></element-citation></ref><ref id="B255-genes-11-00989"><label>255.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goncharova</surname><given-names>E.</given-names></name><name><surname>Goncharov</surname><given-names>D.</given-names></name><name><surname>Noonan</surname><given-names>D.</given-names></name><name><surname>Krymskaya</surname><given-names>V.P.</given-names></name></person-group><article-title>TSC2 modulates actin cytoskeleton and focal adhesion through TSC1-binding domain and the Rac1 GTPase</article-title><source>J. Cell Biol.</source><year>2004</year><volume>167</volume><fpage>1171</fpage><lpage>1182</lpage><pub-id pub-id-type="doi">10.1083/jcb.200405130</pub-id><pub-id pub-id-type="pmid">15611338</pub-id></element-citation></ref><ref id="B256-genes-11-00989"><label>256.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>D.Y.</given-names></name><name><surname>Olefsky</surname><given-names>J.M.</given-names></name></person-group><article-title>G protein-coupled receptors as targets for anti-diabetic therapeutics</article-title><source>Nat. Rev. Drug Discov.</source><year>2016</year><volume>15</volume><fpage>161</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1038/nrd.2015.4</pub-id><pub-id pub-id-type="pmid">26822831</pub-id></element-citation></ref><ref id="B257-genes-11-00989"><label>257.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolar</surname><given-names>G.R.</given-names></name><name><surname>Grote</surname><given-names>S.M.</given-names></name><name><surname>Yosten</surname><given-names>G.L.C.</given-names></name></person-group><article-title>Targeting orphan G protein-coupled receptors for the treatment of diabetes and its complications: C-peptide and GPR146</article-title><source>J. Intern. Med.</source><year>2016</year><volume>281</volume><fpage>25</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1111/joim.12528</pub-id><pub-id pub-id-type="pmid">27306986</pub-id></element-citation></ref><ref id="B258-genes-11-00989"><label>258.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Husted</surname><given-names>A.S.</given-names></name><name><surname>Trauelsen</surname><given-names>M.H.</given-names></name><name><surname>Rudenko</surname><given-names>O.</given-names></name><name><surname>Hjorth</surname><given-names>S.A.</given-names></name><name><surname>Schwartz</surname><given-names>T.W.</given-names></name></person-group><article-title>GPCR-Mediated Signaling of Metabolites</article-title><source>Cell Metab.</source><year>2017</year><volume>25</volume><fpage>777</fpage><lpage>796</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2017.03.008</pub-id><pub-id pub-id-type="pmid">28380372</pub-id></element-citation></ref><ref id="B259-genes-11-00989"><label>259.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorsam</surname><given-names>R.T.</given-names></name><name><surname>Gutkind</surname><given-names>J.S.</given-names></name></person-group><article-title>G-protein-coupled receptors and cancer</article-title><source>Nat. Rev. Cancer</source><year>2007</year><volume>7</volume><fpage>79</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1038/nrc2069</pub-id><pub-id pub-id-type="pmid">17251915</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="genes-11-00989-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Components of mTOR complex 1 (mTORC1) and mTORC2. Left- Core components of mTORC1 are mammalian target of rapamycin (mTOR) (kinase), Raptor (substrate recognizing component), and mLST8 (positive regulator). Other reported mTORC1 components are PRAS40 (negative regulator) and DEP-domain-containing mTOR-interacting protein (DEPTOR) (negative regulator). Five main downstream pathways are shown. The phosphorylation of S6 kinase 1 (S6K1) and 4EBP1 by mTORC1 regulates protein translation. The phosphorylation of ULK1 by mTORC1 regulates autophagy. mTORC1 also regulates lipid synthesis by phosphorylating S6K1 or Lipin1 to control SREBP, lysosome biogenesis by phosphorylating TFEB, and growth factor signaling by phosphorylating Grb10. Right- Core components of mTORC2 are mTOR (kinase), Rictor (substrate recognizing component), and mLST8 (positive regulator). Other complex components include mSin1 (positive regulator), Protor1/2 (positive regulator), and DEPTOR (negative regulator). mTORC2 regulated processes include cytoskeletal remodeling by phosphorylating PKC; cell survival, growth, and proliferation by phosphorylating Akt; and ion transport by phosphorylating SGK.</p></caption><graphic xlink:href="genes-11-00989-g001"/></fig><fig id="genes-11-00989-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>The mTOR upstream signaling network. Upstream regulators of mTOR signaling. Positive regulators of mTORC1 are shown in turquoise and negative regulators are shown in orange. Growth factors activate PI3K though the binding of IRS proteins. PI3K then phosphorylates PIP<sub>2</sub> to PIP<sub>3</sub> which then activates PDK1/2. Akt, containing a specific PIP<sub>2</sub> and PIP<sub>3</sub> PH domain, localizes to the plasma membrane and then subsequently activates through PDK1 phosphorylation. Akt promotes mTORC1 activity through the phosphorylation of TSC, subsequently activating Rheb. mTORC2 also phosphorylates Akt. The Ras-Raf-Mek-Erk signaling cascade leads to the inhibition of TSC through Erk or Rsk. mTORC1 activity is also controlled by Wnt signaling, TNF&#x003b1; through IKK&#x003b2;, hypoxia through REDD1, and DNA damage through p53. Energy stress activates negative regulators such as LKB1 and AMPK to inhibit mTORC1. Rac-&#x003b1; Ser/Thr-protein kinase (Akt also known as PKB); AMP-activated protein kinase (AMPK); epidermal growth factor receptor (EGFR); extracellular signal-related kinase (Erk); GTPase activating protein (GAP); growth factor receptor-bound protein 2 (Grb2); glycogen synthase kinase 3 (GSK3); I&#x003ba;B kinase &#x003b2; (IKK&#x003b2;); insulin receptor substrate (IRS); liver kinase B1 (LKB1); mitogen-activated protein kinase (MAPK); MAPK/ERK kinase (MEK); protein 53 (p53); pleckstrin homology (PH); phosphoinositide-dependent kinase 1/2 (PDK1/2); phosphoinositide 3-kinase (PI3K); phosphatidylinositol 4,5-bisphosphate (PIP<sub>2</sub>); phosphatidylinositol 3,4,5-triphosphate (PIP<sub>3</sub>); phosphatase and tensin homolog (PTEN); rapidly accelerated fibrosarcoma (Raf); rat sarcoma (Ras); DNA damage response 1 (REDD1); Ras homolog enriched in brain (Rheb); p90 ribosomal S6 kinase (Rsk); son of sevenless homolog (SOS); tumor necrosis factor &#x003b1; (TNF&#x003b1;); tuberous sclerosis complex (TSC); wingless-type (Wnt).</p></caption><graphic xlink:href="genes-11-00989-g002"/></fig><fig id="genes-11-00989-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Amino acid sensing by mTORC1. (<bold>A</bold>) The Rag-dependent signaling pathway. Ala, Arg, His, Leu, Met, Ser, Thr, and Val can filter through upstream sensors in order to activate the Rag GTPases. Under sufficient amino acid conditions, the Rag GTPase heterodimer (GTP-RagA or RagB and GDP-RagC or RagD) interacts with mTORC1 at the lysosome, where Rheb resides. The Ragulator (consisting of p18, p14, MP1, C7orf59 and HBXIP) then anchors the Rag proteins to the lysosome and acts as a GEF for RagA and RagB. The FLCN-FNIP complex is a GAP for RagC and RagD. The v-ATPase, which is required for amino acid signaling to mTORC1, then binds to the Ragulator. KICSTOR (consisting of KPTN, ITFG2, C12orf66, and SZT2) anchors GATOR1 (consisting of DEPDC5, NPRL2 and NPRL3), the GAP for RagA and RagB, to the lysosome. GATOR2 (consisting of SEC13, SEH1L, WDR24, WDR59, and MIOS) inhibits GATOR1, through an unknown mechanism. Sestrin2 and CASTOR1 bind to GATOR2, preventing the inhibition of GATOR1 by GATOR2. Leu and Arg bind to sensors Sestrin2 and CASTOR1, respectively, which blocks Sestrin2-GATOR2 and CASTOR1-GATOR2 from interacting. (<bold>B</bold>) The Rag-independent signaling pathway. Only Gln and Asn activate mTORC1. The only known components that are required are the v-ATPase, Rheb, and the small GTPase Arf1. The cycling of Arf1 between a GTP- and a GDP-bound state promotes mTORC1 activation and lysosomal localization through an unknown mechanism. Adenosine diphosphate ribosylation factor 1 (Arf1); cellular Arg sensor for mTORC1 subunit 1 (CASTOR1); DEP domain containing 5 (DEPDC5); folliculin (FLCN); folliculin interacting protein (FNIP); GTPase-activating protein activity toward Rags (GATOR1); guanine nucleotide exchange factor (GEF); GTPase activating protein (GAP); hepatitis B virus X-interacting protein (HBXIP); integrin &#x003b1; FG-GAP repeat containing 2 (ITFG2); Kaptin (KPTN); meiosis regulator for oocyte development (MIOS); MEK partner 1 (MP1); mTOR complex 1 (mTORC1); NPR2 like, GATOR1 complex subunit (NPRL2); NPR3 like, GATOR1 complex subunit (NPRL3); vacuolar H+-ATPase (v-ATPase); Ras homolog enriched in brain (Rheb); SEH1-like nucleoporin (SEH1L); solute carrier family 38 member 9 (SLC38A9); seizure threshold 2 (SZT2); tuberous sclerosis complex (TSC); WD repeat-containing protein 24 (WDR24); WD repeat-containing protein 59 (WDR59).</p></caption><graphic xlink:href="genes-11-00989-g003"/></fig><fig id="genes-11-00989-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>GPCR inhibition of mTORC1. Activation of G&#x003b1;<sub>s</sub>-coupled GPCRs inhibit mTORC1 through the activation of PKA. The GPCR effector is a heterotrimeric G-protein made of three subunits (G&#x003b1;, G&#x003b2; and G&#x003b3;). G-proteins are inactive in the GDP-bound state. GPCRs function as a receptor-catalyzed GEF to activate G&#x003b1; subunit and separate them from the G&#x003b2;&#x003b3; dimer through conformational change. GTP hydrolyzing to GDP is the rate limiting step for G&#x003b1; activity. G&#x003b1; GDP-bound subunit then rejoins the &#x003b2;&#x003b3; dimer until the next activating cycle. The GTP-G&#x003b1;<sub>s</sub> subunit can interact and turn on AC. AC is able to convert ATP cAMP. G-protein signaling induces cAMP, activating second messenger kinases such as PKA. PKA is a holoenzyme made of two regulatory subunits (R) and two catalytic subunits (C). R subunits have cAMP binding motifs. Two molecules of cAMP bind each R subunit to release and activate the C subunit of PKA. A well-known phosphorylation target of PKA is CREB at Ser 133. PKA can phosphorylate Raptor on Ser 791 to inhibit mTORC1 activity. adenylate cyclase (AC); 3&#x02032;,5&#x02032;-cyclic adenosine monophosphate (cAMP); G-protein coupled receptors (GPCRs); protein kinase A (PKA).</p></caption><graphic xlink:href="genes-11-00989-g004"/></fig><table-wrap id="genes-11-00989-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">genes-11-00989-t001_Table 1</object-id><label>Table 1</label><caption><p>Amino acids known to activate mTORC1.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Amino Acid</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Rag GTPase</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sensor</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Alanine</td><td align="center" valign="middle" rowspan="1" colspan="1">Dependent</td><td align="center" valign="middle" rowspan="1" colspan="1">?</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B132-genes-11-00989" ref-type="bibr">132</xref>,<xref rid="B133-genes-11-00989" ref-type="bibr">133</xref>,<xref rid="B134-genes-11-00989" ref-type="bibr">134</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Arginine</td><td align="center" valign="middle" rowspan="1" colspan="1">Dependent</td><td align="center" valign="middle" rowspan="1" colspan="1">CASTOR1, SLC38A9</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B112-genes-11-00989" ref-type="bibr">112</xref>,<xref rid="B113-genes-11-00989" ref-type="bibr">113</xref>,<xref rid="B114-genes-11-00989" ref-type="bibr">114</xref>,<xref rid="B115-genes-11-00989" ref-type="bibr">115</xref>,<xref rid="B116-genes-11-00989" ref-type="bibr">116</xref>,<xref rid="B132-genes-11-00989" ref-type="bibr">132</xref>,<xref rid="B135-genes-11-00989" ref-type="bibr">135</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Asparagine</td><td align="center" valign="middle" rowspan="1" colspan="1">Independent</td><td align="center" valign="middle" rowspan="1" colspan="1">?</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B131-genes-11-00989" ref-type="bibr">131</xref>,<xref rid="B132-genes-11-00989" ref-type="bibr">132</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Glutamine</td><td align="center" valign="middle" rowspan="1" colspan="1">Independent</td><td align="center" valign="middle" rowspan="1" colspan="1">?</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B99-genes-11-00989" ref-type="bibr">99</xref>,<xref rid="B131-genes-11-00989" ref-type="bibr">131</xref>,<xref rid="B132-genes-11-00989" ref-type="bibr">132</xref>,<xref rid="B134-genes-11-00989" ref-type="bibr">134</xref>,<xref rid="B138-genes-11-00989" ref-type="bibr">138</xref>,<xref rid="B139-genes-11-00989" ref-type="bibr">139</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Histidine</td><td align="center" valign="middle" rowspan="1" colspan="1">Dependent</td><td align="center" valign="middle" rowspan="1" colspan="1">?</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B122-genes-11-00989" ref-type="bibr">122</xref>,<xref rid="B132-genes-11-00989" ref-type="bibr">132</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Leucine</td><td align="center" valign="middle" rowspan="1" colspan="1">Dependent</td><td align="center" valign="middle" rowspan="1" colspan="1">Sestrin2</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B90-genes-11-00989" ref-type="bibr">90</xref>,<xref rid="B99-genes-11-00989" ref-type="bibr">99</xref>,<xref rid="B118-genes-11-00989" ref-type="bibr">118</xref>,<xref rid="B119-genes-11-00989" ref-type="bibr">119</xref>,<xref rid="B132-genes-11-00989" ref-type="bibr">132</xref>,<xref rid="B133-genes-11-00989" ref-type="bibr">133</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Methionine</td><td align="center" valign="middle" rowspan="1" colspan="1">Dependent</td><td align="center" valign="middle" rowspan="1" colspan="1">SAMTOR</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B112-genes-11-00989" ref-type="bibr">112</xref>,<xref rid="B121-genes-11-00989" ref-type="bibr">121</xref>,<xref rid="B132-genes-11-00989" ref-type="bibr">132</xref>,<xref rid="B133-genes-11-00989" ref-type="bibr">133</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Serine</td><td align="center" valign="middle" rowspan="1" colspan="1">Dependent</td><td align="center" valign="middle" rowspan="1" colspan="1">?</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B132-genes-11-00989" ref-type="bibr">132</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Threonine</td><td align="center" valign="middle" rowspan="1" colspan="1">Dependent</td><td align="center" valign="middle" rowspan="1" colspan="1">?</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B132-genes-11-00989" ref-type="bibr">132</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Valine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dependent</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">?</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B132-genes-11-00989" ref-type="bibr">132</xref>,<xref rid="B133-genes-11-00989" ref-type="bibr">133</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>? = Unknown; Amino acids and their corresponding signaling pathway are described. Only some have known upstream sensors. Ala, Arg, Asn, Gln, His, Leu, Met, Ser, Thr, and Val can all shuttle and promote mTORC1 activation. Other amino acids (Met, Ile, Val) have been shown to disrupt the Sestrin2-GATOR2 interaction similar to Leu. Cellular Arg sensor for mTORC1 subunit 1 (CASTOR1); solute carrier family 38 member 9 (SLC38A9); S-adenosylmethionine [SAM] sensor upstream of mTORC1, or C7orf60 (SAMTOR).</p></fn></table-wrap-foot></table-wrap><table-wrap id="genes-11-00989-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">genes-11-00989-t002_Table 2</object-id><label>Table 2</label><caption><p>GPCRs known to regulate mTORC1 activity.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">GPCR</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Coupled G-protein</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">mTORC1 Activity</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Model/Cell Line </th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">GLP-1</td><td align="center" valign="middle" rowspan="1" colspan="1">G&#x003b1;(s)</td><td align="center" valign="middle" rowspan="1" colspan="1">Increase</td><td align="center" valign="middle" rowspan="1" colspan="1">BRIN-BD11</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B200-genes-11-00989" ref-type="bibr">200</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b1;2-AR</td><td align="center" valign="middle" rowspan="1" colspan="1">G&#x003b1;(i/o)</td><td align="center" valign="middle" rowspan="1" colspan="1">Increase</td><td align="center" valign="middle" rowspan="1" colspan="1">PC-12</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B185-genes-11-00989" ref-type="bibr">185</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">M<sub>4</sub>mAChR</td><td align="center" valign="middle" rowspan="1" colspan="1">G&#x003b1;(i/o)</td><td align="center" valign="middle" rowspan="1" colspan="1">Increase</td><td align="center" valign="middle" rowspan="1" colspan="1">PC-12</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B186-genes-11-00989" ref-type="bibr">186</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">V<sub>1</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">G&#x003b1;(s)</td><td align="center" valign="middle" rowspan="1" colspan="1">Increase</td><td align="center" valign="middle" rowspan="1" colspan="1">Rat mesangial cells</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B187-genes-11-00989" ref-type="bibr">187</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">TSH</td><td align="center" valign="middle" rowspan="1" colspan="1">G&#x003b1;(s)</td><td align="center" valign="middle" rowspan="1" colspan="1">Increase</td><td align="center" valign="middle" rowspan="1" colspan="1">Rat thyroid, CHO</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B188-genes-11-00989" ref-type="bibr">188</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">PGF2&#x003b1;</td><td align="center" valign="middle" rowspan="1" colspan="1">G&#x003b1;(s)</td><td align="center" valign="middle" rowspan="1" colspan="1">Increase</td><td align="center" valign="middle" rowspan="1" colspan="1">bLCs</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B189-genes-11-00989" ref-type="bibr">189</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">OX1/2R</td><td align="center" valign="middle" rowspan="1" colspan="1">G&#x003b1;(s)</td><td align="center" valign="middle" rowspan="1" colspan="1">Increase</td><td align="center" valign="middle" rowspan="1" colspan="1">HEK-293T, N41, MEF</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B190-genes-11-00989" ref-type="bibr">190</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">mGluR</td><td align="center" valign="middle" rowspan="1" colspan="1">G&#x003b1;(i/o)</td><td align="center" valign="middle" rowspan="1" colspan="1">Increase</td><td align="center" valign="middle" rowspan="1" colspan="1">Primary neuronal</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B193-genes-11-00989" ref-type="bibr">193</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">KOR</td><td align="center" valign="middle" rowspan="1" colspan="1">G&#x003b1;(i/o)</td><td align="center" valign="middle" rowspan="1" colspan="1">Increase</td><td align="center" valign="middle" rowspan="1" colspan="1">Adult male CD-1 mice, N2A-FmK6H cells</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B196-genes-11-00989" ref-type="bibr">196</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">T1R1/T1R3</td><td align="center" valign="middle" rowspan="1" colspan="1">G&#x003b1;(i/o)</td><td align="center" valign="middle" rowspan="1" colspan="1">Increase</td><td align="center" valign="middle" rowspan="1" colspan="1">MIN6</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B197-genes-11-00989" ref-type="bibr">197</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">GPR137B</td><td align="center" valign="middle" rowspan="1" colspan="1">?</td><td align="center" valign="middle" rowspan="1" colspan="1">Increase</td><td align="center" valign="middle" rowspan="1" colspan="1">Hs68, HeLa, HEK-293T/E, HAP1, MEF, zebrafish</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B199-genes-11-00989" ref-type="bibr">199</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;1/&#x003b2;2-AR, AVP, GCGR</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G&#x003b1;(s)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Decrease</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Various cell lines, Primary hepatocytes, mice</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B159-genes-11-00989" ref-type="bibr">159</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>? = Unknown; Listed are some of the known GPCRs that positively or negatively regulate mTORC1. Glucagon-like peptide 1 (GLP-1); &#x003b1;-2 adrenergic receptor (&#x003b1;2-AR); Muscarinic acetylcholine receptor M4 (M<sub>4</sub> mAChR); Vasopressin V1 receptor (V<sub>1</sub>); Thyroid stimulating hormone receptor (TSH); Prostaglandin F2-&#x003b1; receptor (PGF2&#x003b1;); Orexin 1/2 receptor (OX1/2R); Metabotropic glutamate receptor (mGluR); kappa opioid receptor (KOR); Taste receptor type 1 member 1/3 (T1R1/T1R3); GPCR 137B (GPR137B); &#x003b2;-1/&#x003b2;-2 adrenergic receptor (b1/b2-AR); Arg vasopressin receptor (AVP); Glucagon receptor (GCGR). Rat pancreatic hybrid cells of NEDH and RINm5F (BRIN-BD11); rat adrenal gland cells (PC-12); Chinese hamster ovary cells (CHO); bovine steroidogenic luteal cells (bLCs); Human embryonic kidney 293T cells (HEK-293T); mouse embryonic hypothalamus N41 cells (N41); Mouse embryonic fibroblast (MEF); mouse neuro2A neuroblastoma with FmK6H construct (N2A-FmK6H); mouse insulinoma 6 (MIN6) human primary fibroblasts (Hs68); Henrietta Lacks cervical adenocarcinoma cells (HeLa); haploid 1 cells (HAP1). G-proteins presumed, not all GPCRs were presented with coupled G&#x003b1; protein in respective reference.</p></fn></table-wrap-foot></table-wrap><table-wrap id="genes-11-00989-t003" orientation="portrait" position="float"><object-id pub-id-type="pii">genes-11-00989-t003_Table 3</object-id><label>Table 3</label><caption><p>Known phosphorylation sites of mTORC1.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">mTORC1 Subunit</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Site Phosphorylated</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Kinase</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">mTORC1 Activity</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">mTOR</td><td align="center" valign="middle" rowspan="1" colspan="1">Thr 2446, Ser 2448</td><td align="center" valign="middle" rowspan="1" colspan="1">Akt</td><td align="center" valign="middle" rowspan="1" colspan="1">Increase</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B206-genes-11-00989" ref-type="bibr">206</xref>,<xref rid="B207-genes-11-00989" ref-type="bibr">207</xref>,<xref rid="B208-genes-11-00989" ref-type="bibr">208</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Ser 2448</td><td align="center" valign="middle" rowspan="1" colspan="1">S6K1</td><td align="center" valign="middle" rowspan="1" colspan="1">Increase</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B209-genes-11-00989" ref-type="bibr">209</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Thr 2446</td><td align="center" valign="middle" rowspan="1" colspan="1">AMPK</td><td align="center" valign="middle" rowspan="1" colspan="1">Decrease</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B210-genes-11-00989" ref-type="bibr">210</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Ser 1261</td><td align="center" valign="middle" rowspan="1" colspan="1">?</td><td align="center" valign="middle" rowspan="1" colspan="1">Increase</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B211-genes-11-00989" ref-type="bibr">211</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Ser 2481</td><td align="center" valign="middle" rowspan="1" colspan="1">mTOR</td><td align="center" valign="middle" rowspan="1" colspan="1">Increase</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B212-genes-11-00989" ref-type="bibr">212</xref>,<xref rid="B213-genes-11-00989" ref-type="bibr">213</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Ser 1415</td><td align="center" valign="middle" rowspan="1" colspan="1">IKK&#x003b1;</td><td align="center" valign="middle" rowspan="1" colspan="1">Increase</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B214-genes-11-00989" ref-type="bibr">214</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ser 2159, Thr 2164</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TBK1, ?</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Increase</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B215-genes-11-00989" ref-type="bibr">215</xref>,<xref rid="B216-genes-11-00989" ref-type="bibr">216</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Raptor</td><td align="center" valign="middle" rowspan="1" colspan="1">Ser 863, Ser 859</td><td align="center" valign="middle" rowspan="1" colspan="1">mTOR</td><td align="center" valign="middle" rowspan="1" colspan="1">Increase</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B217-genes-11-00989" ref-type="bibr">217</xref>,<xref rid="B218-genes-11-00989" ref-type="bibr">218</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Ser 696, Thr 706, Ser 863</td><td align="center" valign="middle" rowspan="1" colspan="1">?</td><td align="center" valign="middle" rowspan="1" colspan="1">Increase</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B219-genes-11-00989" ref-type="bibr">219</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Ser 719, Ser 721, Ser 722</td><td align="center" valign="middle" rowspan="1" colspan="1">RSK1/2</td><td align="center" valign="middle" rowspan="1" colspan="1">Increase</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B220-genes-11-00989" ref-type="bibr">220</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Ser 8, Ser 696, Ser 863</td><td align="center" valign="middle" rowspan="1" colspan="1">ERK1/2</td><td align="center" valign="middle" rowspan="1" colspan="1">Increase</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B221-genes-11-00989" ref-type="bibr">221</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Ser 696, Thr 706, Ser 863</td><td align="center" valign="middle" rowspan="1" colspan="1">JNK</td><td align="center" valign="middle" rowspan="1" colspan="1">Increase</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B222-genes-11-00989" ref-type="bibr">222</xref>,<xref rid="B223-genes-11-00989" ref-type="bibr">223</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Ser 859</td><td align="center" valign="middle" rowspan="1" colspan="1">GSK3</td><td align="center" valign="middle" rowspan="1" colspan="1">Increase</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B224-genes-11-00989" ref-type="bibr">224</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Ser 722, Ser 792</td><td align="center" valign="middle" rowspan="1" colspan="1">AMPK</td><td align="center" valign="middle" rowspan="1" colspan="1">Decrease</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B86-genes-11-00989" ref-type="bibr">86</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Ser 863</td><td align="center" valign="middle" rowspan="1" colspan="1">NLK</td><td align="center" valign="middle" rowspan="1" colspan="1">Decrease</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B225-genes-11-00989" ref-type="bibr">225</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Ser 791</td><td align="center" valign="middle" rowspan="1" colspan="1">PKA</td><td align="center" valign="middle" rowspan="1" colspan="1">Decrease</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B159-genes-11-00989" ref-type="bibr">159</xref>,<xref rid="B160-genes-11-00989" ref-type="bibr">160</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Ser 606</td><td align="center" valign="middle" rowspan="1" colspan="1">LATS1/2</td><td align="center" valign="middle" rowspan="1" colspan="1">Decrease</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B226-genes-11-00989" ref-type="bibr">226</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ser 696, Thr 706</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">cdc2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Increase</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B227-genes-11-00989" ref-type="bibr">227</xref>,<xref rid="B228-genes-11-00989" ref-type="bibr">228</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>? = Unknown; mTORC1 components mTOR and Raptor and the corresponding phosphorylation sites, kinase and effect on mTORC1 activity. Rac-&#x003b1; Ser/Thr-protein kinase (Akt also known as PKB); p70 ribosomal S6 kinase 1 (S6K1); AMP-activated protein kinase (AMPK); mammalian or mechanistic target of rapamycin (mTOR); I&#x003ba;B kinase &#x003b1; (IKK&#x003b1;); TANK-binding kinase 1 (TBK1); p90 ribosomal S6 kinase 1/2 (Rsk1/2); extracellular signal-related kinase 1/2 (Erk1/2); c-Jun N-terminal kinase (JNK); glycogen synthase kinase 3 (GSK3); Nemo-like kinase (NLK); protein kinase A (PKA); Large tumor suppressor kinase 1/2 (LATS1/2); cell division control 2 (cdc2).</p></fn></table-wrap-foot></table-wrap><table-wrap id="genes-11-00989-t004" orientation="portrait" position="float"><object-id pub-id-type="pii">genes-11-00989-t004_Table 4</object-id><label>Table 4</label><caption><p>Small GTPases known to regulate mTORC1.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Small GTPase</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">mTORC1 Activity</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">RagA/B, RagC/D</td><td align="center" valign="middle" rowspan="1" colspan="1">Increase</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B38-genes-11-00989" ref-type="bibr">38</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Rheb</td><td align="center" valign="middle" rowspan="1" colspan="1">Increase</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B38-genes-11-00989" ref-type="bibr">38</xref>,<xref rid="B70-genes-11-00989" ref-type="bibr">70</xref>,<xref rid="B72-genes-11-00989" ref-type="bibr">72</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">RalA</td><td align="center" valign="middle" rowspan="1" colspan="1">Increase</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B241-genes-11-00989" ref-type="bibr">241</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Rab5</td><td align="center" valign="middle" rowspan="1" colspan="1">Decrease</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B242-genes-11-00989" ref-type="bibr">242</xref>,<xref rid="B243-genes-11-00989" ref-type="bibr">243</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Rab12</td><td align="center" valign="middle" rowspan="1" colspan="1">Decrease</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B244-genes-11-00989" ref-type="bibr">244</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Rab8a</td><td align="center" valign="middle" rowspan="1" colspan="1">Increase</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B245-genes-11-00989" ref-type="bibr">245</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Rab1a</td><td align="center" valign="middle" rowspan="1" colspan="1">Increase</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B233-genes-11-00989" ref-type="bibr">233</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Rac1</td><td align="center" valign="middle" rowspan="1" colspan="1">Increase</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B246-genes-11-00989" ref-type="bibr">246</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">RhoA</td><td align="center" valign="middle" rowspan="1" colspan="1">Decrease</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B247-genes-11-00989" ref-type="bibr">247</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rap1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Decrease</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B248-genes-11-00989" ref-type="bibr">248</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>Listed are known small GTPases and their effect on mTORC1 activity. Ras related GTP binding protein (Rag); Ras homolog enriched in brain (Rheb); Ras-related protein Ral (Ral); Ras-related protein Rab (Rab); Rho homolog gene family (Rac); Ras homolog gene family (Rho); Ras-related protein (Rap).</p></fn></table-wrap-foot></table-wrap></floats-group></article>